Protein_Name	Accession	Description	RefSeq	GI	TREMBL	Ensembl_Transcript	Ensembl_Protein	Ensembl_Gene	Entrez_GeneID	Entrez_GeneName	SwissProt	SwissProt_Name	Chromosome	Sequence_AA_Count	MW	Accession1	Accession2	Accession3	Accession4	Aarhus/Ghent-2DPAGE	ArrayExpress	Bgee	BioCyc	BRENDA	CAZy	CleanEx	Cornea-2DPAGE	CTD	DIP	DisProt	DMDM	DNASU	DOSAC-COBS-2DPAGE	DrugBank	eggNOG	EMBL	EvolutionaryTrace	Gene3D	GeneCards	GeneID	GeneTree	Genevestigator	GermOnline	GlycoSuiteDB	GO	HGNC	H-InvDB	HOGENOM	HOVERGEN	HPA	HSSP	InParanoid	IntAct	InterPro	IPI	KEGG	KO	MEROPS	MIM	MINT	NextBio	neXtProt	OGP	OMA	Orphanet	OrthoDB	PANTHER	Pathway_Interaction_DB	PDB	PDBsum	PeptideAtlas	Pfam	PharmGKB	PhosphoSite	PhylomeDB	PIR	PIRSF	PMAP-CutDB	PRIDE	PRINTS	ProDom	PROSITE	ProteinModelPortal	Reactome	REPRODUCTION-2DPAGE	Siena-2DPAGE	SMART	SMR	STRING	SUPFAM	SWISS-2DPAGE	TCDB	TIGRFAMs	UCD-2DPAGE	UCSC	UniGene
1433B_HUMAN	P31946; A8K9K2; E1P616;	RecName: Full=14-3-3 protein beta/alpha; AltName: Full=Protein 1054; AltName: Full=Protein kinase C inhibitor protein 1; Short=KCIP-1; Contains: RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;	NP_003395.1; NP_647539.1	NM_003404.3; NM_139323.2		ENST00000353703; ENST00000372839	ENSP00000300161; ENSP00000361930	ENSG00000166913; ENSG00000166913						246	28082	P31946	A8K9K2	E1P616			P31946	P31946				HS_YWHAB	P31946	7529	DIP-743N		1345590	7529			COG5040	X57346; CAA40621.1; -; mRNA; AK292717; BAF85406.1; -; mRNA; AL008725; CAA15497.1; -; Genomic_DNA; CH471077; EAW75893.1; -; Genomic_DNA; CH471077; EAW75894.1; -; Genomic_DNA; CH471077; EAW75896.1; -; Genomic_DNA; BC001359; AAH01359.1; -; mRNA	P31946	G3DSA:1.20.190.20; 14-3-3; 1	GC20P043515	7529	ENSGT00650000092989	P31946	ENSG00000166913; Homo sapiens		GO:0005813; C:centrosome; IDA:HPA; GO:0005829; C:cytosol; TAS:Reactome; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL; GO:0050815; F:phosphoserine binding; IPI:BHF-UCL; GO:0019904; F:protein domain specific binding; IPI:UniProtKB; GO:0000186; P:activation of MAPKK activity; TAS:Reactome; GO:0008633; P:activation of pro-apoptotic gene products; TAS:Reactome; GO:0007411; P:axon guidance; TAS:Reactome; GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome; GO:0010467; P:gene expression; TAS:Reactome; GO:0008629; P:induction of apoptosis by intracellular signals; TAS:Reactome; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome; GO:0000165; P:MAPK cascade; TAS:Reactome; GO:0016071; P:mRNA metabolic process; TAS:Reactome; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome; GO:0007265; P:Ras protein signal transduction; TAS:Reactome	HGNC:12849; YWHAB	HIX0015846	HBG611720	HBG050423	CAB003759; HPA007925; HPA011212		P31946	P31946; 36	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00216318; IPI00759832	hsa:7529	K06630		601289; gene	MINT-99570	29453	NX_P31946	P31946	MGREYRE		EOG4N30PR	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; insulin_glucose_pathway; Insulin-mediated glucose transport; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; hdac_classii_pathway; Signaling events mediated by HDAC Class II; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	2BQ0; X-ray; 2.50 A; A/B=1-239; 2C23; X-ray; 2.65 A; A=1-239; 4DNK; X-ray; 2.20 A; A/B=1-246	2BQ0; 2C23; 4DNK		PF00244; 14-3-3; 1	PA37438	P31946	P31946	S34755; S34755	PIRSF000868; 14-3-3; 1		P31946	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	P31946	REACT_111045; Developmental Biology; REACT_111102; Signal Transduction; REACT_116125; Disease; REACT_21257; Metabolism of RNA; REACT_578; Apoptosis; REACT_6900; Immune System; REACT_71; Gene Expression	IPI00216318		SM00101; 14_3_3; 1	P31946; 1-234	P31946	SSF48445; 14-3-3; 1					uc002xmt.3; human	Hs.643544
1433E_HUMAN	Q7M4R4;	RecName: Full=14-3-3 protein epsilon; Short=14-3-3E;	NP_006752.1	NM_006761.4		ENST00000264335	ENSP00000264335	ENSG00000108953						255	29174	Q7M4R4		D3DTH5	P29360		P62258	P62258				HS_YWHAE		7531	DIP-36676N		51702210	7531			COG5040	U20972; AAC50175.1; -; mRNA; U54778; AAC50710.1; -; mRNA; U43399; AAC50625.1; -; mRNA; U43430; AAD00026.1; -; mRNA; U28936; AAA75301.1; -; mRNA; AB017103; BAA32538.1; -; Genomic_DNA; AY883089; AAX68683.1; -; mRNA; AK128785; BAG54733.1; -; mRNA; AK295260; BAG58249.1; -; mRNA; AK316185; BAH14556.1; -; mRNA; BT007161; AAP35825.1; -; mRNA; CH471108; EAW90628.1; -; Genomic_DNA; CH471108; EAW90629.1; -; Genomic_DNA; BC000179; AAH00179.1; -; mRNA; BC001440; AAH01440.1; -; mRNA	P62258	G3DSA:1.20.190.20; 14-3-3; 1	GC17M001247	7531	ENSGT00650000093317	P62258	ENSG00000108953; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL; GO:0050815; F:phosphoserine binding; IPI:BHF-UCL; GO:0006915; P:apoptotic process; TAS:Reactome; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome; GO:0008624; P:induction of apoptosis by extracellular signals; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0035556; P:intracellular signal transduction; TAS:ProtInc; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome	HGNC:12851; YWHAE	HIX0013397; HIX0013751; HIX0030006		HBG050423	CAB016200; CAB021109; CAB047350; HPA008445		P62258	P62258; 82	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00000816; IPI00974544	hsa:7531	K06630		605066; gene	MINT-4998623	29461	NX_P62258	P42655	KESALIM	217385; 17p13.3 microduplication syndrome	EOG4HHP34	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; igf1_pathway; IGF1 pathway; insulin_glucose_pathway; Insulin-mediated glucose transport; lis1pathway; Lissencephaly gene (LIS1) in neuronal migration and development; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; p75ntrpathway; p75(NTR)-mediated signaling; telomerasepathway; Regulation of Telomerase; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; hdac_classii_pathway; Signaling events mediated by HDAC Class II; tgfbrpathway; TGF-beta receptor signaling; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	2BR9; X-ray; 1.75 A; A=1-233; 3UAL; X-ray; 1.80 A; A=1-232; 3UBW; X-ray; 1.90 A; A=1-234	2BR9; 3UAL; 3UBW	P62258	PF00244; 14-3-3; 1	PA37440	P62258	P62258	A61235; A61235; I38947; I38947	PIRSF000868; 14-3-3; 1	P62258	P62258	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	P62258	REACT_111102; Signal Transduction; REACT_115566; Cell Cycle			SM00101; 14_3_3; 1		P62258	SSF48445; 14-3-3; 1				P62258	uc002fsj.3; human	Hs.513851
1433F_HUMAN	Q04917;	RecName: Full=14-3-3 protein eta; AltName: Full=Protein AS1;	NP_003396.1	NM_003405.3		ENST00000248975	ENSP00000248975	ENSG00000128245						246	28219	Q04917					Q04917	Q04917				HS_YWHAH		7533	DIP-27566N		1345593	7533			COG5040	L20422; AAA35483.1; -; mRNA; X80536; CAA56676.1; -; Genomic_DNA; X78138; CAA55017.1; -; mRNA; X57345; CAA40620.1; -; mRNA; D78577; BAA11418.1; -; Genomic_DNA; S80794; AAB36036.1; -; mRNA; CR456612; CAG30498.1; -; mRNA; Z82248; CAB05112.1; -; Genomic_DNA; BC003047; AAH03047.1; -; mRNA	Q04917	G3DSA:1.20.190.20; 14-3-3; 1	GC22P032340	7533	ENSGT00650000092989	Q04917	ENSG00000128245; Homo sapiens		GO:0005737; C:cytoplasm; ISS:UniProtKB; GO:0019899; F:enzyme binding; IPI:BHF-UCL; GO:0035259; F:glucocorticoid receptor binding; IPI:UniProtKB; GO:0005159; F:insulin-like growth factor receptor binding; ISS:UniProtKB; GO:0019904; F:protein domain specific binding; ISS:UniProtKB; GO:0006713; P:glucocorticoid catabolic process; IDA:UniProtKB; GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB; GO:0006886; P:intracellular protein transport; ISS:UniProtKB; GO:0050774; P:negative regulation of dendrite morphogenesis; ISS:UniProtKB; GO:0045893; P:positive regulation of transcription, DNA-dependent; IDA:UniProtKB; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB	HGNC:12853; YWHAH	HIX0016401	HBG611720	HBG050423	CAB025918		Q04917	Q04917; 106	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00216319	hsa:7533	K06630		113508; gene	MINT-124456	29471	NX_Q04917		KYLIKNC		EOG48PMM0	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; insulin_glucose_pathway; Insulin-mediated glucose transport; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	2C63; X-ray; 2.15 A; A/B/C/D=1-246; 2C74; X-ray; 2.70 A; A/B=1-246	2C63; 2C74	Q04917	PF00244; 14-3-3; 1	PA37442	Q04917	Q04917	S34756; S34756; S38509; S38509; S38532; S38532	PIRSF000868; 14-3-3; 1		Q04917	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	Q04917				SM00101; 14_3_3; 1	Q04917; 3-235	Q04917	SSF48445; 14-3-3; 1					uc003alz.3; human	Hs.226755
1433G_HUMAN	P61981; O70457; P35214; Q6FH52; Q9UDP2; Q9UN99;	RecName: Full=14-3-3 protein gamma; AltName: Full=Protein kinase C inhibitor protein 1; Short=KCIP-1; Contains: RecName: Full=14-3-3 protein gamma, N-terminally processed;	NP_036611.2	NM_012479.3		ENST00000307630	ENSP00000306330	ENSG00000170027						247	28303	P61981	O70457	P35214	Q6FH52		P61981	P61981				HS_YWHAG	P61981	7532			48428721	7532			COG5040	AF142498; AAD48408.1; -; mRNA; AB024334; BAA85184.1; -; mRNA; CR541904; CAG46702.1; -; mRNA; CR541925; CAG46723.1; -; mRNA; AC006388; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC020963; AAH20963.1; -; mRNA	P61981	G3DSA:1.20.190.20; 14-3-3; 1	GC07M075956	7532	ENSGT00650000092989	P61981	ENSG00000170027; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB; GO:0005080; F:protein kinase C binding; IPI:UniProtKB; GO:0008426; F:protein kinase C inhibitor activity; NAS:UniProtKB; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome; GO:0045664; P:regulation of neuron differentiation; IMP:UniProtKB; GO:0009966; P:regulation of signal transduction; NAS:UniProtKB; GO:0048167; P:regulation of synaptic plasticity; IMP:UniProtKB	HGNC:12852; YWHAG	HIX0006789	HBG611720	HBG050423	CAB013274; CAB018389; HPA026918		P61981	P61981; 51	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00220642	hsa:7532	K06630		605356; gene	MINT-248956	29467	NX_P61981		CSETQHE		EOG48PMM0	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; insulin_glucose_pathway; Insulin-mediated glucose transport; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	2B05; X-ray; 2.55 A; A/B/C/D/E/F=2-246	2B05	P61981	PF00244; 14-3-3; 1	PA37441	P61981	P61981		PIRSF000868; 14-3-3; 1		P61981	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	P61981	REACT_115566; Cell Cycle	IPI00220642		SM00101; 14_3_3; 1	P61981; 2-234	P61981	SSF48445; 14-3-3; 1					uc011kgj.1; human	Hs.520974
1433S_HUMAN	P31947; Q6FH30; Q6FH51; Q96DH0;	RecName: Full=14-3-3 protein sigma; AltName: Full=Epithelial cell marker protein 1; AltName: Full=Stratifin;	NP_006133.1	NM_006142.3		ENST00000339276	ENSP00000340989	ENSG00000175793						248	27774	P31947	Q6FH30	Q6FH51	Q96DH0	9109; IEF	P31947	P31947				HS_SFN	P31947	2810	DIP-29861N		398953	2810			COG5040	M93010; AAA59546.1; -; mRNA; X57348; CAA40623.1; -; mRNA; AF029081; AAC52029.1; -; Genomic_DNA; AF029082; AAC52030.1; -; mRNA; CR541905; CAG46703.1; -; mRNA; CR541926; CAG46724.1; -; mRNA; AL034380; CAB92118.1; -; Genomic_DNA; BC000329; AAH00329.1; -; mRNA; BC000995; AAH00995.1; -; mRNA; BC001550; AAH01550.1; -; mRNA; BC002995; AAH02995.1; -; mRNA; BC023552; AAH23552.1; -; mRNA	P31947	G3DSA:1.20.190.20; 14-3-3; 1	GC01P027189	2810	ENSGT00650000093317	P31947	ENSG00000175793; Homo sapiens		GO:0005737; C:cytoplasm; IDA:HPA; GO:0005615; C:extracellular space; TAS:ProtInc; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell; GO:0019904; F:protein domain specific binding; IEA:InterPro; GO:0008426; F:protein kinase C inhibitor activity; TAS:ProtInc; GO:0008630; P:DNA damage response, signal transduction resulting in induction of apoptosis; IDA:HGNC; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC; GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC	HGNC:10773; SFN	HIX0199941	HBG611720	HBG050423	CAB006268; CAB040552; HPA011105		P31947	P31947; 19	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00013890; IPI00411765	hsa:2810	K06644		601290; gene	MINT-108060	11071	NX_P31947	P31947	AFMKSAV		EOG4XH00X	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; insulin_glucose_pathway; Insulin-mediated glucose transport; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	1YWT; X-ray; 2.40 A; A/B=1-248; 1YZ5; X-ray; 2.80 A; A/B=1-248; 3IQJ; X-ray; 1.15 A; A=1-231; 3IQU; X-ray; 1.05 A; A=1-231; 3IQV; X-ray; 1.20 A; A=1-231; 3LW1; X-ray; 1.28 A; A=1-248; 3MHR; X-ray; 1.15 A; A=1-231; 3O8I; X-ray; 2.00 A; A=1-231; 3P1N; X-ray; 1.40 A; A=1-231; 3P1O; X-ray; 1.90 A; A=1-231; 3P1P; X-ray; 1.95 A; A=1-231; 3P1Q; X-ray; 1.70 A; A=1-231; 3P1R; X-ray; 1.70 A; A=1-231; 3P1S; X-ray; 1.65 A; A=1-231	1YWT; 1YZ5; 3IQJ; 3IQU; 3IQV; 3LW1; 3MHR; 3O8I; 3P1N; 3P1O; 3P1P; 3P1Q; 3P1R; 3P1S	P31947	PF00244; 14-3-3; 1	PA177	P31947	P31947	S34753; S34753; S38956; S38956	PIRSF000868; 14-3-3; 1		P31947	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	P31947				SM00101; 14_3_3; 1	P31947; 2-232	P31947	SSF48445; 14-3-3; 1	P31947				uc001bnc.1; human	Hs.523718
1433T_HUMAN	P27348; D6W4Z5; Q567U5; Q5TZU8; Q9UP48;	RecName: Full=14-3-3 protein theta; AltName: Full=14-3-3 protein T-cell; AltName: Full=14-3-3 protein tau; AltName: Full=Protein HS1;	NP_006817.1	NM_006826.2		ENST00000238081; ENST00000381844	ENSP00000238081; ENSP00000371267	ENSG00000134308; ENSG00000134308						245	27764	P27348	D6W4Z5	Q567U5	Q5TZU8		P27348	P27348				HS_YWHAQ	P27348	10971	DIP-27584N		112690	10971			COG5040	X56468; CAA39840.1; -; mRNA; X57347; CAA40622.1; -; mRNA; BT020014; AAV38817.1; -; mRNA; CH471053; EAX00977.1; -; Genomic_DNA; CH471053; EAX00979.1; -; Genomic_DNA; BC050601; AAH50601.1; -; mRNA; BC056867; AAH56867.1; -; mRNA; BC093019; AAH93019.1; -; mRNA; AF070556; AAC28640.1; -; mRNA	P27348	G3DSA:1.20.190.20; 14-3-3; 1	GC02M009724	10971	ENSGT00650000092989	P27348	ENSG00000134308; Homo sapiens		GO:0005813; C:centrosome; IDA:HPA; GO:0005634; C:nucleus; IDA:HPA; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB; GO:0045892; P:negative regulation of transcription, DNA-dependent; IDA:BHF-UCL	HGNC:12854; YWHAQ	HIX0029798; HIX0077146	HBG611720	HBG050423	CAB010286; HPA007925		P27348	P27348; 28	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00018146	hsa:10971	K06630		609009; gene	MINT-121282	41686	NX_P27348	P27348	SGDDRKQ		EOG480HXJ	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; insulin_glucose_pathway; Insulin-mediated glucose transport; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	2BTP; X-ray; 2.80 A; A/B=1-234	2BTP	P27348	PF00244; 14-3-3; 1	PA37443	P27348	P27348	S15076; S15076	PIRSF000868; 14-3-3; 1	P27348	P27348	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	P27348		IPI00018146		SM00101; 14_3_3; 1	P27348; 1-230	P27348	SSF48445; 14-3-3; 1					uc002qzx.3; human	Hs.74405
1433Z_HUMAN	Q6NUR9; Q6P3U9; Q86V33;	RecName: Full=14-3-3 protein zeta/delta; AltName: Full=Protein kinase C inhibitor protein 1; Short=KCIP-1;	NP_001129171.1; NP_001129172.1; NP_001129173.1; NP_001129174.1; NP_003397.1; NP_663723.1	NM_001135699.1; NM_001135700.1; NM_001135701.1; NM_001135702.1; NM_003406.3; NM_145690.2		ENST00000353245; ENST00000395951; ENST00000395953; ENST00000395956; ENST00000395957; ENST00000395958; ENST00000419477; ENST00000457309	ENSP00000309503; ENSP00000379281; ENSP00000379283; ENSP00000379286; ENSP00000379287; ENSP00000379288; ENSP00000395114; ENSP00000398599	ENSG00000164924; ENSG00000164924; ENSG00000164924; ENSG00000164924; ENSG00000164924; ENSG00000164924; ENSG00000164924; ENSG00000164924						245	27745	Q6NUR9	Q6P3U9	Q86V33			P63104	P63104					P29312	7534	DIP-563N		52000887	7534	P63104	DB01381; Ginkgo biloba	COG5040	M86400; AAA36446.1; -; mRNA; U28964; AAC52052.1; -; mRNA; AK289945; BAF82634.1; -; mRNA; CH471060; EAW91823.1; -; Genomic_DNA; BC003623; AAH03623.3; -; mRNA; BC051814; AAH51814.1; ALT_INIT; mRNA; BC063824; AAH63824.2; -; mRNA; BC068456; AAH68456.2; -; mRNA; BC072426; AAH72426.2; -; mRNA; BC073141; AAH73141.1; ALT_INIT; mRNA; BC083508; AAH83508.2; -; mRNA; BC099904; AAH99904.1; -; mRNA; BC101483; AAI01484.1; -; mRNA; BC108281; AAI08282.1; -; mRNA; BC111951; AAI11952.1; -; mRNA	P63104	G3DSA:1.20.190.20; 14-3-3; 1	GC08M101930	7534	ENSGT00650000092989	P63104	ENSG00000164924; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell; GO:0005654; C:nucleoplasm; TAS:Reactome; GO:0008134; F:transcription factor binding; IPI:UniProtKB; GO:0006916; P:anti-apoptosis; TAS:ProtInc; GO:0010467; P:gene expression; TAS:Reactome; GO:0016071; P:mRNA metabolic process; TAS:Reactome; GO:0030168; P:platelet activation; TAS:Reactome; GO:0007165; P:signal transduction; TAS:ProtInc	HGNC:12855; YWHAZ	HIX0034328		HBG050423	CAB005065		P63104	P63104; 75	IPR000308; 14-3-3; IPR023409; 14-3-3_CS; IPR023410; 14-3-3_domain	IPI00021263	hsa:7534	K06630		601288; gene	MINT-89071	29475	NX_P63104	P63104	VMDKNEL		EOG4N30PR	PTHR18860; 14-3-3; 1	a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt; foxopathway; FoxO family signaling; igf1_pathway; IGF1 pathway; insulin_glucose_pathway; Insulin-mediated glucose transport; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma	1IB1; X-ray; 2.70 A; A/B/C/D=1-245; 1QJA; X-ray; 2.00 A; A/B=1-245; 1QJB; X-ray; 2.00 A; A/B=1-245; 2C1J; X-ray; 2.60 A; A/B=1-245; 2C1N; X-ray; 2.00 A; A/B=1-245; 2O02; X-ray; 1.50 A; A/B=1-230; 2WH0; X-ray; 2.25 A; A/B/C/D=1-245; 3CU8; X-ray; 2.40 A; A/B=1-245; 3NKX; X-ray; 2.40 A; A/B=1-245; 3RDH; X-ray; 2.39 A; A/B/C/D=1-245	1IB1; 1QJA; 1QJB; 2C1J; 2C1N; 2O02; 2WH0; 3CU8; 3NKX; 3RDH		PF00244; 14-3-3; 1	PA37444	P63104	P63104	A38246; PSHUAM	PIRSF000868; 14-3-3; 1		P63104	PR00305; 1433ZETA		PS00796; 1433_1; 1; PS00797; 1433_2; 1	P63104	REACT_21257; Metabolism of RNA; REACT_604; Hemostasis; REACT_6900; Immune System; REACT_71; Gene Expression			SM00101; 14_3_3; 1		P63104	SSF48445; 14-3-3; 1				P63104	uc003yjv.2; human	Hs.492407
1A01_HUMAN	P30443; O77964; O78171; Q9MYA3; Q9TP25; Q9TQP5;	RecName: Full=HLA class I histocompatibility antigen, A-1 alpha chain; AltName: Full=MHC class I antigen A*1; Flags: Precursor;	NP_001229687.1	NM_001242758.1		ENST00000431795; ENST00000431930; ENST00000443552; ENST00000448357	ENSP00000396220; ENSP00000406366; ENSP00000404678; ENSP00000402461	ENSG00000229215; ENSG00000229215; ENSG00000224320; ENSG00000224320						365	40846	P30443	O77964	O78171	Q9MYA3							HS_HLA-A		3105			231347	3105			NOG42056	M24043; AAA59652.1; -; Genomic_DNA; X55710; CAA39243.1; -; Genomic_DNA; Z93949; CAB07989.1; -; Genomic_DNA; AJ278305; CAB93537.1; -; Genomic_DNA; BC003069; AAH03069.1; -; mRNA; U07161; AAA80569.1; -; mRNA; Y12469; CAA73072.1; -; Genomic_DNA; Y12470; CAA73073.1; -; Genomic_DNA; AF214112; AAF19525.1; -; Genomic_DNA; AF214111; AAF19525.1; JOINED; Genomic_DNA; AF143232; AAD33894.1; -; Genomic_DNA; AF143231; AAD33894.1; JOINED; Genomic_DNA; AF219633; AAF73862.1; -; Genomic_DNA; AF219632; AAF73862.1; JOINED; Genomic_DNA	P30443	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921	3105		P30443			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4931; HLA-A	HIX0165925; HIX0166103		HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00026569	hsa:3105	K06751		142800; gene	MINT-4655826	12319	NX_P30443				EOG4F4SBG			1W72; X-ray; 2.15 A; A/D=25-298; 3BO8; X-ray; 1.80 A; A=25-298	1W72; 3BO8		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I38518; I38518; I61856; I61856			P30443	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30443	REACT_6900; Immune System			SM00407; IGc1; 1	P30443; 25-298	P30443	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011ejp.2; human	Hs.181244
1A02_HUMAN	Q9TQH5; Q9TQI3;	RecName: Full=HLA class I histocompatibility antigen, A-2 alpha chain; AltName: Full=MHC class I antigen A*2; Flags: Precursor;				ENST00000412679; ENST00000457879	ENSP00000399020; ENSP00000403575	ENSG00000235657; ENSG00000235657						365	40922	Q9TQH5	Q9TQI3		Q95352							HS_HLA-A			DIP-6085N		122138				NOG42056	K02883; AAA98727.1; -; Genomic_DNA; M84379; AAA59606.1; -; mRNA; X02457; CAA26297.1; -; mRNA; M11887; AAA52656.1; -; mRNA; M19670; AAA03683.2; -; Genomic_DNA; M17690; AAB02120.1; -; Genomic_DNA; U03863; AAA03604.1; -; mRNA; M86404; -; NOT_ANNOTATED_CDS; mRNA; X57954; CAA41022.1; ALT_SEQ; mRNA; U02935; AAA76608.2; -; Genomic_DNA; AJ555412; CAD87771.1; -; Genomic_DNA; U03862; AAA03603.1; -; mRNA; M24042; AAA59653.1; -; mRNA; Z23071; CAA80612.1; -; mRNA; M84377; AAA59603.1; -; mRNA; X60764; -; NOT_ANNOTATED_CDS; mRNA; M84378; AAA59604.1; -; mRNA; Z27120; CAA81644.1; -; mRNA; Z46633; CAA86602.1; -; mRNA; U18930; AAA87076.1; -; mRNA; D83515; BAA11935.1; -; mRNA; X96724; CAA65501.1; -; mRNA; U56825; AAB17465.1; -; mRNA; AF113924; AAD23437.1; -; Genomic_DNA; AF113923; AAD23437.1; JOINED; Genomic_DNA; AF129431; AAD30272.1; -; Genomic_DNA; AF129429; AAD30272.1; JOINED; Genomic_DNA; AF129430; AAD30272.1; JOINED; Genomic_DNA; AF157311; AAD45690.1; -; Genomic_DNA; AF157310; AAD45690.1; JOINED; Genomic_DNA; AF157309; AAD45689.1; -; Genomic_DNA; AF157308; AAD45689.1; JOINED; Genomic_DNA; AF157564; AAD45324.1; -; Genomic_DNA; AF157563; AAD45324.1; JOINED; Genomic_DNA	P01892	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pk29899			P01892	ENSG00000204632; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0005102; F:receptor binding; IPI:BHF-UCL; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome; GO:0016032; P:viral reproduction; TAS:Reactome	HGNC:4931; HLA-A	HIX0166393; HIX0166937		HBG016709				P01892; 5	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00876963				142800; gene	MINT-5000859		NX_P01892				EOG4F4SBG			1AKJ; X-ray; 2.65 A; A=25-300; 1AO7; X-ray; 2.60 A; A=25-299; 1AQD; X-ray; 2.45 A; C/F/I/L=127-141; 1B0G; X-ray; 2.50 A; A/D=25-299; 1B0R; X-ray; 2.90 A; A=25-299; 1BD2; X-ray; 2.50 A; A=25-299; 1DUY; X-ray; 2.15 A; A/D=25-299; 1DUZ; X-ray; 1.80 A; A/D=25-299; 1EEY; X-ray; 2.25 A; A/D=25-299; 1EEZ; X-ray; 2.30 A; A/D=25-299; 1HHG; X-ray; 2.60 A; A/D=25-299; 1HHH; X-ray; 3.00 A; A=25-299; 1HHI; X-ray; 2.50 A; A/D=25-299; 1HHJ; X-ray; 2.50 A; A/D=25-299; 1HHK; X-ray; 2.50 A; A/D=25-299; 1HLA; X-ray; 3.50 A; A=25-294; 1I1F; X-ray; 2.80 A; A/D=25-299; 1I1Y; X-ray; 2.20 A; A/D=25-299; 1I4F; X-ray; 1.40 A; A=25-299; 1I7R; X-ray; 2.20 A; A/D=25-299; 1I7T; X-ray; 2.80 A; A/D=25-299; 1I7U; X-ray; 1.80 A; A/D=25-299; 1IM3; X-ray; 2.20 A; A/E/I/M=25-299; 1JF1; X-ray; 1.85 A; A=25-299; 1JHT; X-ray; 2.15 A; A=25-299; 1LP9; X-ray; 2.00 A; A/H=25-299; 1OGA; X-ray; 1.40 A; A=25-300; 1P7Q; X-ray; 3.40 A; A=25-300; 1QEW; X-ray; 2.20 A; A=25-299; 1QR1; X-ray; 2.40 A; A/D=25-299; 1QRN; X-ray; 2.80 A; A=25-298; 1QSE; X-ray; 2.80 A; A=25-298; 1QSF; X-ray; 2.80 A; A=25-298; 1S8D; X-ray; 2.20 A; A=25-299; 1S9W; X-ray; 2.20 A; A=25-298; 1S9X; X-ray; 2.50 A; A=25-298; 1S9Y; X-ray; 2.30 A; A=25-298; 1T1W; X-ray; 2.20 A; A=25-299; 1T1X; X-ray; 2.20 A; A=25-299; 1T1Y; X-ray; 2.00 A; A=25-299; 1T1Z; X-ray; 1.90 A; A=25-299; 1T20; X-ray; 2.20 A; A=25-299; 1T21; X-ray; 2.19 A; A=25-299; 1T22; X-ray; 2.20 A; A=25-299; 1TVB; X-ray; 1.80 A; A/D=25-299; 1TVH; X-ray; 1.80 A; A/D=25-299; 1UR7; Model; -; A=25-299; 2AV1; X-ray; 1.95 A; A/D=25-299; 2AV7; X-ray; 2.05 A; A/D=25-299; 2BNQ; X-ray; 1.70 A; A=25-300; 2BNR; X-ray; 1.90 A; A=25-300; 2C7U; X-ray; 2.38 A; A/D=25-300; 2CLR; X-ray; 2.00 A; A/D=25-299; 2F53; X-ray; 2.10 A; A=25-299; 2F54; X-ray; 2.70 A; A/F=25-298; 2GIT; X-ray; 1.70 A; A/D=25-299; 2GJ6; X-ray; 2.56 A; A=25-299; 2GT9; X-ray; 1.75 A; A/D=25-299; 2GTW; X-ray; 1.55 A; A/D=25-299; 2GTZ; X-ray; 1.70 A; A/D=25-299; 2GUO; X-ray; 1.90 A; A/D=25-299; 2J8U; X-ray; 2.88 A; A/H=25-299; 2JCC; X-ray; 2.50 A; A/H=25-299; 2P5E; X-ray; 1.89 A; A=25-300; 2P5W; X-ray; 2.20 A; A=25-300; 2PYE; X-ray; 2.30 A; A=25-300; 2UWE; X-ray; 2.40 A; A/H=25-299; 2V2W; X-ray; 1.60 A; A/D=25-300; 2V2X; X-ray; 1.60 A; A/D=25-300; 2VLJ; X-ray; 2.40 A; A=25-300; 2VLK; X-ray; 2.50 A; A=25-300; 2VLL; X-ray; 1.60 A; A/D=25-300; 2VLR; X-ray; 2.30 A; A/F=25-300; 2X4N; X-ray; 2.34 A; A/D=25-299; 2X4O; X-ray; 2.30 A; A/D=25-299; 2X4P; X-ray; 2.30 A; A/D=25-299; 2X4Q; X-ray; 1.90 A; A/D=25-299; 2X4R; X-ray; 2.30 A; A/D=25-299; 2X4S; X-ray; 2.55 A; A/D=25-299; 2X4T; X-ray; 2.30 A; A/D=25-299; 2X4U; X-ray; 2.10 A; A/D=25-299; 2X70; X-ray; 2.00 A; A/D=25-299; 3BGM; X-ray; 1.60 A; A=25-298; 3BH8; X-ray; 1.65 A; A=25-298; 3BH9; X-ray; 1.70 A; A=25-299; 3BHB; X-ray; 2.20 A; A=25-298; 3D25; X-ray; 1.30 A; A=25-298; 3D39; X-ray; 2.81 A; A=25-299; 3D3V; X-ray; 2.80 A; A=25-299; 3FQN; X-ray; 1.65 A; A=25-299; 3FQR; X-ray; 1.70 A; A=25-299; 3FQT; X-ray; 1.80 A; A=25-299; 3FQU; X-ray; 1.80 A; A=25-299; 3FQW; X-ray; 1.93 A; A=25-299; 3FQX; X-ray; 1.70 A; A=25-299; 3FT2; X-ray; 1.80 A; A=25-299; 3FT3; X-ray; 1.95 A; A=25-299; 3FT4; X-ray; 1.90 A; A=25-299; 3GIV; X-ray; 2.00 A; A/D=25-299; 3GJF; X-ray; 1.90 A; A/D=25-300; 3GSN; X-ray; 2.80 A; H=25-298; 3GSO; X-ray; 1.60 A; A=25-298; 3GSQ; X-ray; 2.12 A; A=25-298; 3GSR; X-ray; 1.95 A; A=25-298; 3GSU; X-ray; 1.80 A; A=25-299; 3GSV; X-ray; 1.90 A; A=25-299; 3GSW; X-ray; 1.81 A; A=25-298; 3GSX; X-ray; 2.10 A; A=25-298; 3H7B; X-ray; 1.88 A; A/D=25-299; 3H9H; X-ray; 2.00 A; A/D=25-299; 3H9S; X-ray; 2.70 A; A=25-299; 3HAE; X-ray; 2.90 A; A/D/J/P=25-300; 3HG1; X-ray; 3.00 A; A=25-300; 3HLA; X-ray; 2.60 A; A=25-294; 3HPJ; X-ray; 2.00 A; A/D=25-299; 3I6G; X-ray; 2.20 A; A/D=25-299; 3I6K; X-ray; 2.80 A; A/E=25-299; 3IXA; X-ray; 2.10 A; A/D=25-299; 3KLA; X-ray; 1.65 A; A/D=25-299; 3MGO; X-ray; 2.30 A; A/D/G/J=25-299; 3MGT; X-ray; 2.20 A; A/D/G/J=25-299; 3MR9; X-ray; 1.93 A; A=25-300; 3MRB; X-ray; 1.40 A; A=25-300; 3MRC; X-ray; 1.80 A; A=25-300; 3MRD; X-ray; 1.70 A; A=25-300; 3MRE; X-ray; 1.10 A; A=25-300; 3MRF; X-ray; 2.30 A; A=25-300; 3MRG; X-ray; 1.30 A; A=25-300; 3MRH; X-ray; 2.40 A; A=25-300; 3MRI; X-ray; 2.10 A; A=25-300; 3MRJ; X-ray; 1.87 A; A=25-300; 3MRK; X-ray; 1.40 A; A=25-300; 3MRL; X-ray; 2.41 A; A=25-300; 3MRM; X-ray; 1.90 A; A=25-300; 3MRN; X-ray; 2.30 A; A=25-300; 3MRO; X-ray; 2.35 A; A=25-300; 3MRP; X-ray; 2.10 A; A=25-300; 3MRQ; X-ray; 2.20 A; A=25-300; 3MRR; X-ray; 1.60 A; A=25-300; 3MYJ; X-ray; 1.89 A; A/D=25-299; 3O3A; X-ray; 1.80 A; A/D=25-299; 3O3B; X-ray; 1.90 A; A/D=25-299; 3O3D; X-ray; 1.70 A; A/D=25-299; 3O3E; X-ray; 1.85 A; A/D=25-299; 3O4L; X-ray; 2.54 A; A=25-300; 3PWJ; X-ray; 1.70 A; A/D=25-299; 3PWL; X-ray; 1.65 A; A/D=25-299; 3PWN; X-ray; 1.60 A; A/D=25-299; 3PWP; X-ray; 2.69 A; A=25-299; 3QDG; X-ray; 2.69 A; A=25-299; 3QDJ; X-ray; 2.30 A; A=25-299; 3QDM; X-ray; 2.80 A; A=25-299; 3QEQ; X-ray; 2.59 A; A=25-299; 3QFD; X-ray; 1.68 A; A/D=25-299; 3QFJ; X-ray; 2.29 A; A=25-299; 3REW; X-ray; 1.90 A; A/D=25-299; 3UTQ; X-ray; 1.67 A; A=25-300; 3UTS; X-ray; 2.71 A; A/F=25-300; 3UTT; X-ray; 2.60 A; A/F=25-299	1AKJ; 1AO7; 1AQD; 1B0G; 1B0R; 1BD2; 1DUY; 1DUZ; 1EEY; 1EEZ; 1HHG; 1HHH; 1HHI; 1HHJ; 1HHK; 1HLA; 1I1F; 1I1Y; 1I4F; 1I7R; 1I7T; 1I7U; 1IM3; 1JF1; 1JHT; 1LP9; 1OGA; 1P7Q; 1QEW; 1QR1; 1QRN; 1QSE; 1QSF; 1S8D; 1S9W; 1S9X; 1S9Y; 1T1W; 1T1X; 1T1Y; 1T1Z; 1T20; 1T21; 1T22; 1TVB; 1TVH; 1UR7; 2AV1; 2AV7; 2BNQ; 2BNR; 2C7U; 2CLR; 2F53; 2F54; 2GIT; 2GJ6; 2GT9; 2GTW; 2GTZ; 2GUO; 2J8U; 2JCC; 2P5E; 2P5W; 2PYE; 2UWE; 2V2W; 2V2X; 2VLJ; 2VLK; 2VLL; 2VLR; 2X4N; 2X4O; 2X4P; 2X4Q; 2X4R; 2X4S; 2X4T; 2X4U; 2X70; 3BGM; 3BH8; 3BH9; 3BHB; 3D25; 3D39; 3D3V; 3FQN; 3FQR; 3FQT; 3FQU; 3FQW; 3FQX; 3FT2; 3FT3; 3FT4; 3GIV; 3GJF; 3GSN; 3GSO; 3GSQ; 3GSR; 3GSU; 3GSV; 3GSW; 3GSX; 3H7B; 3H9H; 3H9S; 3HAE; 3HG1; 3HLA; 3HPJ; 3I6G; 3I6K; 3IXA; 3KLA; 3MGO; 3MGT; 3MR9; 3MRB; 3MRC; 3MRD; 3MRE; 3MRF; 3MRG; 3MRH; 3MRI; 3MRJ; 3MRK; 3MRL; 3MRM; 3MRN; 3MRO; 3MRP; 3MRQ; 3MRR; 3MYJ; 3O3A; 3O3B; 3O3D; 3O3E; 3O4L; 3PWJ; 3PWL; 3PWN; 3PWP; 3QDG; 3QDJ; 3QDM; 3QEQ; 3QFD; 3QFJ; 3REW; 3UTQ; 3UTS; 3UTT		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1		P01892		B24512; HLHU10; I37470; I37470; I37542; I37542; I38418; I38418; I38442; I38442; I38443; I38443; I55948; HLHUA2; I61857; I61857; I61902; I61902; I84448; I84448			P01892	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P01892	REACT_116125; Disease; REACT_6900; Immune System			SM00407; IGc1; 1	P01892; 25-298	P01892	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A03_HUMAN	Q9MYG4; Q9TPR8;	RecName: Full=HLA class I histocompatibility antigen, A-3 alpha chain; AltName: Full=MHC class I antigen A*3; Flags: Precursor;	NP_002107.3	NM_002116.7		ENST00000376809; ENST00000396634	ENSP00000366005; ENSP00000379873	ENSG00000206503; ENSG00000206503						365	40841	Q9MYG4	Q9TPR8		Q65A82			P04439				HS_HLA-A		3105			34223717	3105			NOG42056	X00492; CAA25162.1; ALT_SEQ; Genomic_DNA; U32184; AAB63980.1; -; mRNA; BA000025; BAB63400.1; -; Genomic_DNA; AF217561; AAF28734.1; -; mRNA; AF015930; AAB66582.1; -; mRNA; AF190719; AAF03243.1; -; Genomic_DNA; AF190718; AAF03243.1; JOINED; Genomic_DNA; AJ401085; CAC06086.1; -; Genomic_DNA; AJ401086; CAC06087.1; -; Genomic_DNA; AJ401087; CAC06088.1; -; Genomic_DNA; AJ748743; CAG38621.1; -; Genomic_DNA; AL671277; CAI18372.1; -; Genomic_DNA; AF226843; AAF29557.1; -; Genomic_DNA; AF226842; AAF29557.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921	3105	ENSGT00650000093032	P04439	ENSG00000204632; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4931; HLA-A	HIX0005684		HBG016709				P04439; 2	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00647634	hsa:3105	K06751		142800; gene		12319	NX_P04439				EOG4F4SBG		cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells; il12_2pathway; IL12-mediated signaling events; cd8tcrpathway; TCR signaling in naive CD8+ T cells	2XPG; X-ray; 2.60 A; A=25-298; 3RL2; X-ray; 2.39 A; A=25-298	2XPG; 3RL2		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1	PA35055			A02192; HLHUA3		P04439	P04439	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P04439	REACT_6900; Immune System			SM00407; IGc1; 1	P04439; 25-298	P04439	SSF54452; MHC_I/II-like_Ag-recog; 1					uc003nok.3; human	Hs.181244
1A11_HUMAN	Q9TQP6; Q9TQP7;	RecName: Full=HLA class I histocompatibility antigen, A-11 alpha chain; AltName: Full=MHC class I antigen A*11; Flags: Precursor;				ENST00000376809; ENST00000396634	ENSP00000366005; ENSP00000379873	ENSG00000206503; ENSG00000206503						365	40937	Q9TQP6	Q9TQP7		Q29747			P13746				HS_HLA-A					122157					X13111; CAA31503.1; -; mRNA; X13112; CAA31504.1; -; mRNA; D16841; BAA04117.1; -; mRNA; D16842; BAA04118.1; -; mRNA; M16010; AAA65449.1; -; Genomic_DNA; M16007; AAA65449.1; JOINED; Genomic_DNA; M16008; AAA65449.1; JOINED; Genomic_DNA; M16009; AAA65449.1; JOINED; Genomic_DNA; Y17224; CAB38056.1; -; mRNA; Y17224; CAB38057.1; -; mRNA; X91399; CAA62745.1; -; mRNA; U50574; AAB60406.1; -; mRNA; AF030910; AAB87052.1; -; Genomic_DNA; AF030909; AAB87052.1; JOINED; Genomic_DNA; AF030908; AAB87051.1; -; Genomic_DNA; AF030907; AAB87051.1; JOINED; Genomic_DNA; AJ306733; CAC37336.1; -; Genomic_DNA; AF147455; AAD33991.1; -; Genomic_DNA; AF147454; AAD33991.1; JOINED; Genomic_DNA; AF165065; AAF25781.1; -; mRNA	P13746	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921			P13746	ENSG00000204632; Homo sapiens		GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472112; IPI00472448				142800; gene			NX_P13746							1Q94; X-ray; 2.40 A; A/D=25-299; 1QVO; X-ray; 2.22 A; A/D=25-299; 1X7Q; X-ray; 1.45 A; A=25-299; 2HN7; X-ray; 1.60 A; A=25-299	1Q94; 1QVO; 1X7Q; 2HN7		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I83063; I83063; S03536; A47636			P13746	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P13746				SM00407; IGc1; 1		P13746	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A1L1_HUMAN	Q96QU6; Q8WUL4; Q96LX5;	RecName: Full=1-aminocyclopropane-1-carboxylate synthase-like protein 1; Short=ACC synthase-like protein 1;	NP_001120691.1; NP_115981.1	NM_001127219.1; NM_032592.3		ENST00000263776; ENST00000448099	ENSP00000263776; ENSP00000402569	ENSG00000110455; ENSG00000110455						501	57324	Q96QU6	Q8WUL4	Q96LX5			Q96QU6	Q96QU6				HS_ACCS		84680			74717198	84680			COG0436	AY026508; AAK11482.1; -; mRNA; AK057649; BAB71541.1; -; mRNA; CH471064; EAW68072.1; -; Genomic_DNA; BC020197; AAH20197.1; -; mRNA		G3DSA:3.90.1150.10; PyrdxlP-dep_Trfase_major_sub2; 2	GC11P044045	84680	ENSGT00390000005703	Q96QU6			GO:0016847; F:1-aminocyclopropane-1-carboxylate synthase activity; IEA:InterPro; GO:0042803; F:protein homodimerization activity; NAS:UniProtKB; GO:0030170; F:pyridoxal phosphate binding; NAS:UniProtKB; GO:0016769; F:transferase activity, transferring nitrogenous groups; IEA:InterPro	HGNC:23989; ACCS	HIX0201626	HBG713659	HBG055243	HPA018873; HPA021654	P37821; 1M4N	Q96QU6		IPR001176; ACC_synthase; IPR004839; Aminotransferase_I/II; IPR015424; PyrdxlP-dep_Trfase_major_dom; IPR015422; PyrdxlP-dep_Trfase_major_sub2	IPI00411817	hsa:84680			608405; gene	MINT-1470212	74721	NX_Q96QU6		CEAGEAF		EOG4P8FJ0						PF00155; Aminotran_1_2; 1	PA162375284		Q96QU6				Q96QU6	PR00753; ACCSYNTHASE		PS00105; AA_TRANSFER_CLASS_1; FALSE_NEG	Q96QU6					Q96QU6; 75-482	Q96QU6	SSF53383; PyrdxlP-dep_Trfase_major; 1					uc001mxx.2; human	Hs.126706
1A1L2_HUMAN	Q4AC99;	RecName: Full=1-aminocyclopropane-1-carboxylate synthase-like protein 2; Short=ACC synthase-like protein 2;	NP_001027025.2	NM_001031854.2		ENST00000378832	ENSP00000368109	ENSG00000205126						568	65249	Q4AC99												390110			296439453				COG0436	AB231734; BAE17132.1; -; mRNA; AC134775; -; NOT_ANNOTATED_CDS; Genomic_DNA		G3DSA:3.40.640.10; PyrdxlP-dep_Trfase_major_sub1; 1; G3DSA:3.90.1150.10; PyrdxlP-dep_Trfase_major_sub2; 2	GC11P044027	390110	ENSGT00390000005703	Q4AC99			GO:0016847; F:1-aminocyclopropane-1-carboxylate synthase activity; IEA:InterPro; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro; GO:0016769; F:transferase activity, transferring nitrogenous groups; IEA:InterPro	HGNC:34391; ACCSL		HBG713659	HBG055243			Q4AC99		IPR001176; ACC_synthase; IPR004839; Aminotransferase_I/II; IPR015424; PyrdxlP-dep_Trfase_major_dom; IPR015421; PyrdxlP-dep_Trfase_major_sub1; IPR015422; PyrdxlP-dep_Trfase_major_sub2	IPI00399296	hsa:390110					103406	NX_Q4AC99		IIDEIYM		EOG4P8FJ0						PF00155; Aminotran_1_2; 1	PA164714805						Q4AC99	PR00753; ACCSYNTHASE		PS00105; AA_TRANSFER_CLASS_1; FALSE_NEG	Q4AC99					Q4AC99; 135-554		SSF53383; PyrdxlP-dep_Trfase_major; 1					uc001mxw.1; human	Hs.558851
1A23_HUMAN	P30447; Q9TQF1; Q9TQF8; Q9TQG5; Q9TQM6;	RecName: Full=HLA class I histocompatibility antigen, A-23 alpha chain; AltName: Full=HLA class I histocompatibility antigen, A-9 alpha chain; AltName: Full=MHC class I antigen A*23; Flags: Precursor;				ENST00000442068; ENST00000454091	ENSP00000404428; ENSP00000410645	ENSG00000223980; ENSG00000223980						365	40733	P30447	Q9TQF1	Q9TQF8	Q9TQG5							HS_HLA-A					231359					M64742; AAA03662.1; -; mRNA; AF137080; AAD33736.1; -; Genomic_DNA; AF137079; AAD33736.1; JOINED; Genomic_DNA; AF102572; AAD28171.1; -; Genomic_DNA; AF102571; AAD28171.1; JOINED; Genomic_DNA; AF135549; AAD22272.1; -; Genomic_DNA; AF135548; AAD22272.1; JOINED; Genomic_DNA; AF140860; AAD31878.1; -; Genomic_DNA; AF140859; AAD31878.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Po29897			P30447	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472151				142800; gene			NX_P30447				EOG4T783X						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1							P30447	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30447				SM00407; IGc1; 1	P30447; 25-298	P30447	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A24_HUMAN	P05534; P30448; P30449; Q29908; Q29909; Q29910; Q95355;	RecName: Full=HLA class I histocompatibility antigen, A-24 alpha chain; AltName: Full=Aw-24; AltName: Full=HLA class I histocompatibility antigen, A-9 alpha chain; AltName: Full=MHC class I antigen A*24; Flags: Precursor;				ENST00000431795; ENST00000431930; ENST00000443552; ENST00000448357	ENSP00000396220; ENSP00000406366; ENSP00000404678; ENSP00000402461	ENSG00000229215; ENSG00000229215; ENSG00000224320; ENSG00000224320						365	40689	P05534	P30448	P30449	Q29908							HS_HLA-A					32363482				NOG42056	M15497; AAA59611.1; -; Genomic_DNA; M64740; AAA59600.1; -; mRNA; M64741; AAA59601.1; -; Genomic_DNA; Z72422; CAA96532.1; -; Genomic_DNA; D83516; BAA11936.1; -; mRNA; U37111; AAA83264.1; -; Genomic_DNA; U37110; AAA83264.1; JOINED; Genomic_DNA; U37113; AAA83265.1; -; Genomic_DNA; U37112; AAA83265.1; JOINED; Genomic_DNA; U37115; AAB40048.1; -; Genomic_DNA; U37114; AAB40048.1; JOINED; Genomic_DNA; U19733; AAB60651.1; -; Genomic_DNA; U18987; AAB60651.1; JOINED; Genomic_DNA	P05534	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921			P05534	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00742968				142800; gene			NX_P05534							2BCK; X-ray; 2.80 A; A/D=25-300; 3I6L; X-ray; 2.40 A; D=25-298; 3NFN; X-ray; 2.39 A; A=25-298; 3QZW; X-ray; 2.80 A; A/D=25-298	2BCK; 3I6L; 3NFN; 3QZW		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I54416; I54416			P05534	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P05534				SM00407; IGc1; 1	P05534; 25-298	P05534	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A25_HUMAN	P18462; Q95362; Q9TQE8; Q9TQG0; Q9UQU3;	RecName: Full=HLA class I histocompatibility antigen, A-25 alpha chain; AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain; AltName: Full=MHC class I antigen A*25; Flags: Precursor;				ENST00000383605; ENST00000383617	ENSP00000373100; ENSP00000373112	ENSG00000206505; ENSG00000206505						365	41218	P18462	Q95362	Q9TQE8	Q9TQG0							HS_HLA-A					122158				NOG42056	M32321; AAA36234.1; -; mRNA; BC008611; AAH08611.1; -; mRNA; X97802; CAA66389.1; -; mRNA; AJ238524; CAB41888.1; -; Genomic_DNA; AF137076; AAD33737.1; -; Genomic_DNA; AF137075; AAD33737.1; JOINED; Genomic_DNA; AF148898; AAD34010.1; -; Genomic_DNA; AF148897; AAD34010.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pn29898			P18462	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00785070				142800; gene			NX_P18462				EOG4NZTV0						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A35997; A35997			P18462	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P18462				SM00407; IGc1; 1	P18462; 25-299	P18462	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A26_HUMAN	Q9BD19; Q9MW42; Q9TQK5;	RecName: Full=HLA class I histocompatibility antigen, A-26 alpha chain; AltName: Full=MHC class I antigen A*26; Flags: Precursor;				ENST00000383605; ENST00000383617	ENSP00000373100; ENSP00000373112	ENSG00000206505; ENSG00000206505						365	41062	Q9BD19	Q9MW42	Q9TQK5								HS_HLA-A					1168209					U03697; AAA03720.1; -; mRNA; M98453; AAA35991.1; -; mRNA; D14350; BAA03279.1; -; mRNA; D14351; BAA03280.1; -; mRNA; D14354; BAA03282.1; -; mRNA; D16843; BAA04119.1; -; mRNA; D32130; BAA06856.1; -; mRNA; D32131; BAA06857.1; -; mRNA; D32129; BAA06855.1; -; mRNA; D50068; BAA08783.1; -; mRNA; L48341; AAF25960.1; -; Genomic_DNA; U52429; AAB08574.1; -; mRNA; U45480; AAB38491.1; -; mRNA; AF065487; AAC17438.1; -; Genomic_DNA; AF065486; AAC17438.1; JOINED; Genomic_DNA; AF042187; AAD02210.1; -; Genomic_DNA; AF042186; AAD02210.1; JOINED; Genomic_DNA; AJ291695; CAC27239.1; -; Genomic_DNA; AJ291696; CAC27239.1; JOINED; Genomic_DNA; AJ290394; CAC27416.2; -; mRNA; M24095; AAA59655.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pn29898			P30450	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A	HIX0033011		HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00743359				142800; gene			NX_P30450										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A37028; A37028; I38436; I38436; I84487; I84487			P30450	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30450				SM00407; IGc1; 1		P30450	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A29_HUMAN	P30512; O02955; O19687; O98011; P30451; P79562;	RecName: Full=HLA class I histocompatibility antigen, A-29 alpha chain; AltName: Full=Aw-19; AltName: Full=MHC class I antigen A*29; Flags: Precursor;				ENST00000412057; ENST00000456012	ENSP00000411730; ENSP00000408986	ENSG00000231834; ENSG00000231834						365	40863	P30512	O02955	O19687	O98011							HS_HLA-A					2851401					M23739; AAB47873.1; -; mRNA; U83415; AAB53373.1; -; mRNA; X60108; CAA42702.1; -; mRNA; AJ000661; CAA04209.1; -; mRNA; Y09218; CAA70419.1; -; Genomic_DNA; AF042189; AAD02224.1; -; Genomic_DNA; AF042188; AAD02224.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pl29898			P30512	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A	HIX0166683		HBG016709				P30512; 6	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472921				142800; gene			NX_P30512				EOG4F4SBG						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A45847; A45847			P30512	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30512				SM00407; IGc1; 1	P30512; 25-294	P30512	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A30_HUMAN	P16188; O19598; O62921; P30452; Q9UIP7;	RecName: Full=HLA class I histocompatibility antigen, A-30 alpha chain; AltName: Full=MHC class I antigen A*30; Flags: Precursor;				ENST00000376809; ENST00000396634	ENSP00000366005; ENSP00000379873	ENSG00000206503; ENSG00000206503						365	40905	P16188	O19598	O62921	P30452			P16188				HS_HLA-A					1345596					M30576; AAA59612.1; -; Genomic_DNA; U07234; AAA70162.1; -; mRNA; X61702; CAA43871.1; -; mRNA; M93657; AAA58650.1; -; Genomic_DNA; Z34921; CAA84401.1; -; Genomic_DNA; U19734; AAB53658.1; -; Genomic_DNA; U18988; AAB53658.1; JOINED; Genomic_DNA; U24261; AAB50434.1; -; mRNA; X83770; CAA58723.1; -; Genomic_DNA; X83771; CAA58724.1; -; Genomic_DNA; AF028714; AAC14191.1; -; Genomic_DNA; AF028713; AAC14191.1; JOINED; Genomic_DNA; AF065643; AAC18600.1; -; Genomic_DNA; AF065642; AAC18600.1; JOINED; Genomic_DNA; AJ249308; CAB57306.1; -; Genomic_DNA; AJ249309; CAB57306.1; JOINED; Genomic_DNA; AJ249310; CAB57306.1; JOINED; Genomic_DNA; AJ249311; CAB57306.1; JOINED; Genomic_DNA; AJ249312; CAB57306.1; JOINED; Genomic_DNA; AJ249313; CAB57306.1; JOINED; Genomic_DNA; AJ249314; CAB57306.1; JOINED; Genomic_DNA; AJ249315; CAB57306.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921			P16188	ENSG00000204632; Homo sapiens		GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472855				142800; gene			NX_P16188										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I38519; I38519; I54307; I54307; I56039; I56039			P16188	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P16188				SM00407; IGc1; 1	P16188; 25-298	P16188	SSF54452; MHC_I/II-like_Ag-recog; 1						
1A31_HUMAN	Q9UQU7;	RecName: Full=HLA class I histocompatibility antigen, A-31 alpha chain; AltName: Full=MHC class I antigen A*31; Flags: Precursor;				ENST00000412057; ENST00000456012	ENSP00000411730; ENSP00000408986	ENSG00000231834; ENSG00000231834						365	41004	Q9UQU7		O98009	O98137							HS_HLA-A					231367				NOG42056	M30578; AAA59613.1; -; Genomic_DNA; M84375; AAA59599.1; -; mRNA; L78918; AAB05976.1; -; Genomic_DNA; AF148863; AAD39981.1; -; Genomic_DNA; AF067439; AAC18859.1; -; Genomic_DNA; AF067438; AAC18859.1; JOINED; Genomic_DNA; AF105028; AAC79721.1; -; Genomic_DNA; AF105027; AAC79721.1; JOINED; Genomic_DNA; AJ239045; CAB43109.1; -; Genomic_DNA; AJ239046; CAB43110.1; -; Genomic_DNA; AB032597; BAA84645.1; -; Genomic_DNA; AF041370; AAD02207.1; -; Genomic_DNA; AF041369; AAD02207.1; JOINED; Genomic_DNA; AJ506789; CAD44950.1; -; Genomic_DNA; AJ506790; CAD44950.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pl29898			P16189	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00646225				142800; gene; 608579; phenotype			NX_P16189			179; Chorioretinopathy, Birdshot type							PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I72170; I72170			P16189	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P16189				SM00407; IGc1; 1		P16189	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A32_HUMAN	P10314; O77937; Q29838; Q8MHN9; Q9MYE9; Q9MYG5; Q9TQF5; Q9TQF9;	RecName: Full=HLA class I histocompatibility antigen, A-32 alpha chain; AltName: Full=MHC class I antigen A*32; Flags: Precursor;				ENST00000442068; ENST00000454091	ENSP00000404428; ENSP00000410645	ENSG00000223980; ENSG00000223980						365	41048	P10314	O77937	Q29838	Q8MHN9							HS_HLA-A					1168210					U03907; AAA03605.1; -; mRNA; X97120; CAA65786.1; -; mRNA; AF072762; AAC26020.1; -; Genomic_DNA; AF072761; AAC26020.1; JOINED; Genomic_DNA; AF137078; AAD33738.1; -; Genomic_DNA; AF137077; AAD33738.1; JOINED; Genomic_DNA; AF139892; AAD33849.1; -; Genomic_DNA; AF139891; AAD33849.1; JOINED; Genomic_DNA; AF517562; AAM78538.1; -; Genomic_DNA; AF517561; AAM78538.1; JOINED; Genomic_DNA; AF217560; AAF28733.1; -; mRNA; AF226837; AAF29554.1; -; Genomic_DNA; AF226836; AAF29554.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Po29897			P10314	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A	HIX0078423		HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472825				142800; gene			NX_P10314										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A26088; HLHU32			P10314	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P10314				SM00407; IGc1; 1	P10314; 25-294	P10314	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011jeb.2; human	Hs.181244
1A33_HUMAN	P16190; O02939; O02954;	RecName: Full=HLA class I histocompatibility antigen, A-33 alpha chain; AltName: Full=Aw-19; AltName: Full=Aw-33; AltName: Full=MHC class I antigen A*33; Flags: Precursor;				ENST00000412057; ENST00000456012	ENSP00000411730; ENSP00000408986	ENSG00000231834; ENSG00000231834						365	40892	P16190	O02939	O02954								HS_HLA-A					2851527					M30580; AAB47870.1; -; Genomic_DNA; U83416; AAB53374.1; -; mRNA; L06440; AAA71914.1; -; mRNA; U09740; AAA79865.1; -; mRNA; X83004; CAA58125.1; -; Genomic_DNA; X83005; CAA58126.1; -; Genomic_DNA; X83002; CAA58123.1; -; Genomic_DNA; X83003; CAA58124.1; -; Genomic_DNA; U19735; AAB60652.1; -; Genomic_DNA; U19736; AAB60653.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pl29898			P16190	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472013				142800; gene			NX_P16190										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I38610; I38610; S51099; S51099; S51100; S51100			P16190	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P16190				SM00407; IGc1; 1	P16190; 25-294	P16190	SSF54452; MHC_I/II-like_Ag-recog; 1						
1A34_HUMAN	P30453; P30454;	RecName: Full=HLA class I histocompatibility antigen, A-34 alpha chain; AltName: Full=Aw-34; AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain; AltName: Full=MHC class I antigen A*34; Flags: Precursor;				ENST00000383605; ENST00000383617	ENSP00000373100; ENSP00000373112	ENSG00000206505; ENSG00000206505						365	41055	P30453	P30454									HS_HLA-A					231368					X61704; CAA43873.1; -; mRNA; X61705; CAA43874.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pn29898			P30453	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00743503				142800; gene			NX_P30453										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37477; I37477; I37483; I37483			P30453	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30453				SM00407; IGc1; 1	P30453; 25-294	P30453	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A36_HUMAN	P30455; Q9MY89;	RecName: Full=HLA class I histocompatibility antigen, A-36 alpha chain; AltName: Full=Aw-36; AltName: Full=MHC class I antigen A*36; Flags: Precursor;				ENST00000431795; ENST00000431930; ENST00000443552; ENST00000448357	ENSP00000396220; ENSP00000406366; ENSP00000404678; ENSP00000402461	ENSG00000229215; ENSG00000229215; ENSG00000224320; ENSG00000224320						365	40934	P30455	Q9MY89									HS_HLA-A					231370					X61700; CAA43869.1; -; mRNA; AF274505; AAF78082.1; -; Genomic_DNA; AF274504; AAF78082.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921			P30455			GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00644748				142800; gene			NX_P30455										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37478; I37478			P30455	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30455				SM00407; IGc1; 1		P30455	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A43_HUMAN	P30456; O19509;	RecName: Full=HLA class I histocompatibility antigen, A-43 alpha chain; AltName: Full=Aw-43; AltName: Full=MHC class I antigen A*43; Flags: Precursor;				ENST00000383605; ENST00000383617	ENSP00000373100; ENSP00000373112	ENSG00000206505; ENSG00000206505						365	41033	P30456	O19509									HS_HLA-A					231371					X61703; CAA43872.1; -; mRNA; AF008306; AAB65408.1; -; Genomic_DNA; AF008305; AAB65408.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pn29898			P30456	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00785070				142800; gene			NX_P30456										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I72171; I72171; S16769; S16769			P30456	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30456				SM00407; IGc1; 1	P30456; 25-299	P30456	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A66_HUMAN	P30457; P30458;	RecName: Full=HLA class I histocompatibility antigen, A-66 alpha chain; AltName: Full=Aw-66; AltName: Full=HLA class I histocompatibility antigen, A-10 alpha chain; AltName: Full=MHC class I antigen A*66; Flags: Precursor;				ENST00000383605; ENST00000383617	ENSP00000373100; ENSP00000373112	ENSG00000206505; ENSG00000206505						365	41082	P30457	P30458									HS_HLA-A					231372					X61711; CAA43880.1; -; mRNA; X61712; CAA43881.1; -; mRNA; X51745; CAA36034.1; -; mRNA; U17571; AAA56781.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pn29898			P30457	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00785070				142800; gene			NX_P30457										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				JL0135; JL0135				PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30457				SM00407; IGc1; 1	P30457; 25-299	P30457	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A68_HUMAN	P10315; P79505; Q9MYA5; Q9MYC4; Q9TQG7; Q9TQN5; Q9UIN2;	RecName: Full=HLA class I histocompatibility antigen, A-68 alpha chain; AltName: Full=Aw-68; AltName: Full=HLA class I histocompatibility antigen, A-28 alpha chain; AltName: Full=MHC class I antigen A*68; Flags: Precursor;				ENST00000412679; ENST00000457879	ENSP00000399020; ENSP00000403575	ENSG00000235657; ENSG00000235657						365	40909	P10315	P79505	Q9MYA5	Q9MYC4							HS_HLA-A					13124681					U03861; AAA03602.1; -; mRNA; X03070; CAB56605.1; -; Genomic_DNA; X03071; CAB56606.1; -; Genomic_DNA; U41057; AAB41292.1; -; mRNA; AJ315642; CAC44382.1; -; Genomic_DNA; AF144013; AAF74211.1; -; Genomic_DNA; AJ245567; CAB59722.1; -; Genomic_DNA; U91628; AAB50567.1; -; Genomic_DNA; U91627; AAB50567.1; JOINED; Genomic_DNA; U89946; AAB82079.1; -; Genomic_DNA; U89947; AAB82080.1; -; Genomic_DNA; AJ001274; CAA04647.1; -; mRNA; AF072770; AAC25782.1; -; Genomic_DNA; AF072769; AAC25782.1; JOINED; Genomic_DNA; AF135545; AAD22270.1; -; Genomic_DNA; AF135544; AAD22270.1; JOINED; Genomic_DNA; AF108431; AAD27539.1; -; Genomic_DNA; AF108430; AAD27539.1; JOINED; Genomic_DNA; AJ223972; CAA11708.1; -; Genomic_DNA; AF041372; AAD02208.1; -; Genomic_DNA; AF041371; AAD02208.1; JOINED; Genomic_DNA; AF268398; AAF73477.1; -; Genomic_DNA; AF268397; AAF73477.1; JOINED; Genomic_DNA	P01891	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pk29899			P01891	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472882				142800; gene	MINT-274751		NX_P01891							1HSB; X-ray; 1.90 A; A=25-294; 1TMC; X-ray; 2.30 A; A=25-199; 2HLA; X-ray; 2.60 A; A=25-294	1HSB; 1TMC; 2HLA		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A02187; HLHU28; A24671; HLHUAW; I38441; I38441			P01891	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P01891				SM00407; IGc1; 1	P01891; 25-294	P01891	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A69_HUMAN	P10316; B1PKZ3;	RecName: Full=HLA class I histocompatibility antigen, A-69 alpha chain; AltName: Full=Aw-69; AltName: Full=HLA class I histocompatibility antigen, A-28 alpha chain; AltName: Full=MHC class I antigen A*69;				ENST00000412679; ENST00000457879	ENSP00000399020; ENSP00000403575	ENSG00000235657; ENSG00000235657						365	40977	P10316	B1PKZ3									HS_HLA-A					115502347					EU445484; ACA35004.1; -; Genomic_DNA; X03158; CAB56607.1; -; Genomic_DNA; X03159; CAB56608.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Pk29899			P10316	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00760554				142800; gene			NX_P10316										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				B24671; HLHU69				PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P10316				SM00407; IGc1; 1	P10316; 25-300	P10316	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1A74_HUMAN	P30459; O19647; O43906; O46874; Q95IZ5; Q9UIN1;	RecName: Full=HLA class I histocompatibility antigen, A-74 alpha chain; AltName: Full=Aw-19; AltName: Full=Aw-74; AltName: Full=MHC class I antigen A*74; Flags: Precursor;				ENST00000442068; ENST00000454091	ENSP00000404428; ENSP00000410645	ENSG00000223980; ENSG00000223980						365	40891	P30459	O19647	O43906	O46874							HS_HLA-A					231375					X61701; CAA43870.1; -; mRNA; U17569; AAA56779.1; -; mRNA; U17570; AAA56780.1; -; mRNA; AJ223060; CAA11063.1; -; mRNA; AJ002678; CAA05681.1; -; mRNA; AJ249370; CAB58124.1; -; Genomic_DNA; AF255721; AAK49188.1; -; Genomic_DNA; AF255720; AAK49188.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921; GC06Po29897			P30459	ENSG00000204632; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472222				142800; gene			NX_P30459										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37482; I37482			P30459	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30459				SM00407; IGc1; 1	P30459; 25-294	P30459	SSF54452; MHC_I/II-like_Ag-recog; 1						
1A80_HUMAN	Q09160;	RecName: Full=HLA class I histocompatibility antigen, A-80 alpha chain; AltName: Full=Aw-80; AltName: Full=HLA class I histocompatibility antigen, A-1 alpha chain; AltName: Full=MHC class I antigen A*80; Flags: Precursor;				ENST00000431795; ENST00000431930; ENST00000443552; ENST00000448357	ENSP00000396220; ENSP00000406366; ENSP00000404678; ENSP00000402461	ENSG00000229215; ENSG00000229215; ENSG00000224320; ENSG00000224320						365	40792	Q09160										HS_HLA-A					1168212					U03754; AAC04322.1; -; mRNA; L18898; AAA17012.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06P029921			Q09160	ENSG00000204632; Homo sapiens		GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4931; HLA-A			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472736				142800; gene			NX_Q09160										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I59638; I38439			Q09160	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q09160				SM00407; IGc1; 1		Q09160	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.181244
1B07_HUMAN	Q9TP95;	RecName: Full=HLA class I histocompatibility antigen, B-7 alpha chain; AltName: Full=MHC class I antigen B*7; Flags: Precursor;	NP_005505.2	NM_005514.6		ENST00000412585	ENSP00000399168	ENSG00000234745						362	40460	Q9TP95		Q29681	Q29854			P01889				HS_HLA-B		3106			122162				NOG42056	M32317; AAA36230.1; -; mRNA; M16102; AAA59622.1; ALT_SEQ; mRNA; U29057; AAA91229.1; -; mRNA; X64454; CAA45785.1; -; mRNA; U04245; AAA87398.1; -; mRNA; L33922; AAA65639.1; -; mRNA; U21052; AAA92563.1; -; mRNA; U21053; AAA92564.1; -; mRNA; X91749; CAA62864.1; -; mRNA; AF189017; AAF01052.1; -; mRNA; AJ309047; CAC35468.1; -; Genomic_DNA; AJ292075; CAC33440.1; -; Genomic_DNA; AL671883; CAI18148.1; -; Genomic_DNA; AK313911; BAG36634.1; -; mRNA; AJ401222; CAC10402.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321	3106	ENSGT00650000093032	P01889	ENSG00000204523; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0005102; F:receptor binding; IPI:BHF-UCL; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:2001198; P:regulation of dendritic cell differentiation; IMP:BHF-UCL; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0032655; P:regulation of interleukin-12 production; IMP:BHF-UCL; GO:0032675; P:regulation of interleukin-6 production; IMP:BHF-UCL; GO:0002667; P:regulation of T cell anergy; IMP:BHF-UCL; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B	HIX0078239		HBG016709	CAB015418			P01889; 4	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00004657	hsa:3106	K06751		142830; gene		12323	NX_P01889				EOG4F4SBG						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1	PA35056			B35997; HLHUB7; I54418; I54418; I59651; I59651; S60601; S60601			P01889	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P01889	REACT_6900; Immune System			SM00407; IGc1; 1	P01889; 25-300	P01889	SSF54452; MHC_I/II-like_Ag-recog; 1					uc003ntg.1; human	Hs.77961
1B08_HUMAN	Q9MY78; Q9MYF4; Q9TQH6; Q9TQM2; Q9UQT0;	RecName: Full=HLA class I histocompatibility antigen, B-8 alpha chain; AltName: Full=MHC class I antigen B*8; Flags: Precursor;				ENST00000425848	ENSP00000400842	ENSG00000223532						362	40331	Q9MY78	Q9MYF4	Q9TQH6	Q9TQM2							HS_HLA-B					231381				NOG42056	M24036; AAA52662.1; -; Genomic_DNA; AJ295294; CAC18876.1; -; Genomic_DNA; BA000025; BAB63309.1; -; Genomic_DNA; U67331; AAB07726.1; -; Genomic_DNA; U67330; AAB07726.1; JOINED; Genomic_DNA; U74386; AAB41720.1; -; mRNA; AF056483; AAC14124.2; -; Genomic_DNA; AF105226; AAD05244.1; -; Genomic_DNA; AF127248; AAD31431.1; -; Genomic_DNA; AF127247; AAD31431.1; JOINED; Genomic_DNA; AJ131853; CAA10522.1; -; Genomic_DNA; AF102560; AAD28165.1; -; Genomic_DNA; AF102559; AAD28165.1; JOINED; Genomic_DNA; AF226151; AAF36681.1; -; Genomic_DNA; AF226150; AAF36681.1; JOINED; Genomic_DNA; AF279675; AAF81604.1; -; Genomic_DNA; AF279674; AAF81604.1; JOINED; Genomic_DNA; AF310145; AAG27470.1; -; Genomic_DNA; AF310144; AAG27470.1; JOINED; Genomic_DNA; AY016212; AAK38401.1; -; Genomic_DNA; AY016211; AAK38401.1; JOINED; Genomic_DNA; AJ133101; CAB38945.1; -; Genomic_DNA; AJ133102; CAB38945.1; JOINED; Genomic_DNA	P30460	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30460			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B	HIX0078437		HBG016709			P30460		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00479242				142830; gene			NX_P30460				EOG4F4SBG			1AGB; X-ray; 2.20 A; A=25-300; 1AGC; X-ray; 2.10 A; A=25-300; 1AGD; X-ray; 2.05 A; A=25-300; 1AGE; X-ray; 2.30 A; A=25-300; 1AGF; X-ray; 2.20 A; A=25-300; 1M05; X-ray; 1.90 A; A/C=25-301; 1MI5; X-ray; 2.50 A; A=25-301; 3FFC; X-ray; 2.80 A; A/F=25-301; 3SJV; X-ray; 3.10 A; A/F/K/P=25-301	1AGB; 1AGC; 1AGD; 1AGE; 1AGF; 1M05; 1MI5; 3FFC; 3SJV		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I84431; I84431			P30460	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30460	REACT_6900; Immune System			SM00407; IGc1; 1	P30460; 25-300	P30460	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011fcp.1; human	Hs.130838; Hs.77961
1B13_HUMAN	P30461; O02956; O78180; Q29661; Q29933; Q9GIY5;	RecName: Full=HLA class I histocompatibility antigen, B-13 alpha chain; AltName: Full=MHC class I antigen B*13; Flags: Precursor;				ENST00000435618	ENSP00000405178	ENSG00000224608						362	40474	P30461	O02956	O78180	Q29661							HS_HLA-B					231382				NOG42056	M24041; AAA59660.1; -; Genomic_DNA; M19757; AAA52657.1; -; Genomic_DNA; M24075; AAA59627.1; -; Genomic_DNA; D50290; BAA08821.1; -; mRNA; D50291; BAA08822.1; -; mRNA; U14943; AAB06829.1; -; mRNA; U75533; AAC31793.1; -; mRNA; AJ295279; CAC17137.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30461			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30461		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472458				142830; gene	MINT-1195012		NX_P30461				EOG4F4SBG						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A45850; A45850; I54442; I54442			P30461	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30461	REACT_6900; Immune System			SM00407; IGc1; 1	P30461; 25-300	P30461	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B14_HUMAN	P30462; O02862; P30463;	RecName: Full=HLA class I histocompatibility antigen, B-14 alpha chain; AltName: Full=MHC class I antigen B*14; Flags: Precursor;				ENST00000425848	ENSP00000400842	ENSG00000223532						362	40358	P30462	O02862	P30463								HS_HLA-B					231383				NOG42056	M24040; AAA59661.1; -; Genomic_DNA; M24032; AAA59664.1; -; Genomic_DNA; AJ301657; CAC20461.1; -; Genomic_DNA; U91331; AAB61335.1; -; Genomic_DNA; U91330; AAB61335.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30462			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30462		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472130				142830; gene			NX_P30462										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I61859; I61859			P30462	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30462	REACT_6900; Immune System			SM00407; IGc1; 1	P30462; 25-300	P30462	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B15_HUMAN	Q29982; Q95343; Q95344; Q9BD06;	RecName: Full=HLA class I histocompatibility antigen, B-15 alpha chain; AltName: Full=MHC class I antigen B*15; Flags: Precursor;				ENST00000450871	ENSP00000388208	ENSG00000232126						362	40388	Q29982	Q95343	Q95344	Q9BD06							HS_HLA-B					34305703					M75138; AAA59630.1; -; mRNA; U03859; AAA03601.1; -; mRNA; U03027; AAA18902.1; -; mRNA; L11604; AAA56836.1; -; mRNA; D50292; BAA08823.1; -; mRNA; D50293; BAA08824.1; -; mRNA; D50294; BAA08825.1; -; mRNA; X61709; CAA43878.1; -; mRNA; M84382; AAA59632.1; -; mRNA; U70528; AAB16918.1; -; mRNA; AJ295140; CAC17462.1; -; Genomic_DNA; AJ308399; CAC33441.1; -; Genomic_DNA; CR759828; CAQ10738.1; -; Genomic_DNA; M28203; AAA53258.1; -; mRNA; M83193; AAA58628.1; -; mRNA	P30464	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30464			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30464		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00646083				142830; gene; 608579; phenotype			NX_P30464				EOG4F4SBG			1XR8; X-ray; 2.30 A; A=25-300; 1XR9; X-ray; 1.79 A; A=25-300; 3C9N; X-ray; 1.87 A; A=25-300	1XR8; 1XR9; 3C9N		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				G01230; G01230; I38421; I38421; I62042; I62042; S16789; S16789; S24433; S24433; S77966; S77966			P30464	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30464	REACT_6900; Immune System			SM00407; IGc1; 1		P30464	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011hpo.2; human	Hs.77961
1B18_HUMAN	Q9TP37; Q9TQH7;	RecName: Full=HLA class I histocompatibility antigen, B-18 alpha chain; AltName: Full=MHC class I antigen B*18; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40275	Q9TP37	Q9TQH7		Q5JP37							HS_HLA-B					231388				NOG42056	M24039; AAA59662.1; -; Genomic_DNA; D25275; BAA04965.1; -; mRNA; AJ310507; CAC34572.1; -; Genomic_DNA; AJ309979; CAC34305.1; -; Genomic_DNA; AL845443; CAI41903.1; -; Genomic_DNA; AF117775; AAD13298.1; -; Genomic_DNA; AF117774; AAD13298.1; JOINED; Genomic_DNA; AF054010; AAC32821.1; -; Genomic_DNA; AF054009; AAC32821.1; JOINED; Genomic_DNA; AF198651; AAF20813.1; -; Genomic_DNA; AF198650; AAF20813.1; JOINED; Genomic_DNA; AF266526; AAF73066.1; -; Genomic_DNA; AF266525; AAF73066.1; JOINED; Genomic_DNA; AF275717; AAF85974.1; -; Genomic_DNA; AF275716; AAF85974.1; JOINED; Genomic_DNA; AF310139; AAG27466.1; -; Genomic_DNA; AF310138; AAG27466.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30466			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30466		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00827612				142830; gene			NX_P30466										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I61860; I61860			P30466	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30466	REACT_6900; Immune System			SM00407; IGc1; 1	P30466; 25-300	P30466	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011imy.2; human	Hs.77961
1B27_HUMAN	Q29846; Q29961;	RecName: Full=HLA class I histocompatibility antigen, B-27 alpha chain; AltName: Full=MHC class I antigen B*27; Flags: Precursor;				ENST00000435618	ENSP00000405178	ENSG00000224608						362	40428	Q29846	Q29961		P10318							HS_HLA-B			DIP-6188N		34305677				NOG42056	X03945; CAA27578.1; ALT_SEQ; Genomic_DNA; X03664; CAA27301.1; -; Genomic_DNA; X03667; CAA27301.1; JOINED; Genomic_DNA; L38504; AAA69724.1; -; mRNA; M54883; AAA59616.1; -; Genomic_DNA; X03665; CAA27302.1; -; Genomic_DNA; X03666; CAA27302.1; JOINED; Genomic_DNA; M12967; AAA36221.1; -; Genomic_DNA; U27608; AAC50444.1; -; mRNA; U35734; AAC50447.1; -; mRNA; M14013; AAA59643.1; -; Genomic_DNA; X73578; CAA51980.1; -; mRNA; M62852; AAA59647.1; -; mRNA; L19923; AAA59658.1; -; mRNA; Z33453; CAA83876.1; -; mRNA	P03989	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P03989			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005624; C:membrane fraction; TAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P03989		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00471986				106300; phenotype; 142830; gene	MINT-247525		NX_P03989			240841; Abacavir toxicity; 240845; Allopurinol toxicity; 825; Ankylosing spondylitis; 117; Behcet disease; 240857; Carbamazepine toxicity; 240871; Flucloxacilline toxicity; 240899; Phenytoin toxicity; 36426; Stevens-Johnson syndrome; 241001; Susceptibility to hepatitis due to flucloxacilline treatment; 241005; Susceptibility to hypersensitivity syndrome due to abacavir treatment; 241035; Susceptibility to toxic epidermal necrolysis due to allopurinol treatment				1HSA; X-ray; 2.10 A; A/D=25-300; 1JGD; X-ray; 1.90 A; A=25-300; 1JGE; X-ray; 2.10 A; A=25-300; 1K5N; X-ray; 1.09 A; A=25-300; 1OF2; X-ray; 2.20 A; A=25-300; 1OGT; X-ray; 1.47 A; A=25-300; 1ROG; Model; -; A=25-206; 1ROH; Model; -; A=25-206; 1ROI; Model; -; A=25-206; 1ROJ; Model; -; A=25-206; 1ROK; Model; -; A=25-206; 1ROL; Model; -; A=25-206; 1UXS; X-ray; 1.55 A; A=25-300; 1UXW; X-ray; 1.71 A; A=25-300; 1W0V; X-ray; 2.27 A; A=25-300; 1W0W; X-ray; 2.10 A; A=25-300; 2A83; X-ray; 1.40 A; A=25-300; 2BSR; X-ray; 2.30 A; A=25-300; 2BSS; X-ray; 2.00 A; A=25-300; 2BST; X-ray; 2.10 A; A=25-300; 3B3I; X-ray; 1.86 A; A=25-300; 3B6S; X-ray; 1.80 A; A=25-300; 3BP4; X-ray; 1.85 A; A=25-300; 3BP7; X-ray; 1.80 A; A=25-300; 3CZF; X-ray; 1.20 A; A=25-300; 3D18; X-ray; 1.74 A; A=25-300; 3DTX; X-ray; 2.10 A; A=25-300; 3HCV; X-ray; 1.95 A; A=25-300; 3LV3; X-ray; 1.94 A; A=25-300	1HSA; 1JGD; 1JGE; 1K5N; 1OF2; 1OGT; 1ROG; 1ROH; 1ROI; 1ROJ; 1ROK; 1ROL; 1UXS; 1UXW; 1W0V; 1W0W; 2A83; 2BSR; 2BSS; 2BST; 3B3I; 3B6S; 3BP4; 3BP7; 3CZF; 3D18; 3DTX; 3HCV; 3LV3		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37515; I37515; I56116; I56116; S07441; HLHUB2			P03989	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P03989	REACT_6900; Immune System			SM00407; IGc1; 1	P03989; 25-300	P03989	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B35_HUMAN	P30474; Q9GJM7; Q9TPV2; Q9TQH3; Q9TQH9; Q9TQN4; Q9TQN6;	RecName: Full=HLA class I histocompatibility antigen, B-35 alpha chain; AltName: Full=MHC class I antigen B*35; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40455	P30474	Q9GJM7	Q9TPV2	Q9TQH3							HS_HLA-B					231390					M28115; AAA59617.1; -; Genomic_DNA; M28109; AAA59617.1; JOINED; Genomic_DNA; M28110; AAA59617.1; JOINED; Genomic_DNA; M28111; AAA59617.1; JOINED; Genomic_DNA; M28112; AAA59617.1; JOINED; Genomic_DNA; M28113; AAA59617.1; JOINED; Genomic_DNA; M28114; AAA59617.1; JOINED; Genomic_DNA; M63454; AAA59682.1; -; Genomic_DNA; M81798; AAA59684.1; -; mRNA; D50299; BAA08828.1; -; mRNA; M84385; AAA59635.1; -; mRNA; M84381; AAA59631.1; -; mRNA; L04695; AAA59694.1; -; mRNA; L04696; AAA52674.1; -; mRNA; Z22651; CAA80366.1; -; mRNA; M86403; -; NOT_ANNOTATED_CDS; mRNA; AF117771; AAD23460.1; -; Genomic_DNA; AF117770; AAD23460.1; JOINED; Genomic_DNA; AF134867; AAD30277.1; -; Genomic_DNA; AF134866; AAD30277.1; JOINED; Genomic_DNA; AF061864; AAC32570.1; -; Genomic_DNA; AF061863; AAC32570.1; JOINED; Genomic_DNA; AF108429; AAD27538.1; -; Genomic_DNA; AF108428; AAD27538.1; JOINED; Genomic_DNA; AF176078; AAD51745.1; -; Genomic_DNA; AF176077; AAD51745.1; JOINED; Genomic_DNA; AF110505; AAD26151.1; -; Genomic_DNA; AF110504; AAD26151.1; JOINED; Genomic_DNA; AF282766; AAG01819.1; -; Genomic_DNA; AF282765; AAG01819.1; JOINED; Genomic_DNA	P30685	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30685			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B	HIX0167180		HBG016709			P30685		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00646083				142830; gene			NX_P30685							1A1N; X-ray; 2.00 A; A=25-300; 1A9B; X-ray; 3.20 A; A/D=25-301; 1A9E; X-ray; 2.50 A; A=25-301; 1CG9; X-ray; 2.70 A; A=25-301; 1XH3; X-ray; 1.48 A; A=25-300; 1ZHK; X-ray; 1.60 A; A=25-300; 1ZHL; X-ray; 1.50 A; A=25-300; 1ZSD; X-ray; 1.70 A; A=25-300; 2AK4; X-ray; 2.50 A; A/F/K/Q=25-300; 2AXF; X-ray; 1.80 A; A=25-300; 2AXG; X-ray; 2.00 A; A=25-300; 2CIK; X-ray; 1.75 A; A=25-300; 2FYY; X-ray; 1.50 A; A=25-300; 2FZ3; X-ray; 1.90 A; A=25-300; 2H6P; X-ray; 1.90 A; A=25-300; 2NW3; X-ray; 1.70 A; A=25-300; 2NX5; X-ray; 2.70 A; A/F/K/Q=25-300; 3BW9; X-ray; 1.75 A; A=25-300; 3BWA; X-ray; 1.30 A; A=25-300; 3KWW; X-ray; 2.18 A; A=25-300; 3KXF; X-ray; 3.10 A; A/C/I/K=25-300; 3LKN; X-ray; 2.00 A; A=25-300; 3LKO; X-ray; 1.80 A; A=25-300; 3LKP; X-ray; 1.80 A; A=25-300; 3LKQ; X-ray; 1.80 A; A=25-300; 3LKR; X-ray; 2.00 A; A=25-300; 3LKS; X-ray; 1.90 A; A=25-300; 3MV7; X-ray; 2.00 A; A=25-300; 3MV8; X-ray; 2.10 A; A=25-300; 3MV9; X-ray; 2.70 A; A=25-300; 3VFS; X-ray; 1.85 A; A=25-300; 3VFT; X-ray; 1.95 A; A=25-300; 3VFU; X-ray; 1.65 A; A=25-300; 3VFV; X-ray; 1.55 A; A=25-300; 3VFW; X-ray; 2.30 A; A=25-300	1A1N; 1A9B; 1A9E; 1CG9; 1XH3; 1ZHK; 1ZHL; 1ZSD; 2AK4; 2AXF; 2AXG; 2CIK; 2FYY; 2FZ3; 2H6P; 2NW3; 2NX5; 3BW9; 3BWA; 3KWW; 3KXF; 3LKN; 3LKO; 3LKP; 3LKQ; 3LKR; 3LKS; 3MV7; 3MV8; 3MV9; 3VFS; 3VFT; 3VFU; 3VFV; 3VFW		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A45880; A45880; I54298; I54298; I56133; I56133; I61904; I61904; I61907; I61907; I81233; I81233			P30685	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30685	REACT_6900; Immune System			SM00407; IGc1; 1	P30685; 25-300	P30685	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B37_HUMAN	P18463; O19627; Q546L8; Q95HA3; Q95HA8; Q95HM9; Q9GJ31;	RecName: Full=HLA class I histocompatibility antigen, B-37 alpha chain; AltName: Full=MHC class I antigen B*37; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40456	P18463	O19627	Q546L8	Q95HA3							HS_HLA-B					122160					M32320; AAA36233.1; -; mRNA; AJ310358; CAC38763.1; -; Genomic_DNA; AF389378; AAL26324.1; -; mRNA; AF418978; AAL07502.1; -; mRNA; AF284828; AAK82990.1; -; Genomic_DNA; AF284826; AAK82990.1; JOINED; Genomic_DNA; AF284827; AAK82990.1; JOINED; Genomic_DNA; U11267; AAA19927.1; -; mRNA; AF303102; AAG21400.1; -; Genomic_DNA; AF303101; AAG21400.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P18463			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P18463		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472652				142830; gene			NX_P18463										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				C35997; C35997			P18463	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P18463	REACT_6900; Immune System			SM00407; IGc1; 1	P18463; 25-300	P18463	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B38_HUMAN	Q9BCM8; Q9MY92; Q9MYG1; Q9TPT2;	RecName: Full=HLA class I histocompatibility antigen, B-38 alpha chain; AltName: Full=Bw-4; AltName: Full=MHC class I antigen B*38; Flags: Precursor;				ENST00000425848	ENSP00000400842	ENSG00000223532						362	40416	Q9BCM8	Q9MY92	Q9MYG1	Q9TPT2							HS_HLA-B					34305608					L36591; AAA73509.1; -; mRNA; U40498; AAD00010.1; -; mRNA; L22028; AAA59618.1; -; mRNA; AJ297317; CAC29063.1; -; Genomic_DNA; U90241; AAB82305.1; -; Genomic_DNA; U90240; AAB82305.1; JOINED; Genomic_DNA; AJ308991; CAC34965.1; -; Genomic_DNA; AJ308992; CAC34965.1; JOINED; Genomic_DNA; AF081275; AAC32198.1; -; mRNA; AF081276; AAC32199.1; -; Genomic_DNA; AF181858; AAD56222.1; -; Genomic_DNA; AF181857; AAD56222.1; JOINED; Genomic_DNA; AF262961; AAF78055.1; -; Genomic_DNA; AF262960; AAF78055.1; JOINED; Genomic_DNA; AF218804; AAF67340.1; -; Genomic_DNA; AF218802; AAF67340.1; JOINED; Genomic_DNA; AF218803; AAF67340.1; JOINED; Genomic_DNA; AF281054; AAK69506.1; -; Genomic_DNA; AF281053; AAK69506.1; JOINED; Genomic_DNA; AF402321; AAL04500.1; -; Genomic_DNA; AF402320; AAL04500.1; JOINED; Genomic_DNA; M29864; AAA36222.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q95365			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			Q95365		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00473068				142830; gene			NX_Q95365										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A59028; A59028; I54463; I54463			Q95365	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q95365	REACT_6900; Immune System			SM00407; IGc1; 1	Q95365; 25-300	Q95365	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B39_HUMAN	Q29847; Q29852; Q29858; Q8HWF0; Q9TPQ7;	RecName: Full=HLA class I histocompatibility antigen, B-39 alpha chain; AltName: Full=MHC class I antigen B*39; Flags: Precursor;				ENST00000425848	ENSP00000400842	ENSG00000223532						362	40328	Q29847	Q29852	Q29858	Q8HWF0							HS_HLA-B					231398					M94052; AAA52658.1; -; Genomic_DNA; M94051; AAA52660.1; -; Genomic_DNA; M94053; AAA52659.1; -; Genomic_DNA; U04243; AAA87396.1; -; mRNA; L36318; AAA73942.1; -; mRNA; L22649; AAA69861.1; -; Genomic_DNA; U29480; AAC50392.1; -; mRNA; L42024; AAB59484.1; -; mRNA; U29083; AAC32741.1; -; mRNA; U56246; AAB01985.1; -; Genomic_DNA; Y09058; CAA70261.1; -; mRNA; AB091216; BAC11810.1; -; Genomic_DNA; AB091218; BAC11811.1; -; Genomic_DNA; AF428252; AAN63555.1; -; mRNA; L42280; AAB51452.1; -; Genomic_DNA; U76395; AAB39108.1; -; Genomic_DNA; U76394; AAB39108.1; JOINED; Genomic_DNA; AB032097; BAA84116.1; -; Genomic_DNA; U15640; AAA74047.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30475			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30475		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472800				142830; gene			NX_P30475										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I38876; I38876; I54314; I54314; I54505; I54505; I68850; I68850; I84488; I84488			P30475	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30475	REACT_6900; Immune System			SM00407; IGc1; 1	P30475; 25-300	P30475	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B40_HUMAN	Q29855; Q30173; Q31603; Q9TPT6;	RecName: Full=HLA class I histocompatibility antigen, B-40 alpha chain; AltName: Full=Bw-60; AltName: Full=MHC class I antigen B*40; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40505	Q29855	Q30173	Q31603	Q9TPT6							HS_HLA-B					416557					U03698; AAA03719.1; -; mRNA; L41628; AAA65040.1; -; Genomic_DNA; L09736; AAA36224.1; -; mRNA; D14343; BAA03277.1; -; mRNA; M84383; AAA59633.1; -; mRNA; M84384; AAA59634.1; -; mRNA; M84694; AAA03661.1; -; mRNA; X84725; CAA59215.1; -; mRNA; AJ300180; CAC15501.1; -; Genomic_DNA; AJ292253; CAC29021.1; -; Genomic_DNA; L41353; AAC41923.1; -; Genomic_DNA; L76934; AAA96270.1; -; mRNA; AF017023; AAB70252.1; -; Genomic_DNA; AF017022; AAB70252.1; JOINED; Genomic_DNA; AF181472; AAD56943.1; -; Genomic_DNA; AF181471; AAD56943.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q04826			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			Q04826		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00746105				142830; gene			NX_Q04826										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I38437; HLHU40; I56149; I56149; I59655; I59655; I61905; I61905; I61906; I61906; S52486; S52486			Q04826	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q04826	REACT_6900; Immune System			SM00407; IGc1; 1	Q04826; 25-298	Q04826	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B41_HUMAN	P30479; O19595; Q29848; Q5TK77; Q9MY79; Q9MY94;	RecName: Full=HLA class I histocompatibility antigen, B-41 alpha chain; AltName: Full=Bw-41; AltName: Full=MHC class I antigen B*41; Flags: Precursor;				ENST00000425848	ENSP00000400842	ENSG00000223532						362	40539	P30479	O19595	Q29848	Q5TK77							HS_HLA-B					231402					M24035; AAA59666.1; -; Genomic_DNA; AJ309193; CAC38392.1; -; Genomic_DNA; X81363; CAA57128.1; -; mRNA; AF028596; AAC33187.1; -; Genomic_DNA; AF028595; AAC33187.1; JOINED; Genomic_DNA; AF258782; AAF76144.1; -; Genomic_DNA; AF279118; AAF81603.1; -; Genomic_DNA; AF279117; AAF81603.1; JOINED; Genomic_DNA	P30479	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30479			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30479		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00026602				142830; gene			NX_P30479							3LN4; X-ray; 1.30 A; A=25-298; 3LN5; X-ray; 1.90 A; A=25-298	3LN4; 3LN5		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37492; I37492; I61864; I61864			P30479	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30479	REACT_6900; Immune System			SM00407; IGc1; 1	P30479; 25-298	P30479	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B42_HUMAN	P30480; P79555;	RecName: Full=HLA class I histocompatibility antigen, B-42 alpha chain; AltName: Full=MHC class I antigen B*42; Flags: Precursor;				ENST00000412585	ENSP00000399168	ENSG00000234745						362	40333	P30480	P79555					P30480				HS_HLA-B					231403					M24034; AAA59667.1; -; Genomic_DNA; U88407; AAC16437.1; -; mRNA; AJ309194; CAC38393.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30480	ENSG00000204523; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709	CAB015418			P30480; 26	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472676				142830; gene			NX_P30480										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I61865; I61865			P30480	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30480	REACT_6900; Immune System			SM00407; IGc1; 1	P30480; 25-300	P30480	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B44_HUMAN	Q9BCM7; Q9MYC3; Q9UQS8;	RecName: Full=HLA class I histocompatibility antigen, B-44 alpha chain; AltName: Full=Bw-44; AltName: Full=MHC class I antigen B*44; Flags: Precursor;				ENST00000421349	ENSP00000405365	ENSG00000228964						362	40481	Q9BCM7	Q9MYC3	Q9UQS8								HS_HLA-B					231404				NOG42056	M24038; AAA59663.1; -; Genomic_DNA; X64366; CAA45718.1; -; mRNA; L42282; AAB51454.1; -; Genomic_DNA; L42283; AAB51455.1; -; Genomic_DNA; X90391; CAA62036.1; -; mRNA; U64801; AAB40632.1; -; mRNA; AJ133267; CAB38071.2; -; Genomic_DNA; AJ131118; CAB37868.1; -; mRNA; AJ309936; CAC33891.1; -; Genomic_DNA; AJ309937; CAC33892.1; -; Genomic_DNA; AJ535113; CAD59381.1; -; mRNA; AJ550735; CAD79566.1; -; Genomic_DNA; BX248310; CAI18717.1; -; Genomic_DNA; M15470; AAA59619.1; -; mRNA	P30481	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30481			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B	HIX0167415		HBG016709			P30481		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00743117				142830; gene			NX_P30481				EOG4F4SBG			1M6O; X-ray; 1.60 A; A=25-300; 1SYS; X-ray; 2.40 A; A=25-300; 1SYV; X-ray; 1.70 A; A=25-300; 3DX6; X-ray; 1.70 A; A=25-300; 3DX7; X-ray; 1.60 A; A=25-300; 3DX8; X-ray; 2.10 A; A=25-300; 3DXA; X-ray; 3.50 A; A/F/K=25-300; 3KPL; X-ray; 1.96 A; A=25-300; 3KPM; X-ray; 1.60 A; A=25-300; 3KPN; X-ray; 2.00 A; A=25-300; 3KPO; X-ray; 2.30 A; A=25-300; 3KPP; X-ray; 1.90 A; A=25-300; 3KPQ; X-ray; 1.84 A; A=25-300; 3KPR; X-ray; 2.60 A; A/F=25-300; 3KPS; X-ray; 2.70 A; A=25-300; 3L3D; X-ray; 1.80 A; A=25-300; 3L3G; X-ray; 2.10 A; A=25-300; 3L3I; X-ray; 1.70 A; A=25-300; 3L3J; X-ray; 2.40 A; A=25-300; 3L3K; X-ray; 2.60 A; A=25-300	1M6O; 1SYS; 1SYV; 3DX6; 3DX7; 3DX8; 3DXA; 3KPL; 3KPM; 3KPN; 3KPO; 3KPP; 3KPQ; 3KPR; 3KPS; 3L3D; 3L3G; 3L3I; 3L3J; 3L3K		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A25295; HLHUB4; I61861; I61861; S25415; S25415			P30481	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30481	REACT_6900; Immune System			SM00407; IGc1; 1	P30481; 25-300	P30481	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011jii.2; human	Hs.77961
1B45_HUMAN	P30483; Q9GIZ0; Q9MX21;	RecName: Full=HLA class I histocompatibility antigen, B-45 alpha chain; AltName: Full=Bw-45; AltName: Full=MHC class I antigen B*45; Flags: Precursor;				ENST00000450871	ENSP00000388208	ENSG00000232126						362	40414	P30483	Q9GIZ0	Q9MX21								HS_HLA-B					231406					X61710; CAA43879.1; -; mRNA; AJ278944; CAC07211.1; -; Genomic_DNA; AJ458992; CAD30340.1; -; Genomic_DNA; AJ275937; CAB83041.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30483			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30483		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472416				142830; gene			NX_P30483										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37519; I37519			P30483	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30483	REACT_6900; Immune System			SM00407; IGc1; 1	P30483; 25-298	P30483	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B46_HUMAN	P30484; Q9TPR2;	RecName: Full=HLA class I histocompatibility antigen, B-46 alpha chain; AltName: Full=Bw-46; AltName: Full=MHC class I antigen B*46; Flags: Precursor;				ENST00000450871	ENSP00000388208	ENSG00000232126						362	40440	P30484	Q9TPR2									HS_HLA-B					231407					M24033; AAA59665.1; -; mRNA; AJ310508; CAC34573.1; -; Genomic_DNA; AB032091; BAA84111.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30484	ENSG00000204523; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00744375				142830; gene			NX_P30484										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I61863; I61863			P30484	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30484	REACT_6900; Immune System			SM00407; IGc1; 1	P30484; 25-300	P30484	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B47_HUMAN	P30485; O19555; O77933; Q95392; Q9GIL3;	RecName: Full=HLA class I histocompatibility antigen, B-47 alpha chain; AltName: Full=Bw-47; AltName: Full=MHC class I antigen B*47; Flags: Precursor;				ENST00000435618	ENSP00000405178	ENSG00000224608						362	40571	P30485	O19555	O77933	Q95392							HS_HLA-B					231408					M19756; AAA52664.1; -; Genomic_DNA; AJ308398; CAC33087.2; -; Genomic_DNA; AJ295141; CAC17463.2; -; Genomic_DNA; Y09118; CAA70335.1; -; mRNA; AF016843; AAB70513.1; -; Genomic_DNA; AF016842; AAB70513.1; JOINED; Genomic_DNA; AF071764; AAC23752.1; -; Genomic_DNA; AF071763; AAC23752.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30485			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30485		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472402				142830; gene			NX_P30485										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I68724; I68724			P30485	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30485	REACT_6900; Immune System			SM00407; IGc1; 1	P30485; 25-300	P30485	SSF54452; MHC_I/II-like_Ag-recog; 1						
1B48_HUMAN	P30486; Q29764;	RecName: Full=HLA class I histocompatibility antigen, B-48 alpha chain; AltName: Full=Bw-48; AltName: Full=MHC class I antigen B*48; Flags: Precursor;				ENST00000412585	ENSP00000399168	ENSG00000234745						362	40362	P30486	Q29764					P30486				HS_HLA-B					231409					M84380; AAA59629.1; -; mRNA; AJ309139; CAC38066.1; -; Genomic_DNA; L76931; AAB59617.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30486	ENSG00000204523; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4932; HLA-B			HBG016709	CAB015418				IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472057				142830; gene			NX_P30486										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I61903; I61903			P30486	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30486				SM00407; IGc1; 1	P30486; 25-300	P30486	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B49_HUMAN	P30487; O19625; Q9MY37; Q9MY93;	RecName: Full=HLA class I histocompatibility antigen, B-49 alpha chain; AltName: Full=HLA class I histocompatibility antigen, B-21 alpha chain; AltName: Full=MHC class I antigen B*49; Flags: Precursor;				ENST00000435618	ENSP00000405178	ENSG00000224608						362	40581	P30487	O19625	Q9MY37	Q9MY93							HS_HLA-B					1345599					M24037; AAA02950.1; -; mRNA; U11263; AAA19923.1; -; mRNA; AF262959; AAF78054.1; -; Genomic_DNA; AF262958; AAF78054.1; JOINED; Genomic_DNA; AJ288980; CAB88084.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30487			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B	HIX0166654		HBG016709			P30487		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472456				142830; gene			NX_P30487										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1							P30487	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30487	REACT_6900; Immune System			SM00407; IGc1; 1	P30487; 25-300	P30487	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B50_HUMAN	P30488; O19615; O19624; O19641; O19783; O46702; O78172; Q9TQG1;	RecName: Full=HLA class I histocompatibility antigen, B-50 alpha chain; AltName: Full=Bw-50; AltName: Full=HLA class I histocompatibility antigen, B-21 alpha chain; AltName: Full=MHC class I antigen B*50; Flags: Precursor;				ENST00000450871	ENSP00000388208	ENSG00000232126						362	40541	P30488	O19615	O19624	O19641							HS_HLA-B					231411					X61706; CAA43875.1; -; mRNA; U11261; AAA19921.1; -; mRNA; D50693; BAA23588.1; -; Genomic_DNA; Y08995; CAA70199.1; -; mRNA; AF006634; AAD01274.1; -; mRNA; Y14205; CAA74596.1; -; Genomic_DNA; U58318; AAB87724.1; -; Genomic_DNA; U58317; AAB87724.1; JOINED; Genomic_DNA; AF008927; AAB63511.1; -; Genomic_DNA; AF008926; AAB63511.1; JOINED; Genomic_DNA; AF136398; AAD34474.1; -; Genomic_DNA; AF136397; AAD34474.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30488			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30488		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00471955				142830; gene			NX_P30488										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37520; I37520			P30488	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30488	REACT_6900; Immune System			SM00407; IGc1; 1	P30488; 25-298	P30488	SSF54452; MHC_I/II-like_Ag-recog; 1						
1B51_HUMAN	P18464; O19675; O78173; P30489; Q29851; Q29857; Q96IT9; Q9MY43;	RecName: Full=HLA class I histocompatibility antigen, B-51 alpha chain; AltName: Full=MHC class I antigen B*51; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40566	P18464	O19675	O78173	P30489							HS_HLA-B			DIP-6150N		122172					M32319; AAA36232.1; -; mRNA; M22792; AAA59620.1; ALT_SEQ; Genomic_DNA; M22786; AAA59620.1; JOINED; Genomic_DNA; M22787; AAA59620.1; JOINED; Genomic_DNA; M22788; AAA59620.1; JOINED; Genomic_DNA; M22789; AAA59620.1; JOINED; Genomic_DNA; M22790; AAA59620.1; JOINED; Genomic_DNA; M22791; AAA59620.1; JOINED; Genomic_DNA; L41087; AAA64513.1; -; Genomic_DNA; L41086; AAA64513.1; JOINED; Genomic_DNA; Z15143; CAA78849.1; -; mRNA; M80670; AAA52661.1; -; Genomic_DNA; L41925; AAC41979.1; -; mRNA; Y08994; CAA70198.1; -; mRNA; AB056860; BAB64902.1; -; Genomic_DNA; AB056862; BAB64904.1; -; Genomic_DNA; AB056863; BAB64905.1; -; Genomic_DNA; AB056864; BAB64906.1; -; Genomic_DNA; AB056865; BAB64907.1; -; Genomic_DNA; AJ278903; CAC05371.1; -; Genomic_DNA; BC007243; AAH07243.1; -; mRNA; AJ276995; CAB86196.1; -; Genomic_DNA; Z46808; CAA86838.1; -; mRNA	P18464	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P18464			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B	HIX0005715		HBG016709			P18464		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00718924				142830; gene	MINT-144207		NX_P18464							1E27; X-ray; 2.20 A; A=25-300; 1E28; X-ray; 3.00 A; A=25-300	1E27; 1E28		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A30345; A30345; I37120; I37120			P18464	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P18464	REACT_6900; Immune System			SM00407; IGc1; 1	P18464; 25-300	P18464	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B52_HUMAN	P30490; Q9MY75; Q9TPT4;	RecName: Full=HLA class I histocompatibility antigen, B-52 alpha chain; AltName: Full=Bw-52; AltName: Full=HLA class I histocompatibility antigen, B-5 alpha chain; AltName: Full=MHC class I antigen B*52; Flags: Precursor;				ENST00000450871	ENSP00000388208	ENSG00000232126						362	40521	P30490	Q9MY75	Q9TPT4								HS_HLA-B					231413					M22799; AAA59645.1; ALT_SEQ; Genomic_DNA; M22793; AAA59645.1; JOINED; Genomic_DNA; M22794; AAA59645.1; JOINED; Genomic_DNA; M22795; AAA59645.1; JOINED; Genomic_DNA; M22796; AAA59645.1; JOINED; Genomic_DNA; M22797; AAA59645.1; JOINED; Genomic_DNA; M22798; AAA59645.1; JOINED; Genomic_DNA; AF181845; AAF00933.1; -; Genomic_DNA; AF181844; AAF00933.1; JOINED; Genomic_DNA; AF281153; AAF81610.1; -; Genomic_DNA; AF281152; AAF81610.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30490			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30490		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00744689				142830; gene			NX_P30490										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				B30345; B30345			P30490	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30490	REACT_6900; Immune System			SM00407; IGc1; 1	P30490; 25-300	P30490	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B53_HUMAN	Q9TP36; Q9TQH8;	RecName: Full=HLA class I histocompatibility antigen, B-53 alpha chain; AltName: Full=Bw-53; AltName: Full=MHC class I antigen B*53; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40495	Q9TP36	Q9TQH8		Q30198							HS_HLA-B			DIP-6054N		231414					M58636; AAA36228.1; -; Genomic_DNA; U90566; AAB96793.1; -; Genomic_DNA; AJ311599; CAC35317.1; -; Genomic_DNA; U63562; AAB05926.1; -; Genomic_DNA; U63561; AAB05926.1; JOINED; Genomic_DNA; AF071770; AAC35939.1; -; Genomic_DNA; AF071769; AAC35939.1; JOINED; Genomic_DNA; AF198653; AAF20814.1; -; Genomic_DNA; AF198652; AAF20814.1; JOINED; Genomic_DNA; AF117773; AAD23461.1; -; Genomic_DNA; AF117772; AAD23461.1; JOINED; Genomic_DNA; AF304003; AAG53942.1; -; Genomic_DNA; AF304002; AAG53942.1; JOINED; Genomic_DNA; AJ276996; CAB86197.1; -; Genomic_DNA; AJ293856; CAC05305.1; -; Genomic_DNA; AJ293857; CAC05305.1; JOINED; Genomic_DNA	P30491	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30491			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30491		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00655604				142830; gene			NX_P30491							1A1M; X-ray; 2.30 A; A=25-300; 1A1O; X-ray; 2.30 A; A=25-300	1A1M; 1A1O		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A45834; A45834			P30491	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30491	REACT_6900; Immune System			SM00407; IGc1; 1	P30491; 25-300	P30491	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B54_HUMAN	P30492; Q9TPQ9;	RecName: Full=HLA class I histocompatibility antigen, B-54 alpha chain; AltName: Full=Bw-22; AltName: Full=Bw-54; AltName: Full=MHC class I antigen B*54; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40380	P30492	Q9TPQ9									HS_HLA-B					231415					M77774; AAA03686.1; -; mRNA; AB032095; BAA84114.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30492			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30492		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472282				142830; gene			NX_P30492										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I56130; I56130			P30492	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30492	REACT_6900; Immune System			SM00407; IGc1; 1	P30492; 25-300	P30492	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B55_HUMAN	P30493; O78163; P30494; P79489; P79523; Q8MGQ3; Q9GIZ9; Q9GJ00;	RecName: Full=HLA class I histocompatibility antigen, B-55 alpha chain; AltName: Full=Bw-55; AltName: Full=HLA class I histocompatibility antigen, B-12 alpha chain; AltName: Full=MHC class I antigen B*55; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40496	P30493	O78163	P30494	P79489							HS_HLA-B					231416					M77777; AAA03688.1; -; mRNA; M77778; AAA03687.1; -; mRNA; AY007140; AAG02001.1; -; mRNA; AJ310509; CAC34574.1; -; Genomic_DNA; AJ420106; CAD12250.1; -; Genomic_DNA; AJ420333; CAD12454.1; -; Genomic_DNA; D85761; BAA12868.1; -; mRNA; U63653; AAB40126.1; -; mRNA; AF091344; AAC61281.1; -; Genomic_DNA; AF091343; AAC61281.1; JOINED; Genomic_DNA; AJ250628; CAC12872.1; -; Genomic_DNA; AJ250629; CAC12873.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30493			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30493		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472767				142830; gene			NX_P30493										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I72752; I72752; I72753; I72753			P30493	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30493	REACT_6900; Immune System			SM00407; IGc1; 1	P30493; 25-300	P30493	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B56_HUMAN	P30495; O19758; P30496; P79490; Q9GIM3; Q9GJ17; Q9TPR4;	RecName: Full=HLA class I histocompatibility antigen, B-56 alpha chain; AltName: Full=Bw-22; AltName: Full=Bw-56; AltName: Full=MHC class I antigen B*56; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40478	P30495	O19758	P30496	P79490							HS_HLA-B					231418					M77775; AAA03690.1; -; mRNA; M77776; AAA03689.1; -; mRNA; D85762; BAA12869.1; -; mRNA; U93914; AAB62223.1; -; Genomic_DNA; U93913; AAB62223.1; JOINED; Genomic_DNA; AB030574; BAA82677.1; -; Genomic_DNA; Y18542; CAC12884.1; -; Genomic_DNA; Y18543; CAC12884.1; JOINED; Genomic_DNA; Y18544; CAC12896.1; -; Genomic_DNA; Y18545; CAC12896.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30495			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30495		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472284				142830; gene			NX_P30495										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I72754; I72754; I72755; I72755			P30495	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30495	REACT_6900; Immune System			SM00407; IGc1; 1		P30495	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B57_HUMAN	P18465; O62917; P30497; P79496; Q29679; Q5QT24;	RecName: Full=HLA class I histocompatibility antigen, B-57 alpha chain; AltName: Full=Bw-57; AltName: Full=MHC class I antigen B*57; Flags: Precursor;				ENST00000435618	ENSP00000405178	ENSG00000224608						362	40224	P18465	O62917	P30497	P79496							HS_HLA-B					122174					M32318; AAA36231.1; -; mRNA; X55711; CAA39244.1; -; Genomic_DNA; AJ458991; CAD30339.1; -; Genomic_DNA; X61707; CAA43876.1; -; mRNA; U18790; AAB60361.1; -; mRNA; Y09157; CAA70355.1; -; mRNA; AF061860; AAC32568.1; -; Genomic_DNA; AF061859; AAC32568.1; JOINED; Genomic_DNA	P18465	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P18465			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P18465		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472434				142830; gene			NX_P18465							2BVO; X-ray; 1.65 A; A=25-300; 2BVP; X-ray; 1.35 A; A=25-300; 2BVQ; X-ray; 2.00 A; A=25-300; 2HJL; X-ray; 1.50 A; A=21-45; 2RFX; X-ray; 2.50 A; A=25-299; 3VH8; X-ray; 1.80 A; A/D=25-299	2BVO; 2BVP; 2BVQ; 2HJL; 2RFX; 3VH8		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				D35997; D35997			P18465	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P18465	REACT_6900; Immune System			SM00407; IGc1; 1	P18465; 25-298	P18465	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B58_HUMAN	P10319; Q29925; Q9TP35; Q9TPS6;	RecName: Full=HLA class I histocompatibility antigen, B-58 alpha chain; AltName: Full=Bw-58; AltName: Full=MHC class I antigen B*58; Flags: Precursor;				ENST00000435618	ENSP00000405178	ENSG00000224608						362	40337	P10319	Q29925	Q9TP35	Q9TPS6							HS_HLA-B					122168					M11799; AAA59628.1; -; Genomic_DNA; AB008102; BAA22916.1; -; mRNA; L33923; AAA74406.1; -; mRNA; AF189247; AAF04579.1; -; Genomic_DNA; AF189245; AAF04579.1; JOINED; Genomic_DNA; AF189246; AAF04579.1; JOINED; Genomic_DNA; AF201475; AAF21438.1; -; Genomic_DNA; AF201474; AAF21438.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P10319			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P10319		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472138				142830; gene; 608579; phenotype			NX_P10319										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A23895; HLHUB8; I84490; I84490			P10319	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P10319	REACT_6900; Immune System			SM00407; IGc1; 1	P10319; 25-298	P10319	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B59_HUMAN	Q29940; O02957;	RecName: Full=HLA class I histocompatibility antigen, B-59 alpha chain; AltName: Full=MHC class I antigen B*59; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40584	Q29940	O02957									HS_HLA-B					34305704					L07743; AAA59621.1; -; mRNA; D50300; BAA08829.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q29940			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			Q29940		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472073				142830; gene			NX_Q29940										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I59633; I59633			Q29940	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29940	REACT_6900; Immune System			SM00407; IGc1; 1	Q29940; 25-300	Q29940	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B67_HUMAN	Q29836; Q29678; Q8SNC5; Q95IA6; Q9BD38;	RecName: Full=HLA class I histocompatibility antigen, B-67 alpha chain; AltName: Full=MHC class I antigen B*67; Flags: Precursor;				ENST00000412585	ENSP00000399168	ENSG00000234745						362	40342	Q29836	Q29678	Q8SNC5	Q95IA6			Q29836				HS_HLA-B					34222510					L17005; AAC37548.1; -; mRNA; U18789; AAB60360.1; -; mRNA; AF487379; AAL93257.1; -; Genomic_DNA; AF321835; AAK09378.1; -; Genomic_DNA; AF321834; AAK09378.1; JOINED; Genomic_DNA; AY050196; AAL18235.1; -; Genomic_DNA; AY050195; AAL18235.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q29836	ENSG00000204523; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709	CAB015418				IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472867				142830; gene			NX_Q29836										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I59645; I59645			Q29836	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29836	REACT_6900; Immune System			SM00407; IGc1; 1	Q29836; 25-300	Q29836	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B73_HUMAN	Q31612;	RecName: Full=HLA class I histocompatibility antigen, B-73 alpha chain; AltName: Full=MHC class I antigen B*73; Flags: Precursor;				ENST00000412585	ENSP00000399168	ENSG00000234745						363	40435	Q31612						Q31612				HS_HLA-B					34222512					U04787; AAA53175.1; -; mRNA; X77658; CAA54739.1; -; mRNA; L24373; AAA96733.1; -; mRNA; AJ311601; CAC35319.2; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q31612	ENSG00000204523; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709	CAB015418				IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472943				142830; gene			NX_Q31612										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1		Q31612		I37512; S42102			Q31612	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q31612	REACT_6900; Immune System			SM00407; IGc1; 1	Q31612; 25-300	Q31612	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B78_HUMAN	P30498; O62915; Q29924; Q546M4;	RecName: Full=HLA class I histocompatibility antigen, B-78 alpha chain; AltName: Full=MHC class I antigen B*78; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40478	P30498	O62915	Q29924	Q546M4							HS_HLA-B					231421					X61708; CAA43877.1; -; mRNA; M33573; AAA59644.1; -; Genomic_DNA; L41214; AAC41980.1; -; mRNA; AJ309192; CAC38391.1; -; Genomic_DNA; AF061856; AAC32566.1; -; Genomic_DNA; AF061855; AAC32566.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			P30498			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			P30498		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00746605				142830; gene			NX_P30498										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37522; I37522			P30498	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30498	REACT_6900; Immune System			SM00407; IGc1; 1	P30498; 25-300	P30498	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B81_HUMAN	Q31610;	RecName: Full=HLA class I histocompatibility antigen, B-81 alpha chain; AltName: Full=B'DT; AltName: Full=MHC class I antigen B*81; Flags: Precursor;				ENST00000412585	ENSP00000399168	ENSG00000234745						362	40400	Q31610						Q31610				HS_HLA-B					34222511					L37880; AAC41941.1; -; mRNA; X90390; CAA62035.1; -; mRNA; U09912; AAF70855.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q31610	ENSG00000204523; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709	CAB015418				IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472753				142830; gene			NX_Q31610										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1							Q31610	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q31610	REACT_6900; Immune System			SM00407; IGc1; 1	Q31610; 25-300	Q31610	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.77961
1B82_HUMAN	Q29718; Q29695; Q29742; Q8MHN4; Q9MY61; Q9MYB8;	RecName: Full=HLA class I histocompatibility antigen, B-82 alpha chain; AltName: Full=MHC class I antigen B*82; Flags: Precursor;				ENST00000359635	ENSP00000352656	ENSG00000206450						362	40421	Q29718	Q29695	Q29742	Q8MHN4							HS_HLA-B					34222509					U36492; AAB18369.1; -; mRNA; U29241; AAC50691.1; -; Genomic_DNA; U38800; AAC99997.1; -; mRNA; AJ278748; CAC00634.1; -; Genomic_DNA; U43337; AAA87573.1; -; mRNA; AJ251755; CAB75360.1; -; Genomic_DNA; AF525410; AAM83101.1; -; Genomic_DNA; AF525409; AAM83101.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031321			Q29718			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4932; HLA-B			HBG016709			Q29718		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472210				142830; gene			NX_Q29718										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1							Q29718	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29718	REACT_6900; Immune System			SM00407; IGc1; 1	Q29718; 25-300	Q29718	SSF54452; MHC_I/II-like_Ag-recog; 1						
1C01_HUMAN	P30499; O02865; O19676; P30500; Q29986; Q9UQS9;	RecName: Full=HLA class I histocompatibility antigen, Cw-1 alpha chain; AltName: Full=MHC class I antigen Cw*1; Flags: Precursor;				ENST00000438171	ENSP00000393374	ENSG00000237022						366	40965	P30499	O02865	O19676	P30500							HS_HLA-C					231423				NOG42056	M26429; AAA59701.1; -; mRNA; M16272; AAA59700.1; -; Genomic_DNA; M84171; AAA59685.1; -; mRNA; Z46809; CAA86839.1; -; mRNA; D64145; BAA19531.1; -; mRNA; AJ133100; CAB38942.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236			P30499			GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00026650				142840; gene			NX_P30499				EOG4F4SBG						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37528; I37528; I54430; I54430; I59622; I59622			P30499	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30499				SM00407; IGc1; 1	P30499; 26-298	P30499	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C02_HUMAN	P30501; P30502;	RecName: Full=HLA class I histocompatibility antigen, Cw-2 alpha chain; AltName: Full=MHC class I antigen Cw*2; Flags: Precursor;				ENST00000420206	ENSP00000410214	ENSG00000228299						366	41095	P30501	P30502									HS_HLA-C					231429				NOG42056	M26430; AAA59703.1; -; mRNA; M24030; AAA59671.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mk31228			P30501			GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C	HIX0166423		HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472605				142840; gene			NX_P30501				EOG4F4SBG						PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1		P30501		I61866; I61866			P30501	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30501				SM00407; IGc1; 1	P30501; 26-302	P30501	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C03_HUMAN	Q29993; Q9GIK8; Q9TQB4;	RecName: Full=HLA class I histocompatibility antigen, Cw-3 alpha chain; AltName: Full=MHC class I antigen Cw*3; Flags: Precursor;				ENST00000457903	ENSP00000390851	ENSG00000225691						366	40861	Q29993	Q9GIK8	Q9TQB4								HS_HLA-C					34223716				NOG42056	X00495; CAA25190.1; -; Genomic_DNA; M84172; AAA59686.1; -; mRNA; M99389; AAA88088.1; -; mRNA; M99390; AAA88089.1; -; mRNA; D50853; BAA32610.1; -; mRNA; U44064; AAB02773.1; -; Genomic_DNA; AF039198; AAD37816.1; -; Genomic_DNA; AF037079; AAC17715.1; -; Genomic_DNA; AF037078; AAC17715.1; JOINED; Genomic_DNA; AF003284; AAC17716.1; -; Genomic_DNA; AF003283; AAC17716.1; JOINED; Genomic_DNA; AF037075; AAC17717.1; -; Genomic_DNA; AF037074; AAC17717.1; JOINED; Genomic_DNA; AF037077; AAC17718.1; -; Genomic_DNA; AF037076; AAC17718.1; JOINED; Genomic_DNA; AJ298116; CAC18746.1; -; Genomic_DNA	P04222	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236			P04222			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00651697				142840; gene			NX_P04222				EOG4F4SBG			1EFX; X-ray; 3.00 A; A=25-302	1EFX		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A02190; HLHUW3; I81231; I81231			P04222	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P04222	REACT_6900; Immune System			SM00407; IGc1; 1	P04222; 25-302	P04222	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011hpe.2; human	Hs.654404; Hs.656020; Hs.77961
1C04_HUMAN	P30504; O78067; O78072; O78090; O78149; Q29921; Q9UM42;	RecName: Full=HLA class I histocompatibility antigen, Cw-4 alpha chain; AltName: Full=MHC class I antigen Cw*4; Flags: Precursor;				ENST00000400341; ENST00000400394	ENSP00000383195; ENSP00000383244	ENSG00000206435; ENSG00000206452						366	40995	P30504	O78067	O78072	O78090							HS_HLA-C					231433				NOG42056	M84386; AAA59705.1; -; mRNA; X58536; CAA41427.1; -; mRNA; AJ278494; CAB95011.1; -; Genomic_DNA; AJ238694; CAB41889.2; -; Genomic_DNA; L54059; AAB04639.1; -; Genomic_DNA; U96787; AAC17719.1; -; Genomic_DNA; U96786; AAC17719.1; JOINED; Genomic_DNA; AF036557; AAC17720.1; -; Genomic_DNA; AF036556; AAC17720.1; JOINED; Genomic_DNA; AF076476; AAC27626.1; -; Genomic_DNA; AF062588; AAC16245.1; -; Genomic_DNA; AF062587; AAC16245.1; JOINED; Genomic_DNA	P30504	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mn31226; GC06Mo31229			P30504			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4933; HLA-C	HIX0186567		HBG016709				P30504; 12	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00795906				142840; gene	MINT-101019		NX_P30504				EOG4F4SBG			1IM9; X-ray; 2.80 A; A/E=25-299; 1QQD; X-ray; 2.70 A; A=26-298	1IM9; 1QQD		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A59028; A59028; JH0526; JH0526			P30504	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30504	REACT_6900; Immune System			SM00407; IGc1; 1	P30504; 26-298	P30504	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C05_HUMAN	Q9TNN7; O02866; O62888; Q9TPV8; Q9TPX2;	RecName: Full=HLA class I histocompatibility antigen, Cw-5 alpha chain; AltName: Full=MHC class I antigen Cw*5; Flags: Precursor;				ENST00000400341; ENST00000400394	ENSP00000383195; ENSP00000383244	ENSG00000206435; ENSG00000206452						366	40912	Q9TNN7	O02866	O62888	Q9TPV8							HS_HLA-C					34305707					AJ010748; CAA09340.1; -; mRNA; U57028; AAD11469.1; -; mRNA; D64148; BAA19534.1; -; mRNA; AF047367; AAC05205.2; -; Genomic_DNA; AF047366; AAC05205.2; JOINED; Genomic_DNA; AF168611; AAD50823.1; -; mRNA; AF173008; AAD51331.1; -; Genomic_DNA; AF173007; AAD51331.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mn31226; GC06Mo31229			Q9TNN7			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00795906				142840; gene			NX_Q9TNN7										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A59028; A59028			Q9TNN7	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q9TNN7	REACT_6900; Immune System			SM00407; IGc1; 1	Q9TNN7; 26-298	Q9TNN7	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011imr.2; human	Hs.654404; Hs.656020; Hs.77961
1C06_HUMAN	Q29963; O19505; O78063; Q29989;	RecName: Full=HLA class I histocompatibility antigen, Cw-6 alpha chain; AltName: Full=MHC class I antigen Cw*6; Flags: Precursor;				ENST00000420206	ENSP00000410214	ENSG00000228299						366	40969	Q29963	O19505	O78063	Q29989							HS_HLA-C					34305706					M28160; AAA36235.1; -; mRNA; Z22752; CAA80437.1; -; Genomic_DNA; Z22753; CAA80437.1; JOINED; Genomic_DNA; Z22754; CAA80437.1; JOINED; Genomic_DNA; M28206; AAA57258.1; -; mRNA; AF019568; AAC17721.1; -; Genomic_DNA; AF019567; AAC17721.1; JOINED; Genomic_DNA; AB008136; BAA22919.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mk31228			Q29963			GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00744964				142840; gene; 177900; phenotype			NX_Q29963										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I68749; I68749			Q29963	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29963	REACT_6900; Immune System			SM00407; IGc1; 1	Q29963; 26-298	Q29963	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011gas.2; human	Hs.654404; Hs.656020; Hs.77961
1C07_HUMAN	Q95603; Q9MY31; Q9TQP9;	RecName: Full=HLA class I histocompatibility antigen, Cw-7 alpha chain; AltName: Full=MHC class I antigen Cw*7; Flags: Precursor;	NP_002108.4	NM_002117.5		ENST00000376228	ENSP00000365402	ENSG00000204525						366	40649	Q95603	Q9MY31	Q9TQP9				P10321				HS_HLA-C		3107			84028168	3107				X83394; CAA58313.1; -; mRNA; D38526; BAA07531.1; -; mRNA; D49819; BAA08625.1; -; mRNA; D49552; BAA08500.1; -; mRNA; X97321; CAA65986.1; -; mRNA; AJ001977; CAA05125.1; ALT_SEQ; Genomic_DNA; AJ010749; CAA09341.1; -; mRNA; AJ293016; CAC04321.1; -; Genomic_DNA; AJ293017; CAC04322.1; -; Genomic_DNA; AJ291815; CAC19191.1; -; Genomic_DNA; U09853; AAA50217.1; -; mRNA; AL671883; -; NOT_ANNOTATED_CDS; Genomic_DNA; Z46810; CAA86840.1; -; mRNA; M11886; AAA52665.1; -; mRNA; AF015557; AAC17722.1; -; Genomic_DNA; AF015556; AAC17722.1; JOINED; Genomic_DNA; Y18533; CAB71800.1; -; Genomic_DNA; Y18534; CAB71800.1; JOINED; Genomic_DNA; Y18535; CAB71800.1; JOINED; Genomic_DNA; Y18536; CAB71800.1; JOINED; Genomic_DNA; M28207; AAA53259.1; -; mRNA	P10321	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236	3107	ENSGT00650000093032	P10321	ENSG00000204525; Homo sapiens		GO:0031901; C:early endosome membrane; TAS:Reactome; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome; GO:0000139; C:Golgi membrane; TAS:Reactome; GO:0071556; C:integral to lumenal side of endoplasmic reticulum membrane; TAS:Reactome; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW; GO:0050776; P:regulation of immune response; TAS:Reactome; GO:0060337; P:type I interferon-mediated signaling pathway; TAS:Reactome	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00642409	hsa:3107	K06751		142840; gene		12327	NX_P10321				EOG4F4SBG			3BZF; X-ray; 2.50 A; P/Q=3-11	3BZF		PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1	PA35057		P10321	A24512; HLHUC4; I37078; I37078; I37529; I37529; I68750; I68750			P10321	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; FALSE_NEG	P10321	REACT_6900; Immune System			SM00407; IGc1; 1	P10321; 26-298	P10321	SSF54452; MHC_I/II-like_Ag-recog; 1					uc003nsy.3; human	Hs.654404; Hs.656020; Hs.77961
1C08_HUMAN	P30505; P30506; P30507;	RecName: Full=HLA class I histocompatibility antigen, Cw-8 alpha chain; AltName: Full=MHC class I antigen Cw*8; Flags: Precursor;				ENST00000400341; ENST00000400394	ENSP00000383195; ENSP00000383244	ENSG00000206435; ENSG00000206452						366	40773	P30505	P30506	P30507								HS_HLA-C					231434					M84173; AAA59687.1; -; mRNA; M84174; AAA59688.1; -; mRNA; Z15144; CAA78850.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mn31226; GC06Mo31229			P30505			GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472903				142840; gene			NX_P30505										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37135; I37135; I81232; I81232			P30505	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30505				SM00407; IGc1; 1		P30505	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C12_HUMAN	Q9UM32; Q9UM33;	RecName: Full=HLA class I histocompatibility antigen, Cw-12 alpha chain; AltName: Full=MHC class I antigen Cw*12; Flags: Precursor;				ENST00000420206	ENSP00000410214	ENSG00000228299						366	40886	Q9UM32	Q9UM33		Q860R1							HS_HLA-C					34223723				NOG42056	M21963; AAA59847.1; -; mRNA; M28172; AAA59670.1; -; Genomic_DNA; X70856; CAA50209.1; -; mRNA; X70857; CAA50210.1; -; mRNA; D64152; BAA19537.1; -; mRNA; D83741; BAA32615.1; -; mRNA; AF189726; AAF04581.1; -; Genomic_DNA; AF189725; AAF04581.1; JOINED; Genomic_DNA; U06695; AAA92995.1; -; mRNA; U06696; AAA92996.1; -; mRNA; X82122; CAA57634.1; -; mRNA; AJ420248; CAD12433.1; -; Genomic_DNA; D64146; BAA19532.1; -; mRNA; Y11843; CAA72592.1; -; mRNA; X99704; CAA68035.1; -; mRNA; AF015559; AAC17724.1; -; Genomic_DNA; AF015558; AAC17724.1; JOINED; Genomic_DNA; AF036553; AAC17725.1; -; Genomic_DNA; AF036552; AAC17725.1; JOINED; Genomic_DNA; Z83247; CAB05845.1; -; mRNA; Z80228; CAB02409.1; -; Genomic_DNA; AJ249163; CAB53538.1; -; Genomic_DNA; AJ249164; CAB53539.1; -; Genomic_DNA; AJ304496; CAC19018.1; -; Genomic_DNA; AJ550622; CAD79471.1; -; Genomic_DNA; AJ550623; CAD79472.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mk31228			P30508			GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C			HBG016709				P30508; 5	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00743716				142840; gene			NX_P30508										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A59028; A59028; I37526; I37526; I38507; I38507; I54449; I54449; I72113; I72113			P30508	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30508				SM00407; IGc1; 1	P30508; 26-302	P30508	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C14_HUMAN	P30510; O62879; O78178; Q29641; Q30192; Q9MY35; Q9TQJ5;	RecName: Full=HLA class I histocompatibility antigen, Cw-14 alpha chain; AltName: Full=MHC class I antigen Cw*14; Flags: Precursor;				ENST00000438171	ENSP00000393374	ENSG00000237022						366	40838	P30510	O62879	O78178	Q29641							HS_HLA-C					34395950					M28171; AAA59669.1; -; Genomic_DNA; U06487; AAA92994.1; -; mRNA; U41386; AAC32743.1; -; mRNA; D49820; BAA89793.1; -; mRNA; AF015555; AAC17726.1; -; Genomic_DNA; AF015554; AAC17726.1; JOINED; Genomic_DNA; D31817; BAA06604.1; -; mRNA; AJ420249; CAD12434.1; -; Genomic_DNA; AF104219; AAD21014.1; -; Genomic_DNA; AF104218; AAD21014.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236			P30510			GO:0005887; C:integral to plasma membrane; NAS:UniProtKB; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; NAS:UniProtKB; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00749025				142840; gene			NX_P30510										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I56034; I56034			P30510	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P30510				SM00407; IGc1; 1	P30510; 26-298	P30510	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C15_HUMAN	Q07000; O78165; Q29864; Q29991; Q31605; Q9BD28; Q9GJ33; Q9MY49;	RecName: Full=HLA class I histocompatibility antigen, Cw-15 alpha chain; AltName: Full=MHC class I antigen Cw*15; Flags: Precursor;				ENST00000400341; ENST00000400394	ENSP00000383195; ENSP00000383244	ENSG00000206435; ENSG00000206452						366	40863	Q07000	O78165	Q29864	Q29991							HS_HLA-C					543713					X67818; CAA48029.1; -; mRNA; D83031; BAA32614.1; -; mRNA; AJ420250; CAD12435.1; -; Genomic_DNA; AJ272049; CAB75584.1; -; Genomic_DNA; M99388; AAA88087.1; -; mRNA; X73518; CAA51917.1; -; mRNA; X78343; CAA55138.1; -; mRNA; X87841; CAA61110.1; -; mRNA; AF302134; AAG33823.1; -; Genomic_DNA; AF302133; AAG33823.1; JOINED; Genomic_DNA; AF335317; AAK07656.1; -; Genomic_DNA; AF335316; AAK07656.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mn31226; GC06Mo31229			Q07000			GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C	HIX0167430		HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00471951				142840; gene			NX_Q07000										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				I37523; I37523; I37527; I37527; I37544; I37544			Q07000	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q07000				SM00407; IGc1; 1	Q07000; 26-302	Q07000	SSF54452; MHC_I/II-like_Ag-recog; 1						
1C16_HUMAN	Q29960; O78091; O78202; Q29862; Q29959; Q9MY74; Q9MYI3; Q9TNZ8;	RecName: Full=HLA class I histocompatibility antigen, Cw-16 alpha chain; AltName: Full=MHC class I antigen Cw*16; Flags: Precursor;				ENST00000438171	ENSP00000393374	ENSG00000237022						366	40753	Q29960	O78091	O78202	Q29862							HS_HLA-C					34305705					M24097; AAA59656.1; -; mRNA; M24097; AAA59657.1; -; mRNA; X76189; CAA53783.1; -; mRNA; AJ011883; CAB65547.1; -; Genomic_DNA; Y18657; CAB72095.1; -; Genomic_DNA; Y18658; CAB72095.1; JOINED; Genomic_DNA; Y18659; CAB72095.1; JOINED; Genomic_DNA; Y18139; CAB71932.1; -; Genomic_DNA; U96789; AAC17728.1; -; Genomic_DNA; U96788; AAC17728.1; JOINED; Genomic_DNA; Z75172; CAA99487.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236			Q29960			GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C	HIX0078594		HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472035; IPI00745649				142840; gene			NX_Q29960										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A59028; A59028; S42823; S42823			Q29960	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29960				SM00407; IGc1; 1	Q29960; 26-302	Q29960	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C17_HUMAN	Q95604; O02864; O02958; Q29643; Q9MY30;	RecName: Full=HLA class I histocompatibility antigen, Cw-17 alpha chain; AltName: Full=MHC class I antigen Cw*17; Flags: Precursor;				ENST00000400341; ENST00000400394	ENSP00000383195; ENSP00000383244	ENSG00000206435; ENSG00000206452						372	41238	Q95604	O02864	O02958	Q29643							HS_HLA-C					34395506				NOG42056	X98742; CAA67294.1; -; mRNA; U62824; AAB67322.1; -; mRNA; Y10520; CAA71531.1; -; mRNA; AJ420252; CAD12437.1; -; Genomic_DNA; U06835; AAA17674.1; -; mRNA; D64149; BAA20857.1; -; mRNA; Y18537; CAB71837.1; -; Genomic_DNA; Y18538; CAB71837.1; JOINED; Genomic_DNA; Y18539; CAB71837.1; JOINED; Genomic_DNA; Y18540; CAB71837.1; JOINED; Genomic_DNA; Y18541; CAB71837.1; JOINED; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mn31226; GC06Mo31229			Q95604	ENSG00000204525; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00473006				142840; gene			NX_Q95604										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1				A59028; A59028			Q95604	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q95604				SM00407; IGc1; 1	Q95604; 26-298	Q95604	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.654404; Hs.656020; Hs.77961
1C18_HUMAN	Q29865; O78203; P79498;	RecName: Full=HLA class I histocompatibility antigen, Cw-18 alpha chain; AltName: Full=MHC class I antigen Cw*18; Flags: Precursor;				ENST00000420206	ENSP00000410214	ENSG00000228299						366	40933	Q29865	O78203	P79498								HS_HLA-C					34304188					X96582; CAA65401.1; -; mRNA; AJ420253; CAD12438.1; -; Genomic_DNA; Z80227; CAB02408.1; -; Genomic_DNA; Y09156; CAA70354.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.30.500.10; MHC_I-like_Ag-recog; 1	GC06M031236; GC06Mk31228			Q29865			GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW; GO:0006955; P:immune response; IEA:InterPro; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW	HGNC:4933; HLA-C			HBG016709					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011161; MHC_I-like_Ag-recog; IPR011162; MHC_I/II-like_Ag-recog; IPR001039; MHC_I_a_a1/a2; IPR010579; MHC_I_a_C	IPI00472162				142840; gene			NX_Q29865										PF07654; C1-set; 1; PF00129; MHC_I; 1; PF06623; MHC_I_C; 1							Q29865	PR01638; MHCCLASSI		PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29865				SM00407; IGc1; 1	Q29865; 26-298	Q29865	SSF54452; MHC_I/II-like_Ag-recog; 1						
2A5A_HUMAN	Q15172; B2R6D2; B7Z7L2; D3DT99; Q2NL72; Q5VVB2; Q8TBI9;	RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform; AltName: Full=PP2A B subunit isoform B'-alpha; AltName: Full=PP2A B subunit isoform B56-alpha; AltName: Full=PP2A B subunit isoform PR61-alpha; Short=PR61alpha; AltName: Full=PP2A B subunit isoform R5-alpha;	NP_001186685.1; NP_006234.1	NM_001199756.1; NM_006243.3		ENST00000261461; ENST00000537030	ENSP00000261461; ENSP00000442866	ENSG00000066027; ENSG00000066027						486	56194	Q15172	B2R6D2	B7Z7L2	D3DT99		Q15172	Q15172				HS_PPP2R5A		5525	DIP-459N		7387496	5525			NOG264925	L42373; AAC37601.1; -; mRNA; AK302202; BAH13648.1; -; mRNA; AK312530; BAG35429.1; -; mRNA; AL451060; CAH71821.1; -; Genomic_DNA; AL360091; CAH71821.1; JOINED; Genomic_DNA; AL360091; CAH73229.1; -; Genomic_DNA; AL451060; CAH73229.1; JOINED; Genomic_DNA; CH471100; EAW93392.1; -; Genomic_DNA; CH471100; EAW93393.1; -; Genomic_DNA; BC022474; AAH22474.1; -; mRNA; BC110883; AAI10884.1; -; mRNA			GC01P212458	5525	ENSGT00550000074525	Q15172	ENSG00000066027; Homo sapiens		GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell; GO:0005737; C:cytoplasm; IDA:BHF-UCL; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB; GO:0019900; F:kinase binding; IPI:BHF-UCL; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc; GO:0090005; P:negative regulation of establishment of protein localization in plasma membrane; IMP:BHF-UCL; GO:0090219; P:negative regulation of lipid kinase activity; IMP:BHF-UCL; GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:9309; PPP2R5A	HIX0001568	HBG602178	HBG000009			Q15172	Q15172; 13	IPR016024; ARM-type_fold; IPR002554; PP2A_B56	IPI00014978; IPI00983231	hsa:5525	K11584		601643; gene	MINT-88251	21392	NX_Q15172	Q15172	HELESNR		EOG483D4M	PTHR10257; B56; 1				Q15172	PF01603; B56; 1	PA33672	Q15172	Q15172	I55449; I55449	PIRSF028043; PP2A_B56; 1		Q15172				Q15172	REACT_111102; Signal Transduction; REACT_115566; Cell Cycle; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System				Q15172; 63-461	Q15172	SSF48371; ARM-type_fold; 1					uc001hjb.3; human	Hs.497684
2A5B_HUMAN	Q15173; Q13853;	RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform; AltName: Full=PP2A B subunit isoform B'-beta; AltName: Full=PP2A B subunit isoform B56-beta; AltName: Full=PP2A B subunit isoform PR61-beta; AltName: Full=PP2A B subunit isoform R5-beta;	NP_006235.1	NM_006244.3		ENST00000164133	ENSP00000164133	ENSG00000068971						497	57393	Q15173	Q13853				Q15173	Q15173				HS_PPP2R5B		5526			7387497	5526			NOG264925	L42374; AAC37602.1; -; mRNA; Z69028; CAA93152.1; -; mRNA; BC045619; AAH45619.1; -; mRNA			GC11P064692	5526	ENSGT00550000074525	Q15173	ENSG00000068971; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro; GO:0005515; F:protein binding; IPI:IntAct; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc; GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome	HGNC:9310; PPP2R5B	HIX0009775	HBG602178	HBG000009	HPA036607		Q15173	Q15173; 4	IPR016024; ARM-type_fold; IPR002554; PP2A_B56	IPI00014980; IPI00219690	hsa:5526	K11584		601644; gene	MINT-2835290	21396	NX_Q15173		PQVATSG			PTHR10257; B56; 1					PF01603; B56; 1	PA33673	Q15173	Q15173	I70147; I70147	PIRSF028043; PP2A_B56; 1		Q15173				Q15173	REACT_111102; Signal Transduction; REACT_115566; Cell Cycle; REACT_116125; Disease; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System				Q15173; 66-437	Q15173	SSF48371; ARM-type_fold; 1					uc001oby.3; human	Hs.75199
2A5D_HUMAN	Q14738; A8K3I9; B5BUA6; O00494; O00696; Q15171; Q5TC39;	RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform; AltName: Full=PP2A B subunit isoform B'-delta; AltName: Full=PP2A B subunit isoform B56-delta; AltName: Full=PP2A B subunit isoform PR61-delta; AltName: Full=PP2A B subunit isoform R5-delta;	NP_006236.1; NP_851307.1; NP_851308.1	NM_006245.2; NM_180976.1; NM_180977.1		ENST00000394110; ENST00000485511	ENSP00000377669; ENSP00000417963	ENSG00000112640; ENSG00000112640						602	69992	Q14738	A8K3I9	B5BUA6	O00494		Q14738	Q14738				HS_PPP2R5D		5528	DIP-29961N		7387495	5528			NOG264925	L76702; AAB69751.1; -; mRNA; AB000634; BAA20381.1; -; mRNA; AB000635; BAA20382.1; -; mRNA; D78360; BAA11372.1; -; mRNA; AK290604; BAF83293.1; -; mRNA; AB451342; BAG70156.1; -; mRNA; AB451357; BAG70171.1; -; mRNA; AL136304; CAI19791.1; -; Genomic_DNA; CH471081; EAX04133.1; -; Genomic_DNA; BC010692; AAH10692.1; -; mRNA; BC001095; AAH01095.1; -; mRNA; BC001175; AAH01175.1; -; mRNA			GC06P042952	5528	ENSGT00550000074525	Q14738	ENSG00000112640; Homo sapiens		GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell; GO:0005634; C:nucleus; TAS:ProtInc; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro; GO:0005515; F:protein binding; IPI:IntAct; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc; GO:0007399; P:nervous system development; TAS:ProtInc; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:9312; PPP2R5D		HBG602178	HBG000009	HPA029045; HPA029046		Q14738	Q14738; 14	IPR016024; ARM-type_fold; IPR002554; PP2A_B56	IPI00000030; IPI00219543; IPI00219544	hsa:5528	K11584		601646; gene	MINT-5006095	21410	NX_Q14738		AVIMFSV		EOG4RXXZV	PTHR10257; B56; 1	alphasynuclein_pathway; Alpha-synuclein signaling; aurora_a_pathway; Aurora A signaling; aurora_b_pathway; Aurora B signaling; wnt_canonical_pathway; Canonical Wnt signaling pathway; il2_1pathway; IL2-mediated signaling events; lis1pathway; Lissencephaly gene (LIS1) in neuronal migration and development; mtor_4pathway; mTOR signaling pathway; ps1pathway; Presenilin action in Notch and Wnt signaling				PF01603; B56; 1	PA33676	Q14738	Q14738	S68686; S68686	PIRSF028043; PP2A_B56; 1		Q14738				Q14738	REACT_111102; Signal Transduction; REACT_111217; Metabolism; REACT_115566; Cell Cycle; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System				Q14738; 110-512	Q14738	SSF48371; ARM-type_fold; 1					uc003oth.3; human; uc010jyd.3; human; uc021yzq.1; human	Hs.533308
2A5E_HUMAN	Q16537; A4FU37; B7ZKK8; Q52LW4;	RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform; AltName: Full=PP2A B subunit isoform B'-epsilon; AltName: Full=PP2A B subunit isoform B56-epsilon; AltName: Full=PP2A B subunit isoform PR61-epsilon; AltName: Full=PP2A B subunit isoform R5-epsilon;	NP_006237.1	NM_006246.2		ENST00000337537; ENST00000422769	ENSP00000337641; ENSP00000404632	ENSG00000154001; ENSG00000154001						467	54699	Q16537	A4FU37	B7ZKK8	Q52LW4		Q16537	Q16537				HS_PPP2R5E		5529			7387498	5529			NOG264925	Z69029; CAA93153.1; -; mRNA; L76703; AAB69752.1; -; mRNA; BC093766; AAH93766.1; -; mRNA; BC101479; AAI01480.1; -; mRNA; BC143231; AAI43232.1; -; mRNA		G3DSA:1.25.10.10; ARM-like; 1	GC14M063838	5529	ENSGT00550000074525	Q16537	ENSG00000154001; Homo sapiens		GO:0005737; C:cytoplasm; IDA:HPA; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro; GO:0005515; F:protein binding; IPI:IntAct; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:9313; PPP2R5E	HIX0037720		HBG000009	HPA006034		Q16537	Q16537; 10	IPR011989; ARM-like; IPR016024; ARM-type_fold; IPR002554; PP2A_B56	IPI00002853	hsa:5529	K11584		601647; gene	MINT-1198703	21418	NX_Q16537				EOG483D4M	PTHR10257; B56; 1					PF01603; B56; 1	PA33677	Q16537	Q16537		PIRSF028043; PP2A_B56; 1		Q16537				Q16537	REACT_111102; Signal Transduction; REACT_115566; Cell Cycle; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System				Q16537; 51-423	Q16537	SSF48371; ARM-type_fold; 1					uc001xgd.1; human	Hs.334868
2A5G_HUMAN	Q13362; B5BUA5; Q14391; Q15060; Q15174;	RecName: Full=Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform; AltName: Full=PP2A B subunit isoform B'-gamma; AltName: Full=PP2A B subunit isoform B56-gamma; AltName: Full=PP2A B subunit isoform PR61-gamma; AltName: Full=PP2A B subunit isoform R5-gamma; AltName: Full=Renal carcinoma antigen NY-REN-29;	NP_002710.2; NP_848701.1; NP_848702.1	NM_002719.3; NM_178586.2; NM_178587.2		ENST00000334743	ENSP00000333905	ENSG00000078304						524	61061	Q13362	B5BUA5	Q14391	Q15060		Q13362	Q13362				HS_PPP2R5C		5527	DIP-29396N; DIP-39401N		116241235	5527			NOG264925	U37352; AAC50387.1; ALT_INIT; mRNA; Z69030; CAA93154.1; -; mRNA; AB451341; BAG70155.1; -; mRNA; CH471061; EAW81756.1; -; Genomic_DNA; D26445; BAA05465.1; -; mRNA; L42375; AAC37603.1; -; mRNA	Q13362		GC14P102228	5527	ENSGT00550000074525	Q13362	ENSG00000078304; Homo sapiens		GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB; GO:0005634; C:nucleus; IDA:UniProtKB; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB; GO:0005515; F:protein binding; IPI:UniProtKB; GO:0008601; F:protein phosphatase type 2A regulator activity; NAS:UniProtKB; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:UniProtKB; GO:0042771; P:DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; IMP:UniProtKB; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB; GO:0043161; P:proteasomal ubiquitin-dependent protein catabolic process; IMP:MGI; GO:0007165; P:signal transduction; NAS:UniProtKB	HGNC:9311; PPP2R5C			HBG000009	HPA027553			Q13362; 6	IPR016024; ARM-type_fold; IPR002554; PP2A_B56	IPI00012834; IPI00185637; IPI00220145	hsa:5527	K11584		601645; gene	MINT-2835438	21400	NX_Q13362					PTHR10257; B56; 1		2IAE; X-ray; 3.50 A; B/E=30-436; 2JAK; X-ray; 2.60 A; A=11-380; 2NPP; X-ray; 3.30 A; B/E=1-442; 2NYL; X-ray; 3.80 A; B/E=38-425; 2NYM; X-ray; 3.60 A; B/E=38-425; 3FGA; X-ray; 2.70 A; B=34-436	2IAE; 2JAK; 2NPP; 2NYL; 2NYM; 3FGA		PF01603; B56; 1	PA33674	Q13362	Q13362		PIRSF028043; PP2A_B56; 1	Q13362	Q13362				Q13362	REACT_111102; Signal Transduction; REACT_115566; Cell Cycle; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System				Q13362; 34-436	Q13362	SSF48371; ARM-type_fold; 1					uc001ykn.3; human; uc001yko.3; human; uc001ykp.3; human	Hs.368264
2AAA_HUMAN	P30153; Q13773; Q6ICQ3; Q96DH3;	RecName: Full=Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform; AltName: Full=Medium tumor antigen-associated 61 kDa protein; AltName: Full=PP2A subunit A isoform PR65-alpha; AltName: Full=PP2A subunit A isoform R1-alpha;	NP_055040.2	NM_014225.5		ENST00000322088	ENSP00000324804	ENSG00000105568						589	65309	P30153	Q13773	Q6ICQ3	Q96DH3		P30153	P30153	MetaCyc:ENSG00000105568-MONOMER			HS_PPP2R1A		5518	DIP-29394N		143811355	5518			NOG247268	M31786; AAA35531.1; -; mRNA; J02902; AAA36399.1; -; mRNA; CR450340; CAG29336.1; -; mRNA; BC001537; AAH01537.1; -; mRNA	P30153	G3DSA:1.25.10.10; ARM-like; 1	GC19P052693	5518	ENSGT00510000046709	P30153	ENSG00000105568; Homo sapiens		GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB; GO:0005829; C:cytosol; TAS:UniProtKB; GO:0016020; C:membrane; NAS:UniProtKB; GO:0015630; C:microtubule cytoskeleton; NAS:UniProtKB; GO:0005739; C:mitochondrion; NAS:UniProtKB; GO:0005634; C:nucleus; NAS:UniProtKB; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB; GO:0005625; C:soluble fraction; NAS:UniProtKB; GO:0003823; F:antigen binding; IPI:UniProtKB; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB; GO:0006672; P:ceramide metabolic process; NAS:UniProtKB; GO:0007059; P:chromosome segregation; IDA:UniProtKB; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome; GO:0000188; P:inactivation of MAPK activity; NAS:UniProtKB; GO:0006917; P:induction of apoptosis; TAS:UniProtKB; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB; GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; NAS:UniProtKB; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome; GO:0006461; P:protein complex assembly; TAS:UniProtKB; GO:0030155; P:regulation of cell adhesion; NAS:UniProtKB; GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB; GO:0006275; P:regulation of DNA replication; NAS:UniProtKB; GO:0006355; P:regulation of transcription, DNA-dependent; NAS:UniProtKB; GO:0030111; P:regulation of Wnt receptor signaling pathway; NAS:UniProtKB; GO:0008380; P:RNA splicing; NAS:UniProtKB; GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB	HGNC:9302; PPP2R1A	HIX0015400	HBG526812	HBG000011	CAB018599		P30153	P30153; 84	IPR011989; ARM-like; IPR016024; ARM-type_fold; IPR000357; HEAT; IPR021133; HEAT_type_2	IPI00554737	hsa:5518	K03456		605983; gene	MINT-1141071	21342	NX_P30153	P30153	LFLIQLK		EOG45MN4X			1B3U; X-ray; 2.30 A; A/B=2-589; 2IE3; X-ray; 2.80 A; A=1-589; 2IE4; X-ray; 2.60 A; A=1-589; 2NPP; X-ray; 3.30 A; A/D=1-589; 2NYL; X-ray; 3.80 A; A/D=8-589; 2NYM; X-ray; 3.60 A; A/D=8-589; 2PKG; X-ray; 3.30 A; A/B=10-589; 3C5W; X-ray; 2.80 A; A=9-589; 3DW8; X-ray; 2.85 A; A/D=9-589; 3K7V; X-ray; 2.85 A; A=1-589; 3K7W; X-ray; 2.96 A; A=1-589	1B3U; 2IE3; 2IE4; 2NPP; 2NYL; 2NYM; 2PKG; 3C5W; 3DW8; 3K7V; 3K7W		PF02985; HEAT; 2	PA33666	P30153	P30153	A34541; A34541		P30153	P30153			PS50077; HEAT_REPEAT; 11	P30153	REACT_111102; Signal Transduction; REACT_111217; Metabolism; REACT_115566; Cell Cycle; REACT_21257; Metabolism of RNA; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System; REACT_71; Gene Expression	IPI00554737			P30153; 2-589	P30153	SSF48371; ARM-type_fold; 1					uc002pyp.3; human	Hs.467192
2AAB_HUMAN	P30154; B0YJ69; O75620; Q8NHV8;	RecName: Full=Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform; AltName: Full=PP2A subunit A isoform PR65-beta; AltName: Full=PP2A subunit A isoform R1-beta;	NP_001171033.1; NP_001171034.1; NP_002707.3; NP_859050.1; NP_859051.1	NM_001177562.1; NM_001177563.1; NM_002716.4; NM_181699.2; NM_181700.1		ENST00000427203	ENSP00000415759	ENSG00000137713						601	66214	P30154	B0YJ69	O75620	Q8NHV8		P30154	P30154				HS_PPP2R1B		5519			116241236	5519			NOG247268	AF083439; AAC63525.1; -; Genomic_DNA; AF083425; AAC63525.1; JOINED; Genomic_DNA; AF083426; AAC63525.1; JOINED; Genomic_DNA; AF083427; AAC63525.1; JOINED; Genomic_DNA; AF083428; AAC63525.1; JOINED; Genomic_DNA; AF083429; AAC63525.1; JOINED; Genomic_DNA; AF083430; AAC63525.1; JOINED; Genomic_DNA; AF083431; AAC63525.1; JOINED; Genomic_DNA; AF083432; AAC63525.1; JOINED; Genomic_DNA; AF083433; AAC63525.1; JOINED; Genomic_DNA; AF083434; AAC63525.1; JOINED; Genomic_DNA; AF083435; AAC63525.1; JOINED; Genomic_DNA; AF083436; AAC63525.1; JOINED; Genomic_DNA; AF083437; AAC63525.1; JOINED; Genomic_DNA; AF083438; AAC63525.1; JOINED; Genomic_DNA; AF087438; AAC69624.1; -; mRNA; AF163473; AAG39644.1; -; mRNA; EF445011; ACA06046.1; -; Genomic_DNA; EF445011; ACA06047.1; -; Genomic_DNA; AP000925; -; NOT_ANNOTATED_CDS; Genomic_DNA; AP001781; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471065; EAW67150.1; -; Genomic_DNA; CH471065; EAW67151.1; -; Genomic_DNA; BC027596; AAH27596.1; -; mRNA; M65254; AAA59983.1; ALT_SEQ; mRNA		G3DSA:1.25.10.10; ARM-like; 1	GC11M111631	5519	ENSGT00510000046709	P30154	ENSG00000137713; Homo sapiens		GO:0005515; F:protein binding; IPI:IntAct; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB	HGNC:9303; PPP2R1B			HBG000011	CAB004034; HPA018908			P30154; 51	IPR011989; ARM-like; IPR016024; ARM-type_fold; IPR000357; HEAT; IPR021133; HEAT_type_2	IPI00294178; IPI00335449	hsa:5519	K03456		603113; gene	MINT-1150161	21346	NX_P30154		KQWRVRL								PF02985; HEAT; 2	PA33667	P30154		B34541; B34541			P30154			PS50077; HEAT_REPEAT; 12	P30154	REACT_111102; Signal Transduction; REACT_111217; Metabolism; REACT_115566; Cell Cycle; REACT_383; DNA Replication; REACT_604; Hemostasis; REACT_6900; Immune System				P30154; 19-601	P30154	SSF48371; ARM-type_fold; 1					uc001plw.1; human; uc001plx.1; human	Hs.584790
2ABA_HUMAN	P63151; B2RBU8; B4E1T7; P50409; Q00007;	RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform; AltName: Full=PP2A subunit B isoform B55-alpha; AltName: Full=PP2A subunit B isoform PR55-alpha; AltName: Full=PP2A subunit B isoform R2-alpha; AltName: Full=PP2A subunit B isoform alpha;	NP_001171062.1; NP_002708.1	NM_001177591.1; NM_002717.3		ENST00000315985; ENST00000380737	ENSP00000325074; ENSP00000370113	ENSG00000221914; ENSG00000221914						447	51692	P63151	B2RBU8	B4E1T7	P50409		P63151	P63151				HS_PPP2R2A		5520	DIP-29398N		52783535	5520			COG5170	M64929; AAA36490.1; -; mRNA; AK303981; BAG64899.1; -; mRNA; AK314823; BAG37345.1; -; mRNA; AC022911; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471080; EAW63578.1; -; Genomic_DNA; BC041071; AAH41071.1; -; mRNA	P63151	G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 3	GC08P026204	5520	ENSGT00390000006311	P63151	ENSG00000147459; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB; GO:0005515; F:protein binding; IPI:UniProtKB; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB; GO:0010467; P:gene expression; TAS:Reactome; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:9304; PPP2R2A	HIX0007394		HBG000012			P63151	P63151; 7	IPR000009; PP2A_PR55; IPR018067; PP2A_PR55_CS; IPR015943; WD40/YVTN_repeat-like_dom; IPR001680; WD40_repeat; IPR017986; WD40_repeat_dom	IPI00332511; IPI00798041	hsa:5520	K04354		604941; gene	MINT-2835351	21352	NX_P63151				EOG4M0F1K	PTHR11871; Pp2A_PR55; 1	tgfbrpathway; TGF-beta receptor signaling	3DW8; X-ray; 2.85 A; B/E=1-447	3DW8	P63151		PA33668	P63151	P63151	A38351; A38351	PIRSF037309; PP2A_PR55; 1		P63151	PR00600; PP2APR55		PS01024; PR55_1; 1; PS01025; PR55_2; 1; PS00678; WD_REPEATS_1; FALSE_NEG; PS50082; WD_REPEATS_2; FALSE_NEG; PS50294; WD_REPEATS_REGION; FALSE_NEG	P63151	REACT_115566; Cell Cycle; REACT_21257; Metabolism of RNA; REACT_71; Gene Expression			SM00320; WD40; 7	P63151; 8-446	P63151	SSF50978; WD40_like; 1					uc003xeu.3; human	Hs.146339
2ABB_HUMAN	Q00005; A6NEJ2; A8K102; B3KPD0; B7Z2F2; B7Z304; D3DQF7; D3DQF8;	RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform; AltName: Full=PP2A subunit B isoform B55-beta; AltName: Full=PP2A subunit B isoform PR55-beta; AltName: Full=PP2A subunit B isoform R2-beta; AltName: Full=PP2A subunit B isoform beta;	NP_001120853.1; NP_004567.1; NP_858060.1; NP_858061.1; NP_858062.1; NP_858063.1; NP_858064.1	NM_001127381.1; NM_004576.2; NM_181674.2; NM_181675.2; NM_181676.2; NM_181677.2; NM_181678.2		ENST00000336640; ENST00000356826; ENST00000394409; ENST00000394410; ENST00000394411; ENST00000394413; ENST00000394414; ENST00000453001	ENSP00000336591; ENSP00000349283; ENSP00000377931; ENSP00000377932; ENSP00000377933; ENSP00000377935; ENSP00000377936; ENSP00000398779	ENSG00000156475; ENSG00000156475; ENSG00000156475; ENSG00000156475; ENSG00000156475; ENSG00000156475; ENSG00000156475; ENSG00000156475						443	51710	Q00005	A6NEJ2	A8K102	B3KPD0		Q00005	Q00005				HS_PPP2R2B		5521			231446	5521			COG5170	M64930; AAA36493.1; -; mRNA; AK056192; BAG51642.1; ALT_SEQ; mRNA; AK289717; BAF82406.1; -; mRNA; AK294659; BAH11838.1; -; mRNA; AK295347; BAH12040.1; -; mRNA; AC008728; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC009186; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC010251; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC011386; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC011357; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC091919; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC091924; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471062; EAW61829.1; -; Genomic_DNA; CH471062; EAW61831.1; -; Genomic_DNA; CH471062; EAW61832.1; -; Genomic_DNA; CH471062; EAW61834.1; -; Genomic_DNA; CH471062; EAW61835.1; -; Genomic_DNA; BC031790; AAH31790.1; ALT_INIT; mRNA; BI490027; -; NOT_ANNOTATED_CDS; mRNA		G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 3	GC05M145967; GC05M145969	5521	ENSGT00390000006311	Q00005	ENSG00000156475; Homo sapiens		GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB; GO:0000159; C:protein phosphatase type 2A complex; IEA:InterPro; GO:0005515; F:protein binding; IPI:IntAct; GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:9305; PPP2R2B	HIX0021292		HBG000012	HPA038118		Q00005	Q00005; 168	IPR000009; PP2A_PR55; IPR018067; PP2A_PR55_CS; IPR015943; WD40/YVTN_repeat-like_dom; IPR001680; WD40_repeat; IPR019775; WD40_repeat_CS; IPR017986; WD40_repeat_dom	IPI00020850; IPI00376972; IPI00376973; IPI00944548; IPI00944557	hsa:5521	K04354		604325; gene; 604326; phenotype		21356	NX_Q00005		VFQREQE	98762; Spinocerebellar ataxia type 12	EOG4M0F1K	PTHR11871; Pp2A_PR55; 1						PA33669	Q00005		B38351; B38351	PIRSF037309; PP2A_PR55; 1		Q00005	PR00600; PP2APR55		PS01024; PR55_1; 1; PS01025; PR55_2; 1; PS00678; WD_REPEATS_1; 1; PS50082; WD_REPEATS_2; FALSE_NEG; PS50294; WD_REPEATS_REGION; FALSE_NEG	Q00005				SM00320; WD40; 6	Q00005; 23-442	Q00005	SSF50978; WD40_like; 1					uc003loe.3; human; uc003loi.4; human; uc011dbu.2; human; uc011dbv.2; human	Hs.655213
2ABD_HUMAN	Q66LE6; A8KAK0; Q5SQJ2; Q9P1Y7;	RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform; AltName: Full=PP2A subunit B isoform B55-delta; AltName: Full=PP2A subunit B isoform PR55-delta; AltName: Full=PP2A subunit B isoform R2-delta; AltName: Full=PP2A subunit B isoform delta;	NP_060931.2	NM_018461.3		ENST00000455566	ENSP00000399970	ENSG00000175470						453	52042	Q66LE6	A8KAK0	Q5SQJ2	Q9P1Y7		Q66LE6	Q66LE6				HS_PPP2R2D		55844			74736328	55844			COG5170	AK293065; BAF85754.1; -; mRNA; AL732395; CAI16703.1; ALT_SEQ; Genomic_DNA; BC047379; AAH47379.1; -; mRNA; AB040974; BAA96065.1; ALT_INIT; mRNA		G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 3	GC10P133747	55844	ENSGT00390000006311	Q66LE6	ENSG00000175470; Homo sapiens		GO:0000159; C:protein phosphatase type 2A complex; ISS:UniProtKB; GO:0008601; F:protein phosphatase type 2A regulator activity; ISS:UniProtKB; GO:0051301; P:cell division; IEA:UniProtKB-KW; GO:0010458; P:exit from mitosis; ISS:UniProtKB; GO:0007067; P:mitosis; ISS:UniProtKB; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:23732; PPP2R2D		HBG443924	HBG000012			Q66LE6	Q66LE6; 26	IPR000009; PP2A_PR55; IPR018067; PP2A_PR55_CS; IPR015943; WD40/YVTN_repeat-like_dom; IPR001680; WD40_repeat; IPR017986; WD40_repeat_dom	IPI00470920	hsa:55844	K04354		613992; gene		61085	NX_Q66LE6				EOG4M0F1K	PTHR11871; Pp2A_PR55; 1						PA134899040				PIRSF037309; PP2A_PR55; 1		Q66LE6	PR00600; PP2APR55		PS01024; PR55_1; 1; PS01025; PR55_2; 1; PS00678; WD_REPEATS_1; FALSE_NEG; PS50082; WD_REPEATS_2; FALSE_NEG; PS50294; WD_REPEATS_REGION; FALSE_NEG	Q66LE6				SM00320; WD40; 7	Q66LE6; 14-452	Q66LE6	SSF50978; WD40_like; 1					uc001lks.3; human	Hs.380372; Hs.657480
2ABG_HUMAN	Q9Y2T4; A8MSY7; Q7Z4V7; Q8NEC4; Q9H3G7;	RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform; AltName: Full=IMYPNO1; AltName: Full=PP2A subunit B isoform B55-gamma; AltName: Full=PP2A subunit B isoform PR55-gamma; AltName: Full=PP2A subunit B isoform R2-gamma; AltName: Full=PP2A subunit B isoform gamma;	NP_001193925.1; NP_870991.1	NM_001206996.1; NM_181876.2		ENST00000382599	ENSP00000372042	ENSG00000074211						447	51515	Q9Y2T4	A8MSY7	Q7Z4V7	Q8NEC4		Q9Y2T4	Q9Y2T4				HS_PPP2R2C		5522			145559437	5522			COG5170	AF096160; AAD20987.1; -; Genomic_DNA; AF096153; AAD20987.1; JOINED; Genomic_DNA; AF096154; AAD20987.1; JOINED; Genomic_DNA; AF096155; AAD20987.1; JOINED; Genomic_DNA; AF096156; AAD20987.1; JOINED; Genomic_DNA; AF096157; AAD20987.1; JOINED; Genomic_DNA; AF096158; AAD20987.1; JOINED; Genomic_DNA; AF096159; AAD20987.1; JOINED; Genomic_DNA; AF086924; AAG39636.1; -; mRNA; AF145027; AAP97279.1; -; mRNA; AK093115; BAG52658.1; -; mRNA; AC116317; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471131; EAW82395.1; -; Genomic_DNA; CH471131; EAW82394.1; -; Genomic_DNA; BC032954; AAH32954.1; -; mRNA		G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 2	GC04M006322	5522	ENSGT00390000006311	Q9Y2T4	ENSG00000074211; Homo sapiens		GO:0000159; C:protein phosphatase type 2A complex; NAS:UniProtKB; GO:0008601; F:protein phosphatase type 2A regulator activity; NAS:UniProtKB; GO:0007165; P:signal transduction; NAS:UniProtKB	HGNC:9306; PPP2R2C		HBG443924	HBG000012				Q9Y2T4; 14	IPR000009; PP2A_PR55; IPR018067; PP2A_PR55_CS; IPR015943; WD40/YVTN_repeat-like_dom; IPR001680; WD40_repeat; IPR017986; WD40_repeat_dom	IPI00032462; IPI00178803; IPI00871687	hsa:5522	K04354		605997; gene		21370	NX_Q9Y2T4		MGEDTDT		EOG4M0F1K	PTHR11871; Pp2A_PR55; 1						PA33670	Q9Y2T4		JC7153; JC7153	PIRSF037309; PP2A_PR55; 1		Q9Y2T4	PR00600; PP2APR55		PS01024; PR55_1; 1; PS01025; PR55_2; 1; PS00678; WD_REPEATS_1; FALSE_NEG; PS50082; WD_REPEATS_2; FALSE_NEG; PS50294; WD_REPEATS_REGION; FALSE_NEG	Q9Y2T4				SM00320; WD40; 6	Q9Y2T4; 21-442	Q9Y2T4	SSF50978; WD40_like; 1					uc003gja.3; human; uc003gjb.3; human; uc003gjc.3; human	Hs.479069; Hs.694633
2B11_HUMAN	Q5Y7E9; Q7M2H4; Q95461; Q9BCL7; Q9GIK5; Q9MXZ0; Q9MXZ5; Q9TQ91;	RecName: Full=HLA class II histocompatibility antigen, DRB1-1 beta chain; AltName: Full=MHC class II antigen DRB1*1; Short=DR-1; Short=DR1; Flags: Precursor;				ENST00000360004	ENSP00000353099	ENSG00000196126						266	29914	Q5Y7E9	Q7M2H4	Q95461	Q9BCL7			P04229				HS_HLA-DRB1			DIP-6143N		34395916			DB05259; Glatiramer Acetate	NOG68200	X03069; CAA26873.1; -; mRNA; M11161; AAA59781.1; -; mRNA; M33600; AAA59782.1; -; mRNA; AY663400; AAU87993.1; -; Genomic_DNA; AM419948; CAL99240.1; -; Genomic_DNA; AK289463; BAF82152.1; -; mRNA; X64547; CAA45845.1; -; Genomic_DNA; X99896; CAA68171.1; -; mRNA; AF089723; AAD51131.1; -; Genomic_DNA; AJ276206; CAC27123.1; -; Genomic_DNA; AB015184; BAA28761.1; -; Genomic_DNA; AJ303118; CAC19693.1; -; Genomic_DNA; Z50871; -; NOT_ANNOTATED_CDS; Genomic_DNA; M21008; AAA59780.1; -; mRNA; AF029288; AAF65497.1; -; Genomic_DNA; AF029293; AAF65502.1; -; Genomic_DNA	P04229	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546			P04229	ENSG00000196126; Homo sapiens		GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730	CAB015400; CAB034021		P04229	P04229; 1	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00738107				142857; gene; 181000; phenotype	MINT-203282		NX_P04229				EOG461454		il12_stat4pathway; IL12 signaling mediated by STAT4; il12_2pathway; IL12-mediated signaling events; tcrpathway; TCR signaling in naive CD4+ T cells	1AQD; X-ray; 2.45 A; B/E/H/K=30-227; 1DLH; X-ray; 2.80 A; B/E=32-219; 1FYT; X-ray; 2.60 A; B=30-221; 1HXY; X-ray; 2.60 A; B=30-219; 1JWM; X-ray; 2.70 A; B=30-219; 1JWS; X-ray; 2.60 A; B=30-219; 1JWU; X-ray; 2.30 A; B=30-219; 1KG0; X-ray; 2.65 A; B=32-219; 1KLG; X-ray; 2.40 A; B=30-219; 1KLU; X-ray; 1.93 A; B=30-219; 1LO5; X-ray; 3.20 A; B=30-219; 1PYW; X-ray; 2.10 A; B=30-219; 1R5I; X-ray; 2.60 A; B/F=30-219; 1SEB; X-ray; 2.70 A; B/F=30-221; 1SJE; X-ray; 2.45 A; B=30-219; 1SJH; X-ray; 2.25 A; B=30-219; 1T5W; X-ray; 2.40 A; B/E=30-219; 1T5X; X-ray; 2.50 A; B=30-219; 2FSE; X-ray; 3.10 A; B/D=33-217; 2G9H; X-ray; 2.00 A; B=30-219; 2IAM; X-ray; 2.80 A; B=30-219; 2IAN; X-ray; 2.80 A; B/G/L/Q=30-219; 2ICW; X-ray; 2.41 A; B/E=30-219; 2IPK; X-ray; 2.30 A; B=30-219; 2OJE; X-ray; 3.00 A; B/F=30-219; 2XN9; X-ray; 2.30 A; E=30-219; 3L6F; X-ray; 2.10 A; B=30-221; 3PDO; X-ray; 1.95 A; B=30-227; 3PGC; X-ray; 2.66 A; B/E=30-227; 3PGD; X-ray; 2.72 A; B/E=30-227; 3QXA; X-ray; 2.71 A; B/E=30-219; 3QXD; X-ray; 2.30 A; B/E=30-219; 3S4S; X-ray; 2.40 A; B/E=30-221; 3S5L; X-ray; 2.10 A; B/E=30-221	1AQD; 1DLH; 1FYT; 1HXY; 1JWM; 1JWS; 1JWU; 1KG0; 1KLG; 1KLU; 1LO5; 1PYW; 1R5I; 1SEB; 1SJE; 1SJH; 1T5W; 1T5X; 2FSE; 2G9H; 2IAM; 2IAN; 2ICW; 2IPK; 2OJE; 2XN9; 3L6F; 3PDO; 3PGC; 3PGD; 3QXA; 3QXD; 3S4S; 3S5L		PF07654; C1-set; 1; PF00969; MHC_II_beta; 1		P04229		A19197; A19197; D24669; HLHU1B; I56072; I56072; PH0147; PH0147			P04229		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P04229	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	P04229; 30-219	P04229	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211
2B13_HUMAN	P01912;	RecName: Full=HLA class II histocompatibility antigen, DRB1-3 chain; AltName: Full=Clone P2-beta-3; AltName: Full=MHC class II antigen DRB1*3; Flags: Precursor;	NP_001230894.1	NM_001243965.1		ENST00000328980; ENST00000399450	ENSP00000331343; ENSP00000382378	ENSG00000206306; ENSG00000206240						266	30120	P01912										HS_HLA-DRB1		3123	DIP-6064N			3123				X00699; CAA25295.1; -; mRNA	P01912	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mn32480	3123		P01912			GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730				P01912; 8	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00473139	hsa:3123	K06752		142857; gene		12394	NX_P01912				EOG461454			1A6A; X-ray; 2.75 A; B=34-220	1A6A		PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				I37546; HLHU3D			P01912		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P01912	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	P01912; 34-220	P01912	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011eri.2; human	Hs.534322; Hs.696211
2B14_HUMAN	Q9MY13; Q9XRY5;	RecName: Full=HLA class II histocompatibility antigen, DRB1-4 beta chain; AltName: Full=MHC class II antigen DRB1*4; Short=DR-4; Short=DR4; Flags: Precursor;				ENST00000419393; ENST00000450362	ENSP00000403458; ENSP00000410118	ENSG00000228080; ENSG00000228080						266	30112	Q9MY13	Q9XRY5		P13759		P13760					HS_HLA-DRB1					122253				NOG68200	M20548; -; NOT_ANNOTATED_CDS; Genomic_DNA; M20549; -; NOT_ANNOTATED_CDS; Genomic_DNA; M20550; -; NOT_ANNOTATED_CDS; Genomic_DNA; AL137064; CAC19360.1; -; Genomic_DNA; M17381; AAA59805.1; -; mRNA; K02776; AAA59808.1; -; Genomic_DNA; X96851; -; NOT_ANNOTATED_CDS; Genomic_DNA; AJ297586; CAC08826.2; -; mRNA; AF029269; AAF65479.1; -; Genomic_DNA; AF112876; AAD29581.1; -; Genomic_DNA; AJ295845; CAC08181.1; -; Genomic_DNA; X02902; CAA26660.1; -; mRNA; M15069; AAA59809.1; -; mRNA; L42143; AAA67104.1; -; mRNA	P13760	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546			P13760	ENSG00000196126; Homo sapiens		GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0005887; C:integral to plasma membrane; TAS:UniProtKB; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730			P13760	P13760; 6	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00887633				142857; gene			NX_P13760				EOG461454			1D5M; X-ray; 2.00 A; B=30-221; 1D5X; X-ray; 2.45 A; B=30-221; 1D5Z; X-ray; 2.00 A; B=30-221; 1D6E; X-ray; 2.45 A; B=30-221; 1J8H; X-ray; 2.40 A; B=30-221; 2SEB; X-ray; 2.50 A; B=30-221; 3O6F; X-ray; 2.80 A; B/F=30-221; 3T0E; X-ray; 4.00 A; B=30-221	1D5M; 1D5X; 1D5Z; 1D6E; 1J8H; 2SEB; 3O6F; 3T0E		PF07654; C1-set; 1; PF00969; MHC_II_beta; 1			P13760	A94681; A29310; I79419; I79419			P13760		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P13760	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1		P13760	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211; Hs.716081; Hs.723344
2B17_HUMAN	P13761; B0UYW1; O46699; O46872;	RecName: Full=HLA class II histocompatibility antigen, DRB1-7 beta chain; AltName: Full=MHC class II antigen DRB1*7; Short=DR-7; Short=DR7; Flags: Precursor;	XP_003119307.1; XP_003119308.1; XP_003119339.1; XP_003119340.1	XM_003119259.1; XM_003119260.1; XM_003119291.1; XM_003119292.1		ENST00000418312; ENST00000437784; ENST00000444645	ENSP00000406194; ENSP00000405960; ENSP00000409322	ENSG00000236884; ENSG00000229074; ENSG00000236884						266	29822	P13761	B0UYW1	O46699	O46872							HS_HLA-DRB1					122256				NOG68200	M16941; AAA36282.1; -; mRNA; CR753309; CAQ07518.1; -; Genomic_DNA; CR753835; CAQ08239.1; -; Genomic_DNA; BC001023; AAH01023.1; -; mRNA; Y13785; CAA74112.1; -; Genomic_DNA; Y16224; CAA76123.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mk32516; GC06Ml32694	100507709; 100507714		P13761	ENSG00000196126; Homo sapiens		GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB; GO:0042605; F:peptide antigen binding; IDA:UniProtKB; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0051262; P:protein tetramerization; IDA:UniProtKB; GO:2001179; P:regulation of interleukin-10 secretion; IDA:UniProtKB; GO:0032673; P:regulation of interleukin-4 production; IDA:UniProtKB; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730			P13761		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00465279	hsa:100507709; hsa:100507714			142857; gene; 609532; phenotype		20783901	NX_P13761				EOG461454					P13761	PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				A28031; A28031			P13761		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P13761	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	P13761; 30-219	P13761	SSF54452; MHC_I/II-like_Ag-recog; 1					uc011gjy.2; human	Hs.696211
2B18_HUMAN	Q9BCP2; Q9BD33; Q9TQ37; Q9UIM9;	RecName: Full=HLA class II histocompatibility antigen, DRB1-8 beta chain; AltName: Full=MHC class II antigen DRB1*8; Short=DR-8; Short=DR8; Short=DRw8; Flags: Precursor;				ENST00000328980; ENST00000399450	ENSP00000331343; ENSP00000382378	ENSG00000206306; ENSG00000206240						266	30004	Q9BCP2	Q9BD33	Q9TQ37	Q9UIM9							HS_HLA-DRB1					34395492				NOG68200	M26038; AAA59794.1; -; mRNA; S69987; AAD14052.1; -; Genomic_DNA; M17386; -; NOT_ANNOTATED_CDS; mRNA; M60216; AAA36298.1; -; Genomic_DNA; AJ249626; CAB56284.1; -; Genomic_DNA; AF330103; AAK08504.1; -; Genomic_DNA; AY028515; AAK31608.1; -; Genomic_DNA; AY028514; AAK31608.1; JOINED; Genomic_DNA; AY028517; AAK31609.1; -; Genomic_DNA; AY028516; AAK31609.1; JOINED; Genomic_DNA; AY028519; AAK31610.1; -; Genomic_DNA; AY028518; AAK31610.1; JOINED; Genomic_DNA; M27511; AAA59817.1; -; Genomic_DNA; AF144105; AAD38374.1; -; Genomic_DNA; L10402; AAA51400.1; -; Genomic_DNA; M15074; AAA59810.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mn32480			Q30134			GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00005180				142857; gene			NX_Q30134										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				A45856; A45856; F60748; F60748; I51875; I51875; I54473; I54473; I68778; I68778; PH0160; PH0160; PT0161; PT0161			Q30134		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q30134	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1		Q30134	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211
2B19_HUMAN	Q9TQE0; Q30149;	RecName: Full=HLA class II histocompatibility antigen, DRB1-9 beta chain; AltName: Full=MHC class II antigen DRB1*9; Short=DR-9; Short=DR9; Flags: Precursor;				ENST00000418312; ENST00000437784; ENST00000444645	ENSP00000406194; ENSP00000405960; ENSP00000409322	ENSG00000236884; ENSG00000229074; ENSG00000236884						266	29826	Q9TQE0	Q30149									HS_HLA-DRB1									NOG68200	U66826; AAD43829.1; -; mRNA; M17387; AAA36297.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mk32516; GC06Ml32694			Q9TQE0	ENSG00000198502; Homo sapiens		GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1	HIX0166371; HIX0166636		HBG012730			Q9TQE0		IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00983635				142857; gene		20784208	NX_Q9TQE0			243377; Diabetes mellitus type 1; 802; Multiple sclerosis; 2073; Narcolepsy-cataplexy; 284130; Rheumatoid arthritis; 797; Sarcoidosis							PF07654; C1-set; 1; PF00969; MHC_II_beta; 1		Q9TQE0		A25925; A25925; C28515; C28515			Q9TQE0		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q9TQE0	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1		Q9TQE0	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211
2B1A_HUMAN	Q30167; P01914; Q9MYF5;	RecName: Full=HLA class II histocompatibility antigen, DRB1-10 beta chain; AltName: Full=DRw10; AltName: Full=MHC class II antigen DRB1*10; Flags: Precursor;				ENST00000419393; ENST00000450362	ENSP00000403458; ENSP00000410118	ENSG00000228080; ENSG00000228080						266	30002	Q30167	P01914	Q9MYF5			P01914					HS_HLA-DRB1					292494999					X00700; CAA25296.1; -; mRNA; M20138; AAA59832.1; -; mRNA; AF225565; AAF65542.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546			Q30167			GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1	HIX0175866		HBG012730					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00473139				142857; gene			NX_Q30167										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				A27614; HLHU4D			Q30167		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q30167	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	Q30167; 30-219	Q30167	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211
2B1B_HUMAN	P20039; Q30006; Q9GIX8;	RecName: Full=HLA class II histocompatibility antigen, DRB1-11 beta chain; AltName: Full=DR-5; Short=DR5; AltName: Full=DRw11; AltName: Full=MHC class II antigen DRB1*11; Flags: Precursor;				ENST00000328980; ENST00000399450	ENSP00000331343; ENSP00000382378	ENSG00000206306; ENSG00000206240						266	30160	P20039	Q30006	Q9GIX8								HS_HLA-DRB1					122254					M11867; AAA36274.1; -; mRNA; M22050; AAA59713.1; -; Genomic_DNA; M21966; AAA59713.1; JOINED; Genomic_DNA; M22047; AAA59713.1; JOINED; Genomic_DNA; M22048; AAA59713.1; JOINED; Genomic_DNA; M22049; AAA59713.1; JOINED; Genomic_DNA; AJ297587; CAC08827.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mn32480			P20039			GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00746667				142857; gene; 609532; phenotype			NX_P20039										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				A25324; A25324; F60748; F60748; I54448; I54448; PH0153; PH0153			P20039		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P20039	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	P20039; 34-220	P20039	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211
2B1C_HUMAN	Q861H8; Q95IT6; Q9BD40;	RecName: Full=HLA class II histocompatibility antigen, DRB1-12 beta chain; AltName: Full=MHC class II antigen DRB1*12; Short=DR-12; Short=DR12; Flags: Precursor;				ENST00000328980; ENST00000399437; ENST00000399450; ENST00000399692; ENST00000412634; ENST00000415796; ENST00000419393; ENST00000428566; ENST00000446898; ENST00000450362	ENSP00000331343; ENSP00000382366; ENSP00000382378; ENSP00000382599; ENSP00000408795; ENSP00000412168; ENSP00000403458; ENSP00000392280; ENSP00000397982; ENSP00000410118	ENSG00000206306; ENSG00000206240; ENSG00000206240; ENSG00000206306; ENSG00000228080; ENSG00000206306; ENSG00000228080; ENSG00000206240; ENSG00000228080; ENSG00000228080						266	29878	Q861H8	Q95IT6	Q9BD40			O19585										74760669					AJ302075; CAC44379.1; -; mRNA; AY626551; AAV34808.1; -; mRNA; EU375850; ABY78039.1; -; mRNA; AY663396; AAU87983.1; -; Genomic_DNA; AF316619; AAK07563.1; -; Genomic_DNA; AF315825; AAK07563.1; JOINED; Genomic_DNA; AJ870921; CAI35044.1; -; Genomic_DNA; AY033428; AAK55114.1; -; Genomic_DNA; DQ533486; ABF74752.1; -; Genomic_DNA; FJ374889; ACJ09136.1; -; Genomic_DNA; FJ481086; ACK77491.1; -; Genomic_DNA; D86503; BAA13098.1; -; Genomic_DNA; AB112911; BAD02942.1; -; Genomic_DNA; AY339246; AAQ18913.1; -; Genomic_DNA; AY899825; AAW82078.1; -; Genomic_DNA; DQ250650; ABC59072.1; -; Genomic_DNA; DQ343834; ABC70992.1; -; Genomic_DNA; EF688603; ABS11697.1; -; Genomic_DNA; X83455; -; NOT_ANNOTATED_CDS; Genomic_DNA; AY174091; AAO20088.1; -; Genomic_DNA; AF017439; AAB70553.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mn32480						GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730		P01903; 1JWU			IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00955461							NX_Q95IE3										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				C60748; C60748; F60748; F60748; PH0154; PH0154					PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q95IE3	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	Q95IE3; 34-220	Q95IE3	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211; Hs.716081; Hs.723344
2B1D_HUMAN	Q9MY56; Q9TPW3; Q9TPW9; Q9TPX4; Q9UBY1; Q9UIN0; Q9XRX1; Q9Y453;	RecName: Full=HLA class II histocompatibility antigen, DRB1-13 beta chain; AltName: Full=MHC class II antigen DRB1*13; Short=DR-13; Short=DR13; Flags: Precursor;				ENST00000328980; ENST00000383125; ENST00000399437; ENST00000399450; ENST00000399692; ENST00000415796; ENST00000428566	ENSP00000331343; ENSP00000372606; ENSP00000382366; ENSP00000382378; ENSP00000382599; ENSP00000412168; ENSP00000392280	ENSG00000206306; ENSG00000206240; ENSG00000206240; ENSG00000206240; ENSG00000206306; ENSG00000206306; ENSG00000206240						266	30008	Q9MY56	Q9TPW3	Q9TPW9	Q9TPX4												74757225					AY663413; AAU88029.1; -; Genomic_DNA; AY663415; AAU88035.1; -; Genomic_DNA; AJ697893; CAG27026.1; -; mRNA; AY961069; AAX63457.1; -; mRNA; AY961070; AAX63458.2; -; mRNA; L76133; AAL40069.1; -; mRNA; AK293020; BAF85709.1; -; mRNA; BC007920; AAH07920.1; -; mRNA; L41992; AAA65914.1; -; Genomic_DNA; U17381; AAC50167.1; -; mRNA; M59803; AAA64237.1; -; mRNA; FM196526; CAQ86517.1; -; Genomic_DNA; AM109988; CAJ33595.1; -; Genomic_DNA; AM109989; CAJ33596.1; -; Genomic_DNA; AM109990; CAJ33597.1; -; Genomic_DNA; AM109991; CAJ33598.1; -; Genomic_DNA; AM109992; CAJ33599.1; -; Genomic_DNA; AM109993; CAJ33600.1; -; Genomic_DNA; AM109994; CAJ33601.1; -; Genomic_DNA; AM109995; CAJ33602.1; -; Genomic_DNA; AM109996; CAJ33603.1; -; Genomic_DNA; AM109997; CAJ33604.1; -; Genomic_DNA; D29836; BAA06216.1; -; Genomic_DNA; Z48631; -; NOT_ANNOTATED_CDS; Genomic_DNA; X86326; -; NOT_ANNOTATED_CDS; Genomic_DNA; AF136155; AAD27646.1; -; Genomic_DNA; AF164346; AAD47814.1; -; Genomic_DNA; AF169239; AAD51315.1; -; Genomic_DNA; AF243537; AAG00414.1; -; Genomic_DNA; AF243538; AAG00415.1; -; Genomic_DNA; AF352295; AAK27712.1; -; Genomic_DNA; AF306862; AAG42258.1; -; Genomic_DNA; AF247533; AAF99607.1; -; Genomic_DNA; AY178845; AAO18733.1; -; Genomic_DNA; AJ555156; CAD87537.1; -; Genomic_DNA; AY048687; AAL12226.1; -; Genomic_DNA; AF441789; AAL35834.1; -; Genomic_DNA; AY765349; AAV35213.1; -; Genomic_DNA; AJ634529; CAG25408.1; -; Genomic_DNA; AY963587; AAX51706.1; -; Genomic_DNA; AM086025; CAJ30431.1; -; Genomic_DNA; AM494414; CAM36736.1; -; Genomic_DNA; EF053230; ABK33462.1; -; Genomic_DNA; AM158254; CAJ43560.1; -; Genomic_DNA; EF196873; ABM69041.1; -; Genomic_DNA; AM904556; CAP17407.1; -; Genomic_DNA; U97554; AAB58309.1; -; Genomic_DNA; AF048688; AAC05271.1; -; Genomic_DNA; AF170582; AAD50971.1; -; Genomic_DNA; AJ245717; CAB53346.1; -; Genomic_DNA; AJ249591; CAB56840.1; -; Genomic_DNA; AJ401236; CAB96577.1; -; Genomic_DNA; AB049459; BAB16298.1; -; Genomic_DNA; AF305212; AAG22826.1; -; Genomic_DNA; AJ271206; CAC27122.1; -; Genomic_DNA; AY178184; AAO21939.1; -; Genomic_DNA; AY277392; AAP34696.1; -; Genomic_DNA; AY225520; AAO67727.1; -; Genomic_DNA; AY259126; AAP21612.1; -; Genomic_DNA; AB112913; BAD02944.1; -; Genomic_DNA; AY339247; AAQ18914.1; -; Genomic_DNA; AY379480; AAQ85128.1; -; Genomic_DNA; AY502108; AAR89455.1; -; Genomic_DNA; AJ627565; CAF28889.1; -; Genomic_DNA; AJ783982; CAH04455.1; -; Genomic_DNA; AJ853708; CAH68606.1; -; Genomic_DNA; AM279417; CAK50561.1; -; Genomic_DNA; EF493833; ABP68561.1; -; Genomic_DNA; EF493832; ABP68560.1; -; Genomic_DNA; AM931066; CAP62371.1; -; Genomic_DNA; DQ473293; ABF18979.1; -; Genomic_DNA; DQ514602; ABF60565.1; -; Genomic_DNA; DQ525629; ABF74594.1; -; Genomic_DNA; EU029803; ABU86862.1; -; Genomic_DNA; EU071684; ABS87343.1; -; Genomic_DNA; EU812541; ACE88700.1; -; Genomic_DNA; EU826130; ACF36162.1; -; Genomic_DNA; EU826129; ACF36161.1; -; Genomic_DNA; FJ688163; ACN56340.1; -; Genomic_DNA; U36827; AAC51629.1; -; Genomic_DNA; U36825; AAC51628.1; -; Genomic_DNA; U79025; AAB52235.1; -; Genomic_DNA; AF499445; AAP68877.1; -; Genomic_DNA; X93924; -; NOT_ANNOTATED_CDS; Genomic_DNA; AJ001254; CAA04628.1; -; Genomic_DNA; AJ237964; CAB40418.1; ALT_SEQ; Genomic_DNA; AJ488066; CAD32373.1; -; Genomic_DNA; AY174182; AAO17054.1; -; Genomic_DNA; AY179366; AAO23237.1; -; Genomic_DNA; L23534; AAA62591.1; -; Genomic_DNA; U72264; AAB17276.1; -; Genomic_DNA; X97407; CAA66060.1; -; Genomic_DNA; X96396; CAA65260.1; -; Genomic_DNA; AJ276873; CAB82169.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mn32480						GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1	HIX0176057		HBG012730					IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI01018156				142857; gene			NX_Q5Y7A7										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				D25239; D25239; I38899; I38899; I59647; I59647; I72484; I72484; PH0155; PH0155; S03439; S03439					PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q5Y7A7	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	Q5Y7A7; 34-220	Q5Y7A7	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211; Hs.716081; Hs.723344
2B1E_HUMAN	Q9GJ56; Q9GJ57; Q9GJ58; Q9TPB6; Q9TPW1; Q9XRY4; Q9Y4H7;	RecName: Full=HLA class II histocompatibility antigen, DRB1-14 beta chain; AltName: Full=MHC class II antigen DRB1*14; Short=DR-14; Short=DR14; Flags: Precursor;				ENST00000328980; ENST00000360004; ENST00000383125; ENST00000399437; ENST00000399450; ENST00000399692; ENST00000412634; ENST00000415796; ENST00000419393; ENST00000428566; ENST00000446898; ENST00000450362	ENSP00000331343; ENSP00000353099; ENSP00000372606; ENSP00000382366; ENSP00000382378; ENSP00000382599; ENSP00000408795; ENSP00000412168; ENSP00000403458; ENSP00000392280; ENSP00000397982; ENSP00000410118	ENSG00000206306; ENSG00000196126; ENSG00000206240; ENSG00000206240; ENSG00000206240; ENSG00000206306; ENSG00000228080; ENSG00000206306; ENSG00000228080; ENSG00000206240; ENSG00000228080; ENSG00000228080						266	30139	Q9GJ56	Q9GJ57	Q9GJ58	Q9TPB6		Q3LA90	Q9GIY3									74761361					AB062112; BAB84521.2; -; mRNA; AJ297582; CAC08822.1; -; mRNA; AJ297583; CAC08823.1; -; mRNA; AJ297584; CAC08824.1; -; mRNA; AJ297585; CAC08825.1; -; mRNA; AY663408; AAU88014.1; -; Genomic_DNA; AY935719; AAX33315.1; -; mRNA; AY961071; AAX63459.2; -; mRNA; DQ235685; ABB52004.1; -; Genomic_DNA; DQ390459; ABD60300.1; -; Genomic_DNA; DQ390460; ABD60301.1; -; Genomic_DNA; FJ379259; ACJ06537.1; -; Genomic_DNA; Z38072; CAA86217.1; -; Genomic_DNA; FM196525; CAQ86516.1; -; Genomic_DNA; AM109998; CAJ33605.1; -; Genomic_DNA; AM109999; CAJ33606.1; -; Genomic_DNA; AM110000; CAJ33607.1; -; Genomic_DNA; AM110001; CAJ33608.1; -; Genomic_DNA; AM110002; CAJ33609.1; -; Genomic_DNA; AM110003; CAJ33610.1; -; Genomic_DNA; AB485773; BAH23562.1; -; Genomic_DNA; Z50730; -; NOT_ANNOTATED_CDS; Genomic_DNA; AJ242985; CAB45249.1; ALT_SEQ; Genomic_DNA; AJ251985; CAC19086.1; -; Genomic_DNA; AY050186; AAL23547.1; -; Genomic_DNA; AY054375; AAL15169.1; -; mRNA; AF400066; AAK85431.1; -; Genomic_DNA; AY267905; AAP32696.1; -; Genomic_DNA; AY267906; AAP32697.1; -; Genomic_DNA; AJ969417; CAI94542.1; -; Genomic_DNA; AY912075; AAY17288.1; -; Genomic_DNA; DQ333353; ABC59115.1; -; Genomic_DNA; AM259285; CAJ90660.1; -; Genomic_DNA; EF199810; ABM90423.1; -; Genomic_DNA; AM774161; CAO81738.1; -; Genomic_DNA; EF495154; ABP38039.1; -; Genomic_DNA; AM922324; CAP58300.1; -; Genomic_DNA; DQ494324; ABF50050.1; -; Genomic_DNA; EU588391; ACB97664.1; -; Genomic_DNA; D86502; BAA13097.1; -; Genomic_DNA; D86504; BAA13099.1; -; Genomic_DNA; D88310; BAA13587.1; -; Genomic_DNA; AJ010982; CAA09450.1; -; Genomic_DNA; AF172071; AAD51970.1; -; Genomic_DNA; AJ543433; CAD65908.1; -; Genomic_DNA; AY277390; AAP34694.1; -; Genomic_DNA; AJ581744; CAE46451.1; -; Genomic_DNA; AJ812566; CAH23708.1; -; Genomic_DNA; AY770520; AAV37191.1; -; Genomic_DNA; DQ021915; AAY85747.1; -; Genomic_DNA; AM084908; CAJ29895.1; -; Genomic_DNA; DQ327711; ABC59293.1; -; Genomic_DNA; DQ358688; ABC84557.1; -; Genomic_DNA; AM233907; CAJ80873.1; -; Genomic_DNA; DQ643390; ABG25965.1; -; Genomic_DNA; U95115; AAB58397.2; -; Genomic_DNA; AM933133; CAP69806.1; -; Genomic_DNA; EU545181; ACB30275.1; -; Genomic_DNA; AB049830; BAB16682.1; -; Genomic_DNA; AB049831; BAB16683.1; -; Genomic_DNA; AB049832; BAB16684.1; -; Genomic_DNA; AB087875; BAC02938.1; -; Genomic_DNA; AB087876; BAC02939.1; -; Genomic_DNA; AB436778; BAG32234.1; -; Genomic_DNA; EF078986; ABK56696.1; -; Genomic_DNA; EF536016; ABQ08747.1; -; Genomic_DNA; EU029787; ABU86846.1; -; Genomic_DNA; EU029788; ABU86847.1; -; Genomic_DNA; EU029792; ABU86851.1; -; Genomic_DNA; EU029793; ABU86852.1; -; Genomic_DNA; EU029798; ABU86857.1; -; Genomic_DNA; EU643616; ACD01094.1; -; Genomic_DNA; EU812536; ACE88696.1; -; Genomic_DNA; EU924810; ACH57405.1; -; Genomic_DNA; DQ060439; AAY59541.1; -; Genomic_DNA; DQ060441; AAY59543.1; -; Genomic_DNA; DQ782331; ABG91054.1; -; Genomic_DNA; FM179681; CAQ77159.1; -; Genomic_DNA; FJ594768; ACM47962.1; -; Genomic_DNA; AF177215; AAD53910.1; -; Genomic_DNA; X99839; CAA68150.1; -; Genomic_DNA; AJ289123; CAC19015.1; -; Genomic_DNA; AY174092; AAO20089.1; -; Genomic_DNA; AY174181; AAO17053.1; -; Genomic_DNA; M77673; AAA73131.1; -; Genomic_DNA; AF028010; AAB94612.1; -; Genomic_DNA; AF112879; AAD29584.1; -; Genomic_DNA; X86974; -; NOT_ANNOTATED_CDS; Genomic_DNA; U41489; AAA86242.1; -; Genomic_DNA; AJ508388; CAD48196.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546; GC06Mn32480						GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730	CAB015400; CAB034021	Q9MY13; 1D5M		Q9GIY3; 1	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00956007				142857; gene			NX_Q9GIY3										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				B33287; B33287; C33287; C33287; C60748; C60748; F60748; F60748; PH0157; PH0157; PH0158; PH0158; S03440; S03440					PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q9GIY3	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	Q9GIY3; 34-220	Q9GIY3	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211; Hs.716081; Hs.723344
2B1F_HUMAN	Q5Y7B9;	RecName: Full=HLA class II histocompatibility antigen, DRB1-15 beta chain; AltName: Full=DW2.2/DR2.2; AltName: Full=MHC class II antigen DRB1*15; Flags: Precursor;	NP_002115.2	NM_002124.3		ENST00000360004	ENSP00000353099	ENSG00000196126						266	29966	Q5Y7B9		Q29975	Q30142			P01911				HS_HLA-DRB1		3123				3123				M20430; AAA59831.1; -; mRNA; AY663395; AAU87979.1; -; Genomic_DNA; AY663406; AAU88008.1; -; Genomic_DNA; AY663411; AAU88023.1; -; Genomic_DNA; AY663414; AAU88033.1; -; Genomic_DNA; AY961072; AAX63460.1; -; mRNA; AY961073; AAX63461.1; -; mRNA; AL713966; CAI18081.1; -; Genomic_DNA; BC033827; AAH33827.1; -; mRNA; BC108922; AAI08923.1; -; mRNA; M28584; AAA59681.1; -; mRNA; M16957; AAA36279.1; -; mRNA; M17378; AAA59801.1; -; mRNA	P01911	G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546	3123	ENSGT00560000076676	P01911	ENSG00000196126; Homo sapiens		GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1	HIX0018378		HBG012730	CAB015400; CAB034021		P01911	P01911; 1	IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00472169	hsa:3123	K06752		142857; gene		12394	NX_P01911		DAENWNS					1BX2; X-ray; 2.60 A; B/E=32-222; 1YMM; X-ray; 3.50 A; B=30-227; 2WBJ; X-ray; 3.00 A; B/F=30-227	1BX2; 1YMM; 2WBJ		PF07654; C1-set; 1; PF00969; MHC_II_beta; 1	PA35072		P01911	I68734; HLHUWB			P01911		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	P01911	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	P01911; 32-222	P01911	SSF54452; MHC_I/II-like_Ag-recog; 1					uc003obp.4; human	Hs.534322; Hs.696211
2B1G_HUMAN	Q3HUP9; Q3KTM1; Q3LA84; Q6T865; Q95383;	RecName: Full=HLA class II histocompatibility antigen, DRB1-16 beta chain; AltName: Full=MHC class II antigen DRB1*16; Short=DR-16; Short=DR16; Flags: Precursor;	NP_002115.2	NM_002124.3		ENST00000360004	ENSP00000353099	ENSG00000196126						266	30030	Q3HUP9	Q3KTM1	Q3LA84	Q6T865			Q29974						3123			74762149	3123				M28583; AAA59680.1; -; mRNA; M20504; AAA59827.1; -; mRNA; L02545; AAA59777.1; -; mRNA; AK291987; BAF84676.1; -; mRNA; M16959; AAA36281.1; -; mRNA; AM110006; CAJ33613.1; -; Genomic_DNA; Z72424; -; NOT_ANNOTATED_CDS; Genomic_DNA; AY912074; AAY17287.1; -; Genomic_DNA; DQ837166; ABH05946.1; -; Genomic_DNA; AY428805; AAR07616.1; -; Genomic_DNA; DQ192647; ABA39176.1; -; Genomic_DNA; EU029801; ABU86860.1; -; Genomic_DNA; U59686; AAB52230.1; -; Genomic_DNA; U26659; AAD09441.1; -; Genomic_DNA		G3DSA:2.60.40.10; Ig-like_fold; 1; G3DSA:3.10.320.10; MHC_II_alpha_N; 1	GC06M032546	3123					GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0031902; C:late endosome membrane; IDA:UniProtKB; GO:0005765; C:lysosomal membrane; IDA:UniProtKB; GO:0042613; C:MHC class II protein complex; IEA:UniProtKB-KW; GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB; GO:0002504; P:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IEA:UniProtKB-KW; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome; GO:0031295; P:T cell costimulation; TAS:Reactome; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome	HGNC:4948; HLA-DRB1			HBG012730	CAB015400; CAB034021	P01903; 1JWU			IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003006; Ig/MHC_CS; IPR003597; Ig_C1-set; IPR011162; MHC_I/II-like_Ag-recog; IPR014745; MHC_II_a/b_N; IPR000353; MHC_II_b_N	IPI00955414	hsa:3123	K06752		142857; gene		12394	NX_Q29974										PF07654; C1-set; 1; PF00969; MHC_II_beta; 1				B27618; B27618; D25239; D25239; F27060; F27060; I54509; I54509			Q29974		PD000328; MHC_II_b_N; 1	PS50835; IG_LIKE; 1; PS00290; IG_MHC; 1	Q29974	REACT_6900; Immune System			SM00407; IGc1; 1; SM00921; MHC_II_beta; 1	Q29974; 32-222	Q29974	SSF54452; MHC_I/II-like_Ag-recog; 1						Hs.534322; Hs.696211; Hs.716081; Hs.723344
3BHS1_HUMAN	P14060; A8K691; Q14545; Q8IV65;	RecName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1; AltName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I; Short=3-beta-HSD I; AltName: Full=Trophoblast antigen FDO161G; Includes: RecName: Full=3-beta-hydroxy-Delta(5)-steroid dehydrogenase; EC=1.1.1.145; AltName: Full=3-beta-hydroxy-5-ene steroid dehydrogenase; AltName: Full=Progesterone reductase; Includes: RecName: Full=Steroid Delta-isomerase; EC=5.3.3.1; AltName: Full=Delta-5-3-ketosteroid isomerase;	NP_000853.1	NM_000862.2		ENST00000235547; ENST00000369413	ENSP00000235547; ENSP00000358421	ENSG00000203857; ENSG00000203857						373	42252	P14060	A8K691	Q14545	Q8IV65		P14060	P14060	MetaCyc:HS08829-MONOMER	1.1.1.145; 2681		HS_HSD3B1		3283			112767	3283		DB00157; NADH; DB01108; Trilostane	COG0451	M27137; AAA36015.1; -; mRNA; M28392; AAA36001.1; ALT_SEQ; Genomic_DNA; M28162; AAA36001.1; JOINED; Genomic_DNA; M28391; AAA36001.1; JOINED; Genomic_DNA; X53321; CAA37408.1; -; mRNA; M35493; AAA51538.1; -; mRNA; M63397; AAA51662.1; -; Genomic_DNA; M63395; AAA51662.1; JOINED; Genomic_DNA; M63396; AAA51662.1; JOINED; Genomic_DNA; M38180; AAA51831.1; -; Genomic_DNA; X55997; CAA39469.1; -; mRNA; S45679; AAB23543.1; -; mRNA; AK291556; BAF84245.1; -; mRNA; BC031999; AAH31999.1; -; mRNA		G3DSA:3.40.50.720; NAD(P)-bd; 1	GC01P120049	3283	ENSGT00550000074557	P14060	ENSG00000203857; Homo sapiens		GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0005792; C:microsome; IDA:UniProtKB; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB; GO:0005758; C:mitochondrial intermembrane space; IDA:UniProtKB; GO:0030868; C:smooth endoplasmic reticulum membrane; ISS:UniProtKB; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; ISS:UniProtKB; GO:0000166; F:nucleotide binding; IEA:InterPro; GO:0004769; F:steroid delta-isomerase activity; ISS:UniProtKB; GO:0006702; P:androgen biosynthetic process; TAS:UniProtKB; GO:0006703; P:estrogen biosynthetic process; TAS:UniProtKB; GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome; GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome; GO:0044281; P:small molecule metabolic process; TAS:Reactome	HGNC:5217; HSD3B1	HIX0000948		HBG000014			P14060		IPR002225; 3Beta_OHSteriod_DH/Estase; IPR016040; NAD(P)-bd_dom	IPI00843838	hsa:3283	K00070		109715; gene		13031	NX_P14060				EOG4K3KWG						PF01073; 3Beta_HSD; 1	PA29486		P14060	A36551; DEHUHS			P14060				P14060	REACT_111217; Metabolism; REACT_15493; Steroid hormones				P14060; 3-360	P14060						uc001ehv.1; human	Hs.364941
3BHS2_HUMAN	P26439; A2RRA5; Q16010; Q53GD4; Q6AI10; Q6LDB9; Q99890; Q9UD08;	RecName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2; AltName: Full=3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II; Short=3-beta-HSD II; AltName: Full=3-beta-HSD adrenal and gonadal type; Includes: RecName: Full=3-beta-hydroxy-Delta(5)-steroid dehydrogenase; EC=1.1.1.145; AltName: Full=3-beta-hydroxy-5-ene steroid dehydrogenase; AltName: Full=Progesterone reductase; Includes: RecName: Full=Steroid Delta-isomerase; EC=5.3.3.1; AltName: Full=Delta-5-3-ketosteroid isomerase;	NP_000189.1; NP_001159592.1	NM_000198.3; NM_001166120.1		ENST00000369416	ENSP00000358424	ENSG00000203859						372	42052	P26439	A2RRA5	Q16010	Q53GD4		P26439	P26439	MetaCyc:HS10943-MONOMER	1.1.1.145; 2681		HS_HSD3B2		3284			112770	3284		DB00157; NADH; DB01108; Trilostane	COG0451	M77144; AAA36014.1; -; Genomic_DNA; M67466; AAA36016.1; -; mRNA; CR627415; CAH10504.1; -; mRNA; AK222997; BAD96717.1; -; mRNA; AL359553; CAC19799.1; -; Genomic_DNA; CH471122; EAW56700.1; -; Genomic_DNA; BC038419; AAH38419.1; -; mRNA; BC131488; AAI31489.1; -; mRNA; S80140; AAD14329.1; -; Genomic_DNA; S60309; AAC60599.1; -; Genomic_DNA; S60310; AAC60600.1; ALT_FRAME; Genomic_DNA		G3DSA:3.40.50.720; NAD(P)-bd; 1	GC01P119957	3284	ENSGT00550000074557	P26439	ENSG00000203859; Homo sapiens		GO:0016021; C:integral to membrane; NAS:UniProtKB; GO:0005792; C:microsome; ISS:UniProtKB; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB; GO:0005758; C:mitochondrial intermembrane space; ISS:UniProtKB; GO:0030868; C:smooth endoplasmic reticulum membrane; ISS:UniProtKB; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; IDA:UniProtKB; GO:0000166; F:nucleotide binding; IEA:InterPro; GO:0004769; F:steroid delta-isomerase activity; IDA:UniProtKB; GO:0006702; P:androgen biosynthetic process; TAS:Reactome; GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome; GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome; GO:0044281; P:small molecule metabolic process; TAS:Reactome	HGNC:5218; HSD3B2	HIX0023638		HBG000014			P26439		IPR002225; 3Beta_OHSteriod_DH/Estase; IPR016040; NAD(P)-bd_dom	IPI00218494; IPI00465001	hsa:3284	K00070		201810; phenotype; 613890; gene		13035	NX_P26439		TFSAVIN	90791; Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency; 1331; Familial prostate cancer; 3185; Stein-Leventhal syndrome							PF01073; 3Beta_HSD; 1	PA29487		P26439	A39488; DEHUH2			P26439				P26439	REACT_111217; Metabolism; REACT_15493; Steroid hormones				P26439; 2-360	P26439						uc001ehs.3; human; uc001ehu.3; human	Hs.654399
3BHS7_HUMAN	Q9H2F3; Q96M28; Q9BSN9;	RecName: Full=3 beta-hydroxysteroid dehydrogenase type 7; AltName: Full=3 beta-hydroxysteroid dehydrogenase type VII; Short=3-beta-HSD VII; AltName: Full=3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase; Short=C(27) 3-beta-HSD; EC=1.1.1.-; AltName: Full=Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase; EC=1.1.1.181;	NP_079469.2	NM_025193.3		ENST00000262520; ENST00000297679; ENST00000353250	ENSP00000262520; ENSP00000297679; ENSP00000370662	ENSG00000099377; ENSG00000099377; ENSG00000099377						369	41016	Q9H2F3	Q96M28	Q9BSN9			Q9H2F3	Q9H2F3				HS_HSD3B7		80270			47605550	80270			COG0451	AF277719; AAG37824.1; -; mRNA; AK057436; BAB71486.1; -; mRNA; AK290950; BAF83639.1; -; mRNA; AK292068; BAF84757.1; -; mRNA; AC135048; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471192; EAW52183.1; -; Genomic_DNA; BC004929; AAH04929.1; -; mRNA		G3DSA:3.40.50.720; NAD(P)-bd; 1	GC16P030997	80270	ENSGT00550000074557	Q9H2F3	ENSG00000099377; Homo sapiens		GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; NAS:UniProtKB; GO:0047016; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; IEA:EC; GO:0000166; F:nucleotide binding; IEA:InterPro; GO:0006699; P:bile acid biosynthetic process; TAS:UniProtKB	HGNC:18324; HSD3B7	HIX0022193	HBG755066	HBG000014			Q9H2F3	Q9H2F3; 3	IPR002225; 3Beta_OHSteriod_DH/Estase; IPR016040; NAD(P)-bd_dom	IPI00065225; IPI00106783	hsa:80270	K12408		607764; gene; 607765; phenotype		70733	NX_Q9H2F3		EDFNMEF	79301; Congenital bile acid synthesis defect type 1	EOG4N5VX7						PF01073; 3Beta_HSD; 1	PA134940289	Q9H2F3	Q9H2F3				Q9H2F3				Q9H2F3	REACT_111217; Metabolism				Q9H2F3; 10-365	Q9H2F3						uc002eaf.2; human	Hs.460618
3BP1_HUMAN	Q9Y3L3; Q5R3N0; Q6IBZ2; Q6ZVL9; Q96HQ5; Q9NSQ9;	RecName: Full=SH3 domain-binding protein 1; Short=3BP-1;	NP_061830.3	NM_018957.3		ENST00000357436	ENSP00000350018	ENSG00000100092						701	75713	Q9Y3L3	Q5R3N0	Q6IBZ2	Q6ZVL9		Q9Y3L3	Q9Y3L3				HS_SH3BP1		23616			51338841	23616			NOG318612	CR456576; CAG30462.1; -; mRNA; AK124370; BAC85842.1; ALT_INIT; mRNA; Z83844; CAI20370.2; -; Genomic_DNA; BC008282; AAH08282.1; ALT_INIT; mRNA; AL157480; CAB75671.2; -; mRNA		G3DSA:1.10.555.10; RhoGAP; 1	GC22P038030	23616	ENSGT00650000092854	Q9Y3L3	ENSG00000100092; Homo sapiens		GO:0005737; C:cytoplasm; IEA:InterPro; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW; GO:0007165; P:signal transduction; IEA:InterPro	HGNC:10824; SH3BP1	HIX0016448; HIX0016449	HBG446214	HBG000015	HPA000757		Q9Y3L3	Q9Y3L3; 1	IPR004148; BAR_dom; IPR008936; Rho_GTPase_activation_prot; IPR000198; RhoGAP_dom	IPI00456744; IPI01011491	hsa:23616					46338	NX_Q9Y3L3				EOG495ZRN						PF03114; BAR; 1; PF00620; RhoGAP; 1	PA35732	Q9Y3L3		T46916; T46916			Q9Y3L3			PS51021; BAR; 1; PS50238; RHOGAP; 1	Q9Y3L3				SM00324; RhoGAP; 1		Q9Y3L3	SSF48350; Rho_GAP; 1					uc003ati.3; human	Hs.601143
3BP2_HUMAN	P78314; A6NNC2; B2R5R6; D3DVR0; O00500; O15373; P78315;	RecName: Full=SH3 domain-binding protein 2; Short=3BP-2;	NP_001116153.1; NP_001139327.1; NP_001139328.1; NP_003014.3	NM_001122681.1; NM_001145855.1; NM_001145856.1; NM_003023.4		ENST00000356331; ENST00000442312; ENST00000452765	ENSP00000348685; ENSP00000388152; ENSP00000409746	ENSG00000087266; ENSG00000087266; ENSG00000087266						561	62244	P78314	A6NNC2	B2R5R6	D3DVR0		P78314	P78314				HS_SH3BP2		6452			3023207				NOG42035	AF000936; AAB59973.1; -; mRNA; U56386; AAB72034.1; -; mRNA; AB000462; BAA19119.1; -; mRNA; AB000463; BAA19120.1; -; mRNA; AK312286; BAG35213.1; -; mRNA; AL121750; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471131; EAW82509.1; -; Genomic_DNA; CH471131; EAW82510.1; -; Genomic_DNA; CH471131; EAW82511.1; -; Genomic_DNA; CH471131; EAW82512.1; -; Genomic_DNA; BC022996; AAH22996.1; -; mRNA	P78314	G3DSA:2.30.29.30; PH_type; 1; G3DSA:3.30.505.10; SH2; 1	GC04P002831	6452	ENSGT00390000002216	P78314	ENSG00000087266; Homo sapiens		GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW; GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc; GO:0007165; P:signal transduction; TAS:ProtInc	HGNC:10825; SH3BP2	HIX0004037		HBG000016	HPA036790		P78314	P78314; 3	IPR011993; PH_like_dom; IPR001849; Pleckstrin_homology; IPR000980; SH2	IPI00218997; IPI00219071	hsa:6452	K07984		118400; phenotype; 602104; gene	MINT-254189	25079	NX_P78314			184; Cherubism	EOG4SN1P6		tcrpathway; TCR signaling in naive CD4+ T cells	2CR4; NMR; -; A=446-558; 3TWR; X-ray; 1.55 A; E/F/G/H=410-425	2CR4; 3TWR		PF00169; PH; 1; PF00017; SH2; 1	PA35733	P78314					P78314			PS50003; PH_DOMAIN; 1; PS50001; SH2; 1	P78314				SM00233; PH; 1; SM00252; SH2; 1	P78314; 26-130, 444-560	P78314						uc003gfi.4; human	Hs.167679
3BP5L_HUMAN	Q7L8J4; Q96FI5; Q9BQH8; Q9C0E3;	RecName: Full=SH3 domain-binding protein 5-like; Short=SH3BP-5-like;	NP_085148.1	NM_030645.1		ENST00000366472	ENSP00000355428	ENSG00000175137						393	43499	Q7L8J4	Q96FI5	Q9BQH8	Q9C0E3		Q7L8J4	Q7L8J4				HS_SH3BP5L		80851			74749902				NOG263345	AB051507; BAB21811.1; ALT_INIT; mRNA; AL136569; CAB66504.1; -; mRNA; AY358453; AAQ88818.1; -; mRNA; AK056382; BAB71171.1; -; mRNA; AL732583; CAI18798.1; -; Genomic_DNA; CH471257; EAW57534.1; -; Genomic_DNA; BC010871; AAH10871.1; -; mRNA; BC017254; AAH17254.1; -; mRNA			GC01M249104	80851	ENSGT00390000018500	Q7L8J4				HGNC:29360; SH3BP5L	HIX0021856	HBG716595	HBG057307	HPA038068		Q7L8J4	Q7L8J4; 2	IPR007940; SH3-bd_5	IPI00028359	hsa:80851				MINT-1688351	71284	NX_Q7L8J4		GVRGGRH		EOG4PZJ78	PTHR19423; SH3_bd_5; 1					PF05276; SH3BP5; 1	PA142670923	Q7L8J4					Q7L8J4				Q7L8J4												uc001iev.1; human	Hs.298573
3BP5_HUMAN	O60239; B3KQW6; Q5JWV9;	RecName: Full=SH3 domain-binding protein 5; Short=SH3BP-5; AltName: Full=SH3 domain-binding protein that preferentially associates with BTK;	NP_004835.2	NM_004844.3		ENST00000253688; ENST00000383791	ENSP00000253688; ENSP00000373301	ENSG00000131370; ENSG00000131370						455	50425	O60239	B3KQW6	Q5JWV9			O60239	O60239				HS_SH3BP5		9467				9467			NOG263345	AK090524; BAG52178.1; -; mRNA; AC087590; -; NOT_ANNOTATED_CDS; Genomic_DNA; AL117422; CAI46220.1; -; mRNA; CH471055; EAW64225.1; -; Genomic_DNA; BC010123; AAH10123.2; -; mRNA; AB005047; BAA25922.1; ALT_INIT; mRNA			GC03M015296	9467	ENSGT00390000018500	O60239	ENSG00000131370; Homo sapiens		GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell; GO:0004860; F:protein kinase inhibitor activity; IDA:MGI; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW; GO:0035556; P:intracellular signal transduction; IDA:MGI	HGNC:10827; SH3BP5	HIX0003100	HBG716674	HBG018168	HPA036445		O60239	O60239; 6	IPR007940; SH3-bd_5	IPI00744182; IPI00914942	hsa:9467			605612; gene		35476	NX_O60239		KYNAAMG		EOG4Q84XV	PTHR19423; SH3_bd_5; 1	bcr_5pathway; BCR signaling pathway				PF05276; SH3BP5; 1	PA35735	O60239		JE0086; JE0086			O60239				O60239						O60239						uc003bzp.1; human	Hs.257761; Hs.726063
3HAO_HUMAN	P46952; A6NE56; B4DIN2; Q53QZ7; Q8N6N9;	RecName: Full=3-hydroxyanthranilate 3,4-dioxygenase; EC=1.13.11.6; AltName: Full=3-hydroxyanthranilate oxygenase; Short=3-HAO; AltName: Full=3-hydroxyanthranilic acid dioxygenase; Short=HAD;	NP_036337.2	NM_012205.2		ENST00000294973	ENSP00000294973	ENSG00000162882						286	32556	P46952	A6NE56	B4DIN2	Q53QZ7		P46952	P46952	MetaCyc:MONOMER-15008			HS_HAAO		23498			308153402	23498			NOG77058	Z29481; CAA82618.1; -; mRNA; CR457063; CAG33344.1; -; mRNA; CR624693; -; NOT_ANNOTATED_CDS; mRNA; AK295693; BAG58544.1; -; mRNA; AC098824; AAY14701.1; -; Genomic_DNA; CH471053; EAX00309.1; -; Genomic_DNA; BC029510; AAH29510.1; -; mRNA	P46952		GC02M042994	23498	ENSGT00390000013008	P46952	ENSG00000162882; Homo sapiens		GO:0005829; C:cytosol; IDA:UniProtKB; GO:0005625; C:soluble fraction; IDA:UniProtKB; GO:0000334; F:3-hydroxyanthranilate 3,4-dioxygenase activity; IDA:UniProtKB; GO:0009055; F:electron carrier activity; NAS:UniProtKB; GO:0008198; F:ferrous iron binding; IDA:UniProtKB; GO:0070050; P:neuron homeostasis; IMP:UniProtKB; GO:0019363; P:pyridine nucleotide biosynthetic process; IEA:UniProtKB-KW; GO:0019805; P:quinolinate biosynthetic process; NAS:UniProtKB; GO:0046686; P:response to cadmium ion; IDA:UniProtKB; GO:0010043; P:response to zinc ion; IDA:UniProtKB; GO:0006569; P:tryptophan catabolic process; TAS:Reactome	HGNC:4796; HAAO		HBG717838	HBG000018	HPA036394		P46952	P46952; 1	IPR010329; 3hydroanth_dOase; IPR016700; 3hydroanth_dOase_met; IPR011051; Cupin_RmlC_type	IPI00009375; IPI00921062	hsa:23498	K00452		604521; gene	MINT-1468803	45867	NX_P46952		FYCKDLG		EOG4F4SBR	PTHR15497; PTHR15497; 1		2QNK; X-ray; 1.60 A; A=2-286	2QNK		PF06052; 3-HAO; 1	PA29171	P46952		A54070; A54070	PIRSF017681; 3hydroanth_dOase_animal; 1		P46952				P46952	REACT_111217; Metabolism				P46952; 2-286	P46952	SSF51182; RmlC_like_cupin; 2			TIGR03037; Anthran_nbaC; 1		uc002rst.4; human	Hs.368805
3HIDH_HUMAN	P31937; Q9UDN3;	RecName: Full=3-hydroxyisobutyrate dehydrogenase, mitochondrial; Short=HIBADH; EC=1.1.1.31; Flags: Precursor;	NP_689953.1	NM_152740.3		ENST00000265395	ENSP00000265395	ENSG00000106049						336	35329	P31937	Q9UDN3				P31937	P31937				HS_HIBADH		11112			12643395	11112		DB00157; NADH	COG2084	AC007130; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC005091; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC032324; AAH32324.1; -; mRNA	P31937	G3DSA:3.40.50.720; NAD(P)-bd; 1; G3DSA:1.10.1040.10; Opine_DH; 1	GC07M027565	11112	ENSGT00530000063270	P31937	ENSG00000106049; Homo sapiens		GO:0005759; C:mitochondrial matrix; TAS:Reactome; GO:0008442; F:3-hydroxyisobutyrate dehydrogenase activity; NAS:UniProtKB; GO:0051287; F:NAD binding; IEA:InterPro; GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; IEA:InterPro; GO:0009083; P:branched chain family amino acid catabolic process; TAS:Reactome; GO:0006098; P:pentose-phosphate shunt; IEA:InterPro; GO:0006573; P:valine metabolic process; NAS:UniProtKB	HGNC:4907; HIBADH	HIX0006550	HBG729179	HBG050424	HPA019522; HPA021002		P31937		IPR002204; 3-OH-isobutyrate_DH-rel_CS; IPR015815; 3hydroxyacid_DH/Rdtase; IPR008927; 6-PGluconate_DH_C-like; IPR006115; 6PGDH_NADP-bd; IPR013328; DH_multihelical; IPR011548; IsoBut3OH_DH; IPR016040; NAD(P)-bd_dom	IPI00013860	hsa:11112	K00020		608475; gene		42238	NX_P31937		PMARNLI		EOG476K0N	PTHR22981; 3hydroxy_acid_DH; 1		2GF2; X-ray; 2.38 A; A/B/C/D=41-335; 2I9P; X-ray; 2.55 A; A/B/C/D=41-336	2GF2; 2I9P		PF03446; NAD_binding_2; 1	PA29280	P31937	P31937				P31937			PS00895; 3_HYDROXYISOBUT_DH; 1	P31937	REACT_111217; Metabolism		P31937		P31937; 41-335	P31937	SSF48179; 6DGDH_C_like; 1	P31937		TIGR01692; HIBADH; 1		uc003szf.3; human	Hs.406758
3MG_HUMAN	P29372; Q13770; Q15275; Q15961; Q96BZ6; Q96S33; Q9NNX5;	RecName: Full=DNA-3-methyladenine glycosylase; EC=3.2.2.21; AltName: Full=3-alkyladenine DNA glycosylase; AltName: Full=3-methyladenine DNA glycosidase; AltName: Full=ADPG; AltName: Full=N-methylpurine-DNA glycosylase;	NP_001015052.1; NP_001015054.1; NP_002425.2	NM_001015052.1; NM_001015054.1; NM_002434.2		ENST00000219431; ENST00000397818	ENSP00000219431; ENSP00000380919	ENSG00000103152; ENSG00000103152						298	32869	P29372	Q13770	Q15275	Q15961		P29372	P29372				HS_MID1; HS_MPG		4350			206729922	4350			COG2094	M74905; AAA58627.1; -; mRNA; L10752; AAF77073.1; -; mRNA; AF499437; AAM14628.1; -; Genomic_DNA; AE006462; AAK61213.1; -; Genomic_DNA; Z69720; CAA93540.1; -; Genomic_DNA; BC014991; AAH14991.1; -; mRNA; S51033; AAB19537.1; -; mRNA; X56528; CAA39875.1; -; mRNA; M71215; AAA58369.1; -; mRNA; M99626; AAB46421.1; -; mRNA	P29372	G3DSA:3.10.300.10; PurDNA_glycsylse; 1	GC16P000127	4350	ENSGT00390000009825	P29372	ENSG00000103152; Homo sapiens		GO:0005654; C:nucleoplasm; TAS:Reactome; GO:0003684; F:damaged DNA binding; TAS:ProtInc; GO:0008725; F:DNA-3-methyladenine glycosylase activity; IEA:EC; GO:0052822; F:DNA-3-methylguanine glycosylase activity; IEA:EC; GO:0052821; F:DNA-7-methyladenine glycosylase activity; IEA:EC; GO:0043916; F:DNA-7-methylguanine glycosylase activity; IEA:EC; GO:0005515; F:protein binding; IPI:IntAct; GO:0045007; P:depurination; TAS:Reactome; GO:0006307; P:DNA dealkylation involved in DNA repair; TAS:ProtInc	HGNC:7211; MPG	HIX0012638		HBG000019	HPA006531		P29372	P29372; 1	IPR011034; Formyl_transferase_C-like; IPR003180; PurDNA_glycsylse	IPI00218495; IPI00295497	hsa:4350	K03652		156565; gene		17110	NX_P29372		EHISSQY			PTHR10429; PurDNA_glycsylse; 1		1BNK; X-ray; 2.70 A; A=80-295; 1EWN; X-ray; 2.10 A; A=80-298; 1F4R; X-ray; 2.40 A; A=80-298; 1F6O; X-ray; 2.40 A; A=80-298; 3QI5; X-ray; 2.20 A; A/B=84-298; 3UBY; X-ray; 2.00 A; A/B=84-298	1BNK; 1EWN; 1F4R; 1F6O; 3QI5; 3UBY		PF02245; Pur_DNA_glyco; 1	PA30917	P29372	P29372	A40798; A40798; A41230; A41230; A47471; A47471; JN0062; JN0062			P29372				P29372	REACT_216; DNA Repair				P29372; 80-295	P29372	SSF50486; FMT_C_like; 1			TIGR00567; 3mg; 1		uc002cfm.3; human	Hs.459596
41_HUMAN	Q5VXN8; Q8IXV9; Q9Y578; Q9Y579;	RecName: Full=Protein 4.1; Short=P4.1; AltName: Full=4.1R; AltName: Full=Band 4.1; AltName: Full=EPB4.1;	NP_001159477.1; NP_001159478.1; NP_004428.1; NP_976217.1; NP_976218.1	NM_001166005.1; NM_001166006.1; NM_004437.3; NM_203342.2; NM_203343.2		ENST00000343067; ENST00000373798	ENSP00000345259; ENSP00000362904	ENSG00000159023; ENSG00000159023						864	97017	Q5VXN8	Q8IXV9	Q9Y578	Q9Y579		P11171	P11171				HS_EPB41		2035	DIP-17032N		90101808	2035			NOG242913	M14993; AAA35795.1; -; mRNA; J03796; AAA35793.1; -; mRNA; J03796; AAA35794.1; -; mRNA; M61733; AAA35797.1; -; mRNA; AF156225; AAD42222.1; -; mRNA; AL138785; CAI21967.1; -; Genomic_DNA; AL357500; CAI21967.1; JOINED; Genomic_DNA; AL138785; CAI21966.1; -; Genomic_DNA; AL357500; CAI21966.1; JOINED; Genomic_DNA; AL138785; CAI21968.1; -; Genomic_DNA; AL138785; CAI21969.1; -; Genomic_DNA; AL357500; CAI21969.1; JOINED; Genomic_DNA; AL138785; CAI21970.1; -; Genomic_DNA; AL357500; CAI21970.1; JOINED; Genomic_DNA; AL357500; CAH71636.1; -; Genomic_DNA; AL138785; CAH71636.1; JOINED; Genomic_DNA; AL357500; CAH71637.1; -; Genomic_DNA; AL138785; CAH71637.1; JOINED; Genomic_DNA; AL357500; CAH71638.1; -; Genomic_DNA; AL138785; CAH71638.1; JOINED; Genomic_DNA; AL357500; CAH71639.1; -; Genomic_DNA; AL138785; CAH71639.1; JOINED; Genomic_DNA; CH471059; EAX07663.1; -; Genomic_DNA; CH471059; EAX07665.1; -; Genomic_DNA; CH471059; EAX07667.1; -; Genomic_DNA; CH471059; EAX07668.1; -; Genomic_DNA; BC039079; AAH39079.1; -; mRNA; AF156226; AAD42223.1; -; Genomic_DNA	P11171	G3DSA:1.20.80.10; ACBP; 1; G3DSA:2.30.29.30; PH_type; 1	GC01P029213	2035	ENSGT00650000092876	P11171	ENSG00000159023; Homo sapiens	P11171	GO:0019898; C:extrinsic to membrane; IEA:InterPro; GO:0005794; C:Golgi apparatus; IDA:HPA; GO:0005634; C:nucleus; IDA:HPA; GO:0005886; C:plasma membrane; IDA:HPA; GO:0043234; C:protein complex; IDA:UniProtKB; GO:0008091; C:spectrin; TAS:ProtInc; GO:0014731; C:spectrin-associated cytoskeleton; TAS:BHF-UCL; GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB; GO:0003779; F:actin binding; IEA:UniProtKB-KW; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW; GO:0030507; F:spectrin binding; TAS:BHF-UCL; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc; GO:0008015; P:blood circulation; TAS:ProtInc; GO:0030866; P:cortical actin cytoskeleton organization; IEA:InterPro; GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL	HGNC:3377; EPB41			HBG007777	HPA028414		P11171	P11171; 2	IPR008379; Band_4.1_C; IPR019749; Band_41_domain; IPR019750; Band_41_fam; IPR021187; Band_41_protein; IPR000798; Ez/rad/moesin; IPR014847; FERM-adjacent; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx; IPR019748; FERM_central; IPR019747; FERM_CS; IPR000299; FERM_domain; IPR018979; FERM_N; IPR018980; FERM_PH-like_C; IPR011993; PH_like_dom; IPR007477; SAB	IPI00003921; IPI00218697; IPI00218698; IPI00218699; IPI00218700; IPI00218701; IPI00553103	hsa:2035	K06107		130500; gene; 266140; phenotype; 611804; phenotype	MINT-1208648	8259	NX_P11171		HREDPDF	288; Hereditary elliptocytosis	EOG4K3KVZ		syndecan_2_pathway; Syndecan-2-mediated signaling events	1GG3; X-ray; 2.80 A; A/B/C=210-488; 2RQ1; NMR; -; A=292-396; 3QIJ; X-ray; 1.80 A; A/B=211-488	1GG3; 2RQ1; 3QIJ		PF05902; 4_1_CTD; 1; PF08736; FA; 1; PF09380; FERM_C; 1; PF00373; FERM_M; 1; PF09379; FERM_N; 1; PF04382; SAB; 1	PA27810	P11171	P11171	A39810; MMHUE4	PIRSF002304; Membrane_skeletal_4_1; 1	B1ALH9	P11171	PR00935; BAND41; PR00661; ERMFAMILY		PS00660; FERM_1; 1; PS00661; FERM_2; 1; PS50057; FERM_3; 1	P11171				SM00295; B41; 1	P11171; 206-517	P11171	SSF47031; FERM_3-hlx; 1					uc001brg.2; human; uc001brh.2; human; uc001bri.2; human; uc001brk.3; human; uc001brl.2; human; uc001brm.2; human; uc009vtm.2; human	Hs.175437; Hs.708933; Hs.712722
4EBP1_HUMAN	Q13541; B2R502; D3DSW8; Q6IBN3;	RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 1; Short=4E-BP1; Short=eIF4E-binding protein 1; AltName: Full=Phosphorylated heat- and acid-stable protein regulated by insulin 1; Short=PHAS-I;	NP_004086.1	NM_004095.3		ENST00000338825	ENSP00000340691	ENSG00000187840						118	12580	Q13541	B2R502	D3DSW8	Q6IBN3		Q13541	Q13541				HS_EIF4EBP1		1978	DIP-30944N	DP00028	34921508	1978			NOG78084	L36055; AAA62269.1; -; mRNA; AB044548; BAB18650.1; -; mRNA; BT007162; AAP35826.1; -; mRNA; CR456769; CAG33050.1; -; mRNA; AK312011; BAG34949.1; -; mRNA; CH471080; EAW63341.1; -; Genomic_DNA; CH471080; EAW63342.1; -; Genomic_DNA; BC004459; AAH04459.1; -; mRNA; BC058073; AAH58073.1; -; mRNA	Q13541		GC08P037888	1978	ENSGT00390000013843	Q13541	ENSG00000187840; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB; GO:0031929; P:TOR signaling cascade; IDA:UniProtKB; GO:0006413; P:translational initiation; TAS:Reactome	HGNC:3288; EIF4EBP1	HIX0004694	HBG714775	HBG050425	CAB005032; CAB005039; HPA023501		Q13541	Q13541; 10	IPR008606; EIF4EBP	IPI00002569	hsa:1978	K07205		602223; gene	MINT-210160	8003	NX_Q13541		DKPAGGE		EOG40P486	PTHR12669; EIF4EBP; 1	insulin_pathway; Insulin Pathway; mtor_4pathway; mTOR signaling pathway; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta	1WKW; X-ray; 2.10 A; B=47-66; 2JGB; X-ray; 1.70 A; B=51-67; 2JGC; X-ray; 2.40 A; B=51-67; 2V8W; X-ray; 2.30 A; B/F=51-64; 2V8X; X-ray; 2.30 A; B/F=51-64; 2V8Y; X-ray; 2.10 A; B/F=51-64; 3HXG; X-ray; 2.10 A; C=51-67; 3HXI; X-ray; 1.80 A; C=51-67; 3M93; X-ray; 2.90 A; C=51-67; 3M94; X-ray; 2.05 A; C=51-67; 3U7X; X-ray; 2.10 A; C/D=47-66	1WKW; 2JGB; 2JGC; 2V8W; 2V8X; 2V8Y; 3HXG; 3HXI; 3M93; 3M94; 3U7X	Q13541	PF05456; eIF_4EBP; 1	PA27715	Q13541	Q13541	S50866; S50866		Q13541	Q13541				Q13541	REACT_111102; Signal Transduction; REACT_17015; Metabolism of proteins; REACT_71; Gene Expression					Q13541						uc003xks.3; human	Hs.411641
4EBP2_HUMAN	Q13542;	RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 2; Short=4E-BP2; Short=eIF4E-binding protein 2;	NP_004087.1	NM_004096.4		ENST00000373218	ENSP00000362314	ENSG00000148730						120	12939	Q13542					Q13542	Q13542				HS_EIF4EBP2		1979			34921510	1979			NOG78084	L36056; AAA62270.1; -; mRNA; BT007317; AAP35981.1; -; mRNA; BC005057; AAH05057.1; -; mRNA; BC050633; AAH50633.1; -; mRNA			GC10P072163	1979	ENSGT00390000013843	Q13542	ENSG00000148730; Homo sapiens		GO:0008190; F:eukaryotic initiation factor 4E binding; IEA:InterPro; GO:0045947; P:negative regulation of translational initiation; IEA:InterPro; GO:0006412; P:translation; TAS:ProtInc	HGNC:3289; EIF4EBP2	HIX0008896	HBG714775	HBG050425	CAB019415		Q13542	Q13542; 3	IPR008606; EIF4EBP	IPI00002570	hsa:1979			602224; gene		8007	NX_Q13542		NKKNEAN		EOG47SSG8	PTHR12669; EIF4EBP; 1		3AM7; X-ray; 2.20 A; B=47-65	3AM7	Q13542	PF05456; eIF_4EBP; 1	PA27716	Q13542	Q13542	S50867; S50867			Q13542				Q13542						Q13542						uc001jrb.3; human	Hs.621200; Hs.730236
4EBP3_HUMAN	O60516;	RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 3; Short=4E-BP3; Short=eIF4E-binding protein 3;	NP_003723.1	NM_003732.2		ENST00000310331	ENSP00000308472	ENSG00000243056						100	10873	O60516					O60516							8637							NOG78084	AF038869; AAC39761.1; -; mRNA; BC010881; AAH10881.1; -; mRNA; BC069293; AAH69293.1; -; mRNA; BC073751; AAH73751.1; -; mRNA			GC05P139928	8637	ENSGT00390000013843	O60516	ENSG00000131503; Homo sapiens		GO:0016281; C:eukaryotic translation initiation factor 4F complex; NAS:UniProtKB; GO:0008190; F:eukaryotic initiation factor 4E binding; IEA:InterPro; GO:0030371; F:translation repressor activity; NAS:UniProtKB; GO:0045947; P:negative regulation of translational initiation; NAS:UniProtKB	HGNC:3290; EIF4EBP3			HBG050425	HPA045537			O60516; 3	IPR008606; EIF4EBP	IPI00021476	hsa:8637			603483; gene		32379	NX_O60516				EOG47SSG8	PTHR12669; EIF4EBP; 1					PF05456; eIF_4EBP; 1	PA27718	O60516					O60516				O60516						O60516						uc003lfy.1; human	Hs.594084
4ET_HUMAN	Q9NRA8; B1AKL2; B2RBF1; Q8NCF2; Q9H708;	RecName: Full=Eukaryotic translation initiation factor 4E transporter; Short=4E-T; Short=eIF4E transporter; AltName: Full=Eukaryotic translation initiation factor 4E nuclear import factor 1;	NP_001157973.1; NP_001157974.1; NP_062817.2	NM_001164501.1; NM_001164502.1; NM_019843.3		ENST00000330125; ENST00000397525; ENST00000420671	ENSP00000328103; ENSP00000380659; ENSP00000409372	ENSG00000184708; ENSG00000184708; ENSG00000184708						985	108201	Q9NRA8	B1AKL2	B2RBF1	Q8NCF2		Q9NRA8	Q9NRA8				HS_EIF4ENIF1		56478			22095430	56478			NOG43453	AF240775; AAF81693.1; -; mRNA; CR456386; CAG30272.1; -; mRNA; AK025254; BAB15092.1; ALT_INIT; mRNA; AK074768; BAC11194.1; ALT_INIT; mRNA; AK314636; BAG37198.1; -; mRNA; AL096701; CAI12878.1; -; Genomic_DNA; CH471095; EAW59977.1; -; Genomic_DNA; BC032941; AAH32941.1; -; mRNA; BC033028; AAH33028.1; -; mRNA			GC22M031835	56478	ENSGT00390000012071	Q9NRA8	ENSG00000184708; Homo sapiens		GO:0005634; C:nucleus; TAS:ProtInc; GO:0005515; F:protein binding; IPI:IntAct; GO:0008565; F:protein transporter activity; TAS:ProtInc	HGNC:16687; EIF4ENIF1		HBG267574	HBG023298	HPA001619; HPA002078		Q9NRA8	Q9NRA8; 10	IPR018862; eIF4E_transporter	IPI00291800; IPI00550518	hsa:56478			607445; gene	MINT-1956064	62017	NX_Q9NRA8		GRKTPTL								PF10477; EIF4E-T; 1	PA38410	Q9NRA8	Q9NRA8				Q9NRA8				Q9NRA8						Q9NRA8						uc003aky.2; human	Hs.517559
4F2_HUMAN	P08195; Q13543;	RecName: Full=4F2 cell-surface antigen heavy chain; Short=4F2hc; AltName: Full=4F2 heavy chain antigen; AltName: Full=Lymphocyte activation antigen 4F2 large subunit; AltName: CD_antigen=CD98;	NP_001012680.1; NP_001012682.1; NP_001013269.1; NP_002385.3	NM_001012662.2; NM_001012664.2; NM_001013251.2; NM_002394.5		ENST00000338663; ENST00000377889; ENST00000377890; ENST00000377891; ENST00000377892	ENSP00000340815; ENSP00000367121; ENSP00000367122; ENSP00000367123; ENSP00000367124	ENSG00000168003; ENSG00000168003; ENSG00000168003; ENSG00000168003; ENSG00000168003						630	67994	P08195	Q13543				P08195	P08195	MetaCyc:MONOMER-15188		GH13; Glycoside Hydrolase Family 13	HS_SLC3A2		6520			257051063	6520			COG0366	J02939; AAA52497.1; -; mRNA; J02769; AAA51540.1; -; mRNA; J03569; AAA35536.1; -; mRNA; M21904; AAA35489.1; -; Genomic_DNA; M21898; AAA35489.1; JOINED; Genomic_DNA; M21899; AAA35489.1; JOINED; Genomic_DNA; M21900; AAA35489.1; JOINED; Genomic_DNA; M21901; AAA35489.1; JOINED; Genomic_DNA; M21902; AAA35489.1; JOINED; Genomic_DNA; M21903; AAA35489.1; JOINED; Genomic_DNA; AB018010; BAA84649.1; -; mRNA; AP001160; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC001061; AAH01061.2; -; mRNA; BC003000; AAH03000.2; -; mRNA; BE794697; -; NOT_ANNOTATED_CDS; mRNA	P08195	G3DSA:2.60.40.1180; Glyco_hydro_13_b; 1; G3DSA:3.20.20.80; Glyco_hydro_cat; 1	GC11P062623	6520	ENSGT00530000063127	P08195			GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell; GO:0009986; C:cell surface; IDA:UniProtKB; GO:0016021; C:integral to membrane; NAS:UniProtKB; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell; GO:0005432; F:calcium:sodium antiporter activity; TAS:UniProtKB; GO:0003824; F:catalytic activity; IEA:InterPro; GO:0043169; F:cation binding; IEA:InterPro; GO:0015175; F:neutral amino acid transmembrane transporter activity; ISS:UniProtKB; GO:0005515; F:protein binding; IPI:UniProtKB; GO:0007596; P:blood coagulation; TAS:Reactome; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro; GO:0016049; P:cell growth; NAS:UniProtKB; GO:0060356; P:leucine import; ISS:UniProtKB; GO:0050900; P:leukocyte migration; TAS:Reactome; GO:0015827; P:tryptophan transport; ISS:UniProtKB	HGNC:11026; SLC3A2	HIX0018301	HBG714831	HBG000023			P08195	P08195; 4	IPR015902; Alpha_amylase; IPR013780; Glyco_hydro_13_b; IPR006047; Glyco_hydro_13_cat_dom; IPR013781; Glyco_hydro_subgr_catalytic; IPR017853; Glycoside_hydrolase_SF	IPI00027493; IPI00554481; IPI00554722; IPI00604710	hsa:6520	K06519		158070; gene		25353	NX_P08195		NMTVKGQ		EOG4S7JPP	PTHR10357; Alpha_amylase; 1	nfat_tfpathway; Calcineurin-regulated NFAT-dependent transcription in lymphocytes	2DH2; X-ray; 2.10 A; A=212-630; 2DH3; X-ray; 2.80 A; A/B=212-630	2DH2; 2DH3		PF00128; Alpha-amylase; 1	PA35894	P08195		A28455; SAHU4F			P08195				P08195	REACT_15518; Transmembrane transport of small molecules; REACT_19419; Amino acid and oligopeptide SLC transporters; REACT_604; Hemostasis				P08195; 212-630	P08195	SSF51445; Glyco_hydro_cat; 1		8.A.9.2.2; rBAT transport accessory protein (rBAT) family			uc001nwc.3; human; uc001nwd.3; human; uc001nwf.3; human	Hs.502769
5HT1A_HUMAN	P08908; Q6LAE7;	RecName: Full=5-hydroxytryptamine receptor 1A; Short=5-HT-1A; Short=5-HT1A; AltName: Full=G-21; AltName: Full=Serotonin receptor 1A;	NP_000515.2	NM_000524.2		ENST00000323865	ENSP00000316244	ENSG00000178394						422	46107	P08908	Q6LAE7				P08908	P08908				HS_HTR1A		3350			231454	3350		DB00866; Alprenolol; DB01238; Aripiprazole; DB00490; Buspirone; DB00363; Clozapine; DB00216; Eletriptan; DB01049; Ergoloid mesylate; DB00176; Fluvoxamine; DB00589; Lisuride; DB00247; Methysergide; DB00370; Mirtazapine; DB00960; Pindolol; DB00571; Propranolol; DB01224; Quetiapine; DB01104; Sertraline; DB01079; Tegaserod; DB00656; Trazodone; DB00285; Venlafaxine; DB00246; Ziprasidone	NOG249628	M28269; AAA36440.1; -; Genomic_DNA; X13556; CAA31908.1; -; Genomic_DNA; X57829; CAA40962.1; -; Genomic_DNA; M83181; AAA66493.1; -; Genomic_DNA; AB041403; BAA94488.1; -; Genomic_DNA; AF498978; AAM21125.1; -; mRNA; BC069159; AAH69159.1; -; mRNA; Z11168; CAA77560.1; -; Genomic_DNA			GC05M063292	3350	ENSGT00650000092921	P08908	ENSG00000178394; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0004993; F:serotonin receptor activity; TAS:ProtInc; GO:0007610; P:behavior; TAS:ProtInc; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc	HGNC:5286; HTR1A	HIX0032004	HBG445348	HBG106962	HPA018073		P08908		IPR000610; 5HT1A_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00031686	hsa:3350	K04153		109760; gene		13248	NX_P08908		ETECDST		EOG4CC41F						PF00001; 7tm_1; 1	PA192	P08908	P08908	I38209; I38209			P08908	PR00512; 5HT1ARECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P08908	REACT_111102; Signal Transduction				P08908; 32-417	P08908						uc011cqt.2; human	Hs.247940
5HT1B_HUMAN	P28222; Q4VAY7;	RecName: Full=5-hydroxytryptamine receptor 1B; Short=5-HT-1B; Short=5-HT1B; AltName: Full=S12; AltName: Full=Serotonin 1D beta receptor; Short=5-HT-1D-beta; AltName: Full=Serotonin receptor 1B;	NP_000854.1	NM_000863.1		ENST00000369947	ENSP00000358963	ENSG00000135312						390	43568	P28222	Q4VAY7				P28222	P28222				HS_HTR1B		3351			112821			DB00918; Almotriptan; DB01191; Dexfenfluramine; DB00320; Dihydroergotamine; DB00216; Eletriptan; DB00696; Ergotamine; DB00998; Frovatriptan; DB00952; Naratriptan; DB00960; Pindolol; DB00571; Propranolol; DB00953; Rizatriptan; DB00669; Sumatriptan; DB00285; Venlafaxine; DB00315; Zolmitriptan	NOG249628	M89478; -; NOT_ANNOTATED_CDS; Genomic_DNA; D10995; BAA01763.1; -; Genomic_DNA; M83180; AAA36029.1; -; Genomic_DNA; L09732; AAA36030.1; -; Genomic_DNA; M81590; AAA60316.1; -; mRNA; M75128; AAA58675.1; -; Genomic_DNA; AB041370; BAA94455.1; -; Genomic_DNA; AY225227; AAO67712.1; -; Genomic_DNA; AL049595; CAB51537.1; -; Genomic_DNA; BC069065; AAH69065.1; -; mRNA; BC096206; AAH96206.1; -; mRNA; BC096207; AAH96207.1; -; mRNA; BC096208; AAH96208.1; -; mRNA			GC06M078228	3351	ENSGT00650000092921	P28222	ENSG00000135312; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0004993; F:serotonin receptor activity; TAS:ProtInc; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc; GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:UniProtKB; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5287; HTR1B	HIX0032923	HBG445348	HBG106962			P28222		IPR002147; 5HT1B_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00002184	hsa:3351	K04153		182131; gene		13252	NX_P28222		ALPWKVL		EOG4R7VB6			2G1X; Model; -; A=1-390	2G1X		PF00001; 7tm_1; 1	PA29549	P28222	P28222	JN0268; JN0268			P28222	PR00513; 5HT1BRECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P28222	REACT_111102; Signal Transduction				P28222; 43-387	P28222						uc003pil.1; human	Hs.123016
5HT1D_HUMAN	P28221;	RecName: Full=5-hydroxytryptamine receptor 1D; Short=5-HT-1D; Short=5-HT1D; AltName: Full=5-HT-1D-alpha; AltName: Full=Serotonin receptor 1D;	NP_000855.1	NM_000864.4		ENST00000314113; ENST00000374619	ENSP00000313661; ENSP00000363748	ENSG00000179546; ENSG00000179546						377	41907	P28221					P28221	P28221				HS_HTR1D		3352			112819	3352		DB00918; Almotriptan; DB00320; Dihydroergotamine; DB00216; Eletriptan; DB00696; Ergotamine; DB00998; Frovatriptan; DB00952; Naratriptan; DB00953; Rizatriptan; DB00669; Sumatriptan; DB01079; Tegaserod; DB00246; Ziprasidone; DB00315; Zolmitriptan	NOG249628	M89955; AAA35491.1; -; Genomic_DNA; M81589; AAA60315.1; -; mRNA; AF498979; AAM21126.1; -; mRNA; BT007027; AAP35673.1; -; mRNA; AL049576; CAB81617.1; -; Genomic_DNA; BC007720; AAH07720.1; -; mRNA			GC01M023517	3352	ENSGT00650000092921	P28221	ENSG00000179546; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0004993; F:serotonin receptor activity; TAS:ProtInc; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc; GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5289; HTR1D	HIX0199958	HBG445348	HBG106962			P28221		IPR000505; 5HT1D_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00002183	hsa:3352	K04153		182133; gene		13256	NX_P28221		LHEGHSH		EOG4R7VB6						PF00001; 7tm_1; 1	PA29550		P28221	A53279; A53279			P28221	PR00514; 5HT1DRECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P28221	REACT_111102; Signal Transduction				P28221; 35-375	P28221						uc001bgn.3; human	Hs.121482
5HT1E_HUMAN	P28566; E1P503; Q9P1Y1;	RecName: Full=5-hydroxytryptamine receptor 1E; Short=5-HT-1E; Short=5-HT1E; AltName: Full=S31; AltName: Full=Serotonin receptor 1E;	NP_000856.1	NM_000865.2		ENST00000305344; ENST00000369584	ENSP00000307766; ENSP00000358597	ENSG00000168830; ENSG00000168830						365	41682	P28566	E1P503	Q9P1Y1			P28566	P28566				HS_HTR1E		3354			112822			DB00216; Eletriptan	NOG249628	M91467; AAA58353.1; -; mRNA; Z11166; CAA77558.1; -; Genomic_DNA; M92826; AAA58355.1; -; Genomic_DNA; AF498980; AAM21127.1; -; mRNA; AL157777; CAC10582.1; -; Genomic_DNA; CH471051; EAW48616.1; -; Genomic_DNA; CH471051; EAW48617.1; -; Genomic_DNA; BC069751; AAH69751.1; -; mRNA; AB041373; BAA94458.1; -; Genomic_DNA			GC06P087647	3354	ENSGT00650000092921	P28566	ENSG00000168830; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0051378; F:serotonin binding; IDA:MGI; GO:0004993; F:serotonin receptor activity; IDA:MGI; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5291; HTR1E	HIX0032800	HBG445348	HBG106962	HPA004931		P28566		IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00003932	hsa:3354	K04153		182132; gene		13262	NX_P28566		PLFWRSH		EOG43XV41						PF00001; 7tm_1; 1	PA29552		P28566	S20579; A45260			P28566	PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P28566	REACT_111102; Signal Transduction				P28566; 18-359	P28566						uc003pli.3; human	Hs.1611
5HT1F_HUMAN	P30939;	RecName: Full=5-hydroxytryptamine receptor 1F; Short=5-HT-1F; Short=5-HT1F; AltName: Full=Serotonin receptor 1F;	NP_000857.1	NM_000866.3		ENST00000319595	ENSP00000322924	ENSG00000179097						366	41709	P30939					P30939	P30939				HS_HTR1F		3355			398967			DB00216; Eletriptan; DB00952; Naratriptan; DB00953; Rizatriptan; DB00669; Sumatriptan; DB00315; Zolmitriptan	NOG249628	L05597; AAA36605.1; -; Genomic_DNA; L04962; AAA36646.1; -; Genomic_DNA; AF498981; AAM21128.1; -; mRNA; BC069125; AAH69125.1; -; mRNA			GC03P088031	3355	ENSGT00650000092921	P30939	ENSG00000179097; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0051378; F:serotonin binding; IDA:MGI; GO:0004993; F:serotonin receptor activity; IDA:MGI; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5292; HTR1F	HIX0030749	HBG445348	HBG106962	HPA005555		P30939		IPR000450; 5HT1F_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00028093	hsa:3355	K04153		182134; gene		13266	NX_P30939		VNVCEKC		EOG43XV41						PF00001; 7tm_1; 1	PA29553		P30939	A47321; A47321			P30939	PR00515; 5HT1FRECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P30939	REACT_111102; Signal Transduction				P30939; 21-364	P30939						uc003dqr.2; human	Hs.248136
5HT2A_HUMAN	P28223; B2RAC5; Q5T8C0;	RecName: Full=5-hydroxytryptamine receptor 2A; Short=5-HT-2; Short=5-HT-2A; AltName: Full=Serotonin receptor 2A;	NP_000612.1	NM_000621.4		ENST00000378688	ENSP00000367959	ENSG00000102468						471	52603	P28223	B2RAC5	Q5T8C0			P28223	P28223				HS_HTR2A		3356			543727			DB01238; Aripiprazole; DB00477; Chlorpromazine; DB01239; Chlorprothixene; DB00604; Cisapride; DB01242; Clomipramine; DB00363; Clozapine; DB00924; Cyclobenzaprine; DB00434; Cyproheptadine; DB00320; Dihydroergotamine; DB00843; Donepezil; DB00751; Epinastine; DB00696; Ergotamine; DB00176; Fluvoxamine; DB00933; Mesoridazine; DB00247; Methysergide; DB06148; Mianserin; DB00805; Minaprine; DB00370; Mirtazapine; DB01149; Nefazodone; DB00334; Olanzapine; DB01267; Paliperidone; DB00715; Paroxetine; DB00433; Prochlorperazine; DB00420; Promazine; DB01069; Promethazine; DB00777; Propiomazine; DB01224; Quetiapine; DB00734; Risperidone; DB06144; Sertindole; DB00372; Thiethylperazine; DB00679; Thioridazine; DB00752; Tranylcypromine; DB00656; Trazodone; DB00285; Venlafaxine; DB00246; Ziprasidone	NOG247243	X57830; CAA40963.1; -; mRNA; S42168; AAB22791.2; -; Genomic_DNA; S42165; AAB22791.2; JOINED; Genomic_DNA; S42167; AAB22791.2; JOINED; Genomic_DNA; S71229; AAB31320.1; -; mRNA; AF498982; AAM21129.1; -; mRNA; AK314132; BAG36822.1; -; mRNA; AL160397; CAI16877.1; -; Genomic_DNA; AL136958; CAI16877.1; JOINED; Genomic_DNA; AL136958; CAI12227.1; -; Genomic_DNA; AL160397; CAI12227.1; JOINED; Genomic_DNA; CH471075; EAX08770.1; -; Genomic_DNA; BC069356; AAH69356.1; -; mRNA; BC069576; AAH69576.1; -; mRNA; BC074848; AAH74848.1; -; mRNA; BC074849; AAH74849.1; -; mRNA; BC096839; AAH96839.1; -; mRNA; M86841; AAA58354.1; -; mRNA; S50130; AAB24166.2; -; Genomic_DNA; S49737; AAB24166.2; JOINED; Genomic_DNA; S50113; AAB24166.2; JOINED; Genomic_DNA			GC13M047407	3356	ENSGT00650000093057	P28223	ENSG00000102468; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB; GO:0008144; F:drug binding; IDA:UniProtKB; GO:0004435; F:phosphatidylinositol phospholipase C activity; IMP:UniProtKB; GO:0051378; F:serotonin binding; IDA:UniProtKB; GO:0004993; F:serotonin receptor activity; IDA:UniProtKB; GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB; GO:0014065; P:phosphatidylinositol 3-kinase cascade; IMP:UniProtKB; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB; GO:0042493; P:response to drug; IDA:UniProtKB; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5293; HTR2A	HIX0026550	HBG445348	HBG107487	HPA014011		P28223		IPR000455; 5HT2A_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00002185	hsa:3356	K04157		182135; gene	MINT-443877	13270	NX_P28223		NSGEANT		EOG4TMR24						PF00001; 7tm_1; 1	PA193	P28223	P28223	A43956; A43956			P28223	PR00516; 5HT2ARECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P28223	REACT_111102; Signal Transduction				P28223; 74-395	P28223						uc010acr.3; human	Hs.654586
5HT2B_HUMAN	P41595; B2R9D5; Q53TI1; Q62221; Q6P523;	RecName: Full=5-hydroxytryptamine receptor 2B; Short=5-HT-2B; Short=5-HT2B; AltName: Full=Serotonin receptor 2B;	NP_000858.3	NM_000867.4		ENST00000258400	ENSP00000258400	ENSG00000135914						481	54298	P41595	B2R9D5	Q53TI1	Q62221		P41595	P41595				HS_HTR2B		3357			1168220			DB01239; Chlorprothixene; DB00216; Eletriptan; DB00574; Fenfluramine; DB01403; Methotrimeprazine; DB00805; Minaprine; DB01224; Quetiapine; DB00669; Sumatriptan; DB01079; Tegaserod; DB00508; Triflupromazine	NOG247243	X77307; CAA54513.1; -; mRNA; Z36748; CAA85319.1; -; mRNA; AF156160; AAD39259.1; -; Genomic_DNA; AF156158; AAD39259.1; JOINED; Genomic_DNA; AF156159; AAD39259.1; JOINED; Genomic_DNA; AY136751; AAN01277.1; -; mRNA; AC009407; AAX93128.1; -; Genomic_DNA; AK313741; BAG36482.1; -; mRNA; CH471063; EAW70949.1; -; Genomic_DNA; BC063123; AAH63123.1; -; mRNA			GC02M231936	3357	ENSGT00650000093057	P41595	ENSG00000135914; Homo sapiens		GO:0005737; C:cytoplasm; IDA:UniProtKB; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0005886; C:plasma membrane; IDA:UniProtKB; GO:0005262; F:calcium channel activity; IMP:UniProtKB; GO:0008144; F:drug binding; IDA:UniProtKB; GO:0001965; F:G-protein alpha-subunit binding; IMP:UniProtKB; GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB; GO:0005099; F:Ras GTPase activator activity; ISS:UniProtKB; GO:0051378; F:serotonin binding; IDA:UniProtKB; GO:0004993; F:serotonin receptor activity; IDA:UniProtKB; GO:0007205; P:activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway; ISS:UniProtKB; GO:0019722; P:calcium-mediated signaling; IMP:UniProtKB; GO:0003300; P:cardiac muscle hypertrophy; ISS:UniProtKB; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB; GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB; GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB; GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB; GO:0002031; P:G-protein coupled receptor internalization; IMP:UniProtKB; GO:0003007; P:heart morphogenesis; ISS:UniProtKB; GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB; GO:0010507; P:negative regulation of autophagy; IMP:UniProtKB; GO:0001755; P:neural crest cell migration; ISS:UniProtKB; GO:0014065; P:phosphatidylinositol 3-kinase cascade; IMP:UniProtKB; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB; GO:0016310; P:phosphorylation; IMP:UniProtKB; GO:0051781; P:positive regulation of cell division; ISS:UniProtKB; GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB; GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; IEP:UniProtKB; GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:UniProtKB; GO:0070528; P:protein kinase C signaling cascade; IMP:UniProtKB; GO:0050795; P:regulation of behavior; IMP:UniProtKB; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB; GO:0042493; P:response to drug; IDA:UniProtKB; GO:0042310; P:vasoconstriction; IMP:UniProtKB	HGNC:5294; HTR2B	HIX0029887	HBG445348	HBG107487	CAB011448; HPA012867		P41595		IPR000482; 5HT2B_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00015134	hsa:3357	K04157		601122; gene	MINT-444010	13274	NX_P41595		FTPLAIM		EOG41ZF9R						PF00001; 7tm_1; 1	PA29554		P41595	S43687; S43687; S49442; S49442			P41595	PR00651; 5HT2BRECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P41595	REACT_111102; Signal Transduction				P41595; 57-395	P41595						uc002vro.3; human	Hs.421649
5HT2C_HUMAN	P28335; Q5VUF8; Q9NP28;	RecName: Full=5-hydroxytryptamine receptor 2C; Short=5-HT-2C; Short=5-HT2C; Short=5-HTR2C; AltName: Full=5-hydroxytryptamine receptor 1C; Short=5-HT-1C; Short=5-HT1C; AltName: Full=Serotonin receptor 2C;	NP_000859.1; NP_001243689.1	NM_000868.2; NM_001256760.1		ENST00000276198; ENST00000371951	ENSP00000276198; ENSP00000361019	ENSG00000147246; ENSG00000147246						458	51821	P28335	Q5VUF8	Q9NP28			P28335	P28335				HS_HTR2C		3358			112816			DB01239; Chlorprothixene; DB00363; Clozapine; DB01191; Dexfenfluramine; DB00574; Fenfluramine; DB00247; Methysergide; DB06148; Mianserin; DB00805; Minaprine; DB00370; Mirtazapine; DB00334; Olanzapine; DB00420; Promazine; DB00777; Propiomazine; DB01224; Quetiapine; DB06144; Sertindole; DB00372; Thiethylperazine; DB00193; Tramadol; DB00246; Ziprasidone	NOG247243	M81778; AAA60317.1; -; mRNA; X80763; CAB59978.1; -; Genomic_DNA; U49516; AAB40898.1; -; mRNA; AF208053; AAF35842.1; -; mRNA; AF498983; AAM21130.1; -; mRNA; AC004822; AAC71658.1; -; Genomic_DNA; AL355812; CAI41335.1; -; Genomic_DNA; AL590097; CAI41335.1; JOINED; Genomic_DNA; AC004822; CAI41335.1; JOINED; Genomic_DNA; AL590097; CAH70193.1; -; Genomic_DNA; AC004822; CAH70193.1; JOINED; Genomic_DNA; AL355812; CAH70193.1; JOINED; Genomic_DNA; BC095543; AAH95543.1; -; mRNA			GC0XP113818	3358	ENSGT00650000093057	P28335	ENSG00000147246; Homo sapiens		GO:0005737; C:cytoplasm; IDA:HPA; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0005634; C:nucleus; IDA:HPA; GO:0005886; C:plasma membrane; IDA:UniProtKB; GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB; GO:0008144; F:drug binding; IDA:UniProtKB; GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB; GO:0051378; F:serotonin binding; IDA:UniProtKB; GO:0004993; F:serotonin receptor activity; IDA:MGI; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB; GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB; GO:0007631; P:feeding behavior; TAS:ProtInc; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB; GO:0042493; P:response to drug; IDA:UniProtKB; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5295; HTR2C	HIX0028341	HBG445348	HBG107487	CAB006857; HPA003133		P28335	P28335; 1	IPR000377; 5HT2C_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00002876	hsa:3358	K04157		312861; gene	MINT-443944	13278	NX_P28335		ACNQKLM		EOG4M0F2D						PF00001; 7tm_1; 1	PA194	P28335	P28335	JS0616; JS0616			P28335	PR00517; 5HT2CRECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P28335	REACT_111102; Signal Transduction				P28335; 56-384	P28335						uc004epu.1; human	Hs.149037
5HT3A_HUMAN	P46098; B4DSY6; O60854; Q99918; Q9BSZ9;	RecName: Full=5-hydroxytryptamine receptor 3A; Short=5-HT3-A; Short=5-HT3A; AltName: Full=5-hydroxytryptamine receptor 3; Short=5-HT-3; Short=5-HT3R; AltName: Full=Serotonin receptor 3A; AltName: Full=Serotonin-gated ion channel receptor; Flags: Precursor;	NP_000860.2; NP_001155244.1; NP_998786.2	NM_000869.5; NM_001161772.2; NM_213621.3		ENST00000299961; ENST00000375498	ENSP00000299961; ENSP00000364648	ENSG00000166736; ENSG00000166736						478	55280	P46098	B4DSY6	O60854	Q99918		P46098	B4DSY6				HS_HTR3A		3359			1168222	3359		DB00969; Alosetron; DB01161; Chloroprocaine; DB00604; Cisapride; DB00757; Dolasetron; DB00889; Granisetron; DB00370; Mirtazapine; DB00904; Ondansetron; DB00377; Palonosetron; DB00721; Procaine; DB01199; Tubocurarine	NOG302526	D49394; BAA08387.1; -; mRNA; S82612; AAB37533.2; -; mRNA; AJ003078; CAA05851.1; -; mRNA; AJ003079; CAA05852.1; -; mRNA; AJ005205; CAA06442.3; -; Genomic_DNA; AF498984; AAM21131.1; -; mRNA; AK299973; BAG61798.1; -; mRNA; AP000908; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC002354; AAH02354.1; -; mRNA; BC004453; AAH04453.2; -; mRNA		G3DSA:2.70.170.10; Neur_chan_lig_bd; 1	GC11P113879	3359	ENSGT00570000078866	P46098	ENSG00000166736; Homo sapiens		GO:0030054; C:cell junction; IEA:UniProtKB-KW; GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell; GO:0051378; F:serotonin binding; IDA:MGI; GO:0004993; F:serotonin receptor activity; NAS:UniProtKB; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome; GO:0007586; P:digestion; TAS:ProtInc; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5297; HTR3A	HIX0010139		HBG106638					IPR008132; 5HT3_rcpt; IPR008133; 5HT3_rcpt_A; IPR006202; Neur_chan_lig-bd; IPR006201; Neur_channel; IPR006029; Neurotrans-gated_channel_TM; IPR018000; Neurotransmitter_ion_chnl_CS	IPI00179555; IPI00748737	hsa:3359	K04819		182139; gene		13282	NX_P46098		GEVQNYK			PTHR18945; Neur_channel; 1					PF02931; Neur_chan_LBD; 1; PF02932; Neur_chan_memb; 1	PA29555	P46098					P46098	PR01709; 5HT3ARECEPTR; PR01708; 5HT3RECEPTOR; PR00252; NRIONCHANNEL		PS00236; NEUROTR_ION_CHANNEL; 1	P46098	REACT_15518; Transmembrane transport of small molecules				P46098; 31-471	P46098	SSF90112; Neu_channel_TM; 1; SSF63712; Neur_chan_LBD; 1		1.A.9.2.1; neurotransmitter receptor, cys loop, ligand-gated ion channel (LIC) family	TIGR00860; LIC; 1		uc010rxb.2; human	Hs.413899
5HT3B_HUMAN	O95264; B0YJ23; Q0VJC3;	RecName: Full=5-hydroxytryptamine receptor 3B; Short=5-HT3-B; Short=5-HT3B; AltName: Full=Serotonin receptor 3B; Flags: Precursor;	NP_006019.1	NM_006028.4		ENST00000260191	ENSP00000260191	ENSG00000149305						441	50292	O95264	B0YJ23	Q0VJC3			O95264	O95264				HS_HTR3B		9177				9177			NOG260507	AF169255; AAF03691.1; -; mRNA; AF080582; AAD12242.1; -; mRNA; AM293589; CAL25321.1; -; mRNA; EF444985; ACA06001.1; -; Genomic_DNA; AK314268; BAG36930.1; -; mRNA		G3DSA:2.70.170.10; Neur_chan_lig_bd; 1	GC11P113809	9177	ENSGT00570000078866	O95264			GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0045211; C:postsynaptic membrane; IEA:InterPro; GO:0004993; F:serotonin receptor activity; TAS:ProtInc; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5298; HTR3B	HIX0035859	HBG714660	HBG106638	HPA039559	P02711; 2BG9	O95264		IPR008132; 5HT3_rcpt; IPR008134; 5HT3_rcpt_B; IPR006202; Neur_chan_lig-bd; IPR006201; Neur_channel; IPR006029; Neurotrans-gated_channel_TM	IPI00005673; IPI00876974	hsa:9177	K04819		604654; gene		34409	NX_O95264		RSREDIK		EOG4N8R4Z	PTHR18945; Neur_channel; 1					PF02931; Neur_chan_LBD; 1; PF02932; Neur_chan_memb; 1	PA29556		O95264				O95264	PR01710; 5HT3BRECEPTR; PR01708; 5HT3RECEPTOR; PR00252; NRIONCHANNEL		PS00236; NEUROTR_ION_CHANNEL; FALSE_NEG	O95264	REACT_15518; Transmembrane transport of small molecules				O95264; 30-434	O95264	SSF90112; Neu_channel_TM; 1; SSF63712; Neur_chan_LBD; 1			TIGR00860; LIC; 1		uc001pok.3; human; uc001pol.3; human	Hs.241377
5HT3C_HUMAN	Q8WXA8; A2RRR5;	RecName: Full=5-hydroxytryptamine receptor 3C; Short=5-HT3-C; Short=5-HT3C; AltName: Full=Serotonin receptor 3C; Flags: Precursor;	NP_570126.2	NM_130770.2		ENST00000318351	ENSP00000322617	ENSG00000178084						447	50220	Q8WXA8	A2RRR5				Q8WXA8	Q8WXA8				HS_HTR3C		170572			166198366				NOG316889	AF459285; AAL66182.1; -; mRNA; CH471052; EAW78305.1; -; Genomic_DNA; BC131799; AAI31800.1; -; mRNA		G3DSA:2.70.170.10; Neur_chan_lig_bd; 1	GC03P183770	170572	ENSGT00570000078866	Q8WXA8			GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0005886; C:plasma membrane; TAS:Reactome; GO:0045211; C:postsynaptic membrane; IEA:InterPro; GO:0004872; F:receptor activity; IEA:UniProtKB-KW; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome	HGNC:24003; HTR3C	HIX0030746	HBG714660	HBG106638		P02711; 2BG9	Q8WXA8		IPR006202; Neur_chan_lig-bd; IPR006201; Neur_channel; IPR006029; Neurotrans-gated_channel_TM; IPR018000; Neurotransmitter_ion_chnl_CS	IPI00103496	hsa:170572	K04819		610121; gene		89041	NX_Q8WXA8		AFTINCS		EOG4R5034	PTHR18945; Neur_channel; 1					PF02931; Neur_chan_LBD; 1; PF02932; Neur_chan_memb; 1	PA134925741		Q8WXA8				Q8WXA8	PR00252; NRIONCHANNEL		PS00236; NEUROTR_ION_CHANNEL; 1	Q8WXA8	REACT_15518; Transmembrane transport of small molecules				Q8WXA8; 43-445	Q8WXA8	SSF90112; Neu_channel_TM; 1; SSF63712; Neur_chan_LBD; 1					uc003fmk.3; human	Hs.632579
5HT3D_HUMAN	Q70Z44; C9J2I6; Q495N5; Q495N6; Q7Z6B3;	RecName: Full=5-hydroxytryptamine receptor 3D; Short=5-HT3-D; Short=5-HT3D; AltName: Full=Serotonin receptor 3D; Flags: Precursor;	NP_001157118.1; NP_872343.2	NM_001163646.1; NM_182537.2		ENST00000382489; ENST00000428798	ENSP00000371929; ENSP00000405409	ENSG00000186090; ENSG00000186090						454	50191	Q70Z44	C9J2I6	Q495N5	Q495N6		Q495N5					HS_HTR3D		200909			300669602				NOG302603	AJ437318; CAD24817.1; -; mRNA; AY159812; AAO38166.2; -; mRNA; AC068644; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC131235; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC101090; AAI01091.1; -; mRNA; BC101091; AAI01092.1; -; mRNA		G3DSA:2.70.170.10; Neur_chan_lig_bd; 1	GC03P183749	200909	ENSGT00570000078866	Q70Z44			GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0005886; C:plasma membrane; TAS:Reactome; GO:0004872; F:receptor activity; IEA:UniProtKB-KW; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome	HGNC:24004; HTR3D	HIX0030755	HBG714660	HBG106638		P02711; 1OED	Q70Z44		IPR006202; Neur_chan_lig-bd; IPR006201; Neur_channel; IPR006029; Neurotrans-gated_channel_TM	IPI00376256; IPI00429176; IPI00877166	hsa:200909	K04819		610122; gene		90004	NX_Q70Z44					PTHR18945; Neur_channel; 1					PF02931; Neur_chan_LBD; 1; PF02932; Neur_chan_memb; 1	PA134866755						Q70Z44			PS00236; NEUROTR_ION_CHANNEL; FALSE_NEG	Q70Z44	REACT_15518; Transmembrane transport of small molecules					Q70Z44	SSF90112; Neu_channel_TM; 1; SSF63712; Neur_chan_LBD; 1					uc010hxp.3; human; uc011bqv.2; human	Hs.448004
5HT3E_HUMAN	A5X5Y0; Q495G1; Q495G3; Q6V706; Q6V707; Q7Z6B2;	RecName: Full=5-hydroxytryptamine receptor 3E; Short=5-HT3-E; Short=5-HT3E; AltName: Full=Serotonin receptor 3E; Flags: Precursor;	NP_001243542.1; NP_872395.2; NP_938055.1; NP_938056.1	NM_001256613.1; NM_182589.2; NM_198313.2; NM_198314.2		ENST00000415389	ENSP00000401444	ENSG00000186038						456	51438	A5X5Y0	Q495G1	Q495G3	Q6V706							HS_HTR3E		285242							NOG316889	AY349352; AAQ93476.1; -; mRNA; AY349353; AAQ93477.1; -; mRNA; AY159813; AAO38167.2; -; mRNA; DQ644022; ABG35128.1; -; mRNA; BC101182; AAI01183.1; -; mRNA; BC101183; AAI01184.1; -; mRNA; BC101185; AAI01186.1; -; mRNA		G3DSA:2.70.170.10; Neur_chan_lig_bd; 1	GC03P183814	285242	ENSGT00570000078866	A5X5Y0			GO:0016021; C:integral to membrane; IEA:UniProtKB-KW; GO:0005886; C:plasma membrane; TAS:Reactome; GO:0045211; C:postsynaptic membrane; IEA:InterPro; GO:0004872; F:receptor activity; IEA:UniProtKB-KW; GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:Reactome	HGNC:24005; HTR3E			HBG106638			A5X5Y0		IPR006202; Neur_chan_lig-bd; IPR006201; Neur_channel; IPR006029; Neurotrans-gated_channel_TM; IPR018000; Neurotransmitter_ion_chnl_CS	IPI00376255; IPI00876853; IPI00877063; IPI00877086	hsa:285242	K04819		610123; gene		95380	NX_A5X5Y0				EOG4R5034	PTHR18945; Neur_channel; 1					PF02931; Neur_chan_LBD; 1; PF02932; Neur_chan_memb; 1	PA134900226						A5X5Y0	PR00252; NRIONCHANNEL		PS00236; NEUROTR_ION_CHANNEL; 1	A5X5Y0	REACT_15518; Transmembrane transport of small molecules					A5X5Y0	SSF90112; Neu_channel_TM; 1; SSF63712; Neur_chan_LBD; 1					uc003fml.4; human; uc003fmm.3; human; uc003fmn.3; human; uc010hxq.3; human	Hs.449179
5HT4R_HUMAN	Q9UE23; Q9UQR6;	RecName: Full=5-hydroxytryptamine receptor 4; Short=5-HT-4; Short=5-HT4; AltName: Full=Serotonin receptor 4;	NP_000861.1; NP_001035259.1; NP_001035262.2; NP_955525.1	NM_000870.5; NM_001040169.2; NM_001040172.2; NM_199453.3		ENST00000377888	ENSP00000367120	ENSG00000164270						388	43761	Q9UE23	Q9UQR6		Q9H199		Q13639	Q13639						3360			12644029			DB00604; Cisapride; DB00953; Rizatriptan; DB01079; Tegaserod; DB00315; Zolmitriptan	NOG262978	Y08756; CAA70002.1; -; mRNA; Y12505; CAA73107.1; -; mRNA; Y12506; CAA73108.1; -; mRNA; Y12507; CAA73109.1; -; mRNA; Y10437; CAA71462.1; -; mRNA; Y13584; CAA73911.1; -; mRNA; Y09586; CAA70774.1; -; mRNA; AJ011371; CAA09600.1; -; mRNA; AJ278979; CAC22248.1; -; mRNA; AJ278981; CAC22250.1; -; mRNA; AJ278982; CAC22251.1; -; mRNA; BC074755; AAH74755.1; -; mRNA; AJ243213; CAB71316.1; -; Genomic_DNA; Z48150; CAA88167.1; -; mRNA			GC05M147810	3360	ENSGT00650000092903	Q13639	ENSG00000164270; Homo sapiens		GO:0005768; C:endosome; IEA:UniProtKB-SubCell; GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0005624; C:membrane fraction; IDA:MGI; GO:0004993; F:serotonin receptor activity; IDA:MGI; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB	HGNC:5299; HTR4			HBG106962					IPR001520; 5HT4_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00014378; IPI00064638; IPI00186777; IPI00216427; IPI00216428; IPI00216429; IPI00291659	hsa:3360	K04160		602164; gene	MINT-1347413	13288	NX_Q13639				EOG4933HZ						PF00001; 7tm_1; 1	PA29557			S66493; S66493			Q13639	PR01059; 5HT4RECEPTR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	Q13639	REACT_111102; Signal Transduction				Q13639; 12-327	Q13639						uc003lpn.3; human; uc021yfh.1; human; uc021yfi.1; human	Hs.483773
5HT5A_HUMAN	P47898; Q2M2D2;	RecName: Full=5-hydroxytryptamine receptor 5A; Short=5-HT-5; Short=5-HT-5A; Short=5-HT5A; AltName: Full=Serotonin receptor 5A;	NP_076917.1	NM_024012.3		ENST00000287907	ENSP00000287907	ENSG00000157219						357	40255	P47898	Q2M2D2				P47898	P47898				HS_HTR5A		3361			1345607	3361			NOG260742	X81411; CAA57168.1; -; Genomic_DNA; X81412; CAA57168.1; JOINED; Genomic_DNA; AF498985; AAM21132.1; -; mRNA; BC112021; AAI12022.1; -; mRNA			GC07P154862	3361	ENSGT00650000092921	P47898	ENSG00000157219; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0004993; F:serotonin receptor activity; IDA:MGI	HGNC:5300; HTR5A	HIX0033634	HBG445348	HBG106962	CAB017467		P47898		IPR001397; 5HT5A_rcpt; IPR002231; 5HT_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00026666	hsa:3361	K04161		601305; gene		13304	NX_P47898		NSAFKNF		EOG4K6G4Q						PF00001; 7tm_1; 1	PA29558		P47898	I37107; I37107			P47898	PR00518; 5HT5ARECEPTR; PR01101; 5HTRECEPTOR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P47898	REACT_111102; Signal Transduction				P47898; 38-356	P47898						uc003wlu.1; human	Hs.65791
5HT6R_HUMAN	P50406; Q13640; Q5TGZ1;	RecName: Full=5-hydroxytryptamine receptor 6; Short=5-HT-6; Short=5-HT6; AltName: Full=Serotonin receptor 6;	NP_000862.1	NM_000871.1		ENST00000289753	ENSP00000289753	ENSG00000158748						440	46954	P50406	Q13640	Q5TGZ1			P50406	P50406				HS_HTR6		3362			1703010			DB00889; Granisetron; DB00904; Ondansetron; DB06144; Sertindole	NOG299437	L41147; AAA92622.1; -; mRNA; AY429105; AAR07900.1; -; mRNA; AL031727; CAI19020.1; -; Genomic_DNA; CH471134; EAW94896.1; -; Genomic_DNA; BC074995; AAH74995.1; -; mRNA; BC074996; AAH74996.1; -; mRNA; Z49119; CAA88929.1; -; mRNA			GC01P019991	3362	ENSGT00650000092903	P50406	ENSG00000158748; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0004969; F:histamine receptor activity; TAS:ProtInc; GO:0005515; F:protein binding; IPI:IntAct; GO:0007187; P:G-protein signaling, coupled to cyclic nucleotide second messenger; TAS:ProtInc; GO:0007268; P:synaptic transmission; TAS:ProtInc	HGNC:5301; HTR6	HIX0200015	HBG445348	HBG106962			P50406	P50406; 1	IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00032009	hsa:3362	K04162		601109; gene		13308	NX_P50406		RMTPPRA		EOG47WNPD						PF00001; 7tm_1; 1	PA29560	P50406		JC5520; JC5520			P50406	PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P50406	REACT_111102; Signal Transduction				P50406; 25-338	P50406						uc001bcl.3; human	Hs.22180
5HT7R_HUMAN	P34969; B5BUP6; P78336; P78372; P78516; Q5VX01; Q5VX02;	RecName: Full=5-hydroxytryptamine receptor 7; Short=5-HT-7; Short=5-HT7; AltName: Full=5-HT-X; AltName: Full=Serotonin receptor 7;	NP_000863.1; NP_062873.1; NP_062874.1	NM_000872.4; NM_019859.3; NM_019860.3		ENST00000336152	ENSP00000337949	ENSG00000148680						479	53555	P34969	B5BUP6	P78336	P78372		P34969	P34969				HS_HTR7		3363			8488960			DB00216; Eletriptan; DB00247; Methysergide; DB00246; Ziprasidone	NOG249628	U68487; AAB48393.1; -; mRNA; U68488; AAB48394.1; -; mRNA; U68492; AAF07218.1; -; Genomic_DNA; U68493; AAF07217.1; -; Genomic_DNA; U68492; AAF07217.1; JOINED; Genomic_DNA; U68493; AAB48397.2; -; Genomic_DNA; U68492; AAB48397.2; JOINED; Genomic_DNA; L21195; AAC37538.1; -; mRNA; AY493988; AAR87480.1; -; mRNA; AB451482; BAG70296.1; -; mRNA; AL360011; CAH69967.1; -; Genomic_DNA; AL360011; CAH69968.1; -; Genomic_DNA; CH471066; EAW50118.1; -; Genomic_DNA; CH471066; EAW50119.1; -; Genomic_DNA; BC047526; AAH47526.1; -; mRNA			GC10M092490	3363	ENSGT00650000092921	P34969	ENSG00000148680; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0004993; F:serotonin receptor activity; TAS:ProtInc; GO:0008015; P:blood circulation; TAS:ProtInc; GO:0007623; P:circadian rhythm; TAS:ProtInc	HGNC:5302; HTR7	HIX0025953	HBG445348	HBG106962	CAB022708		P34969	P34969; 2	IPR001069; 5HT_7_rcpt; IPR000276; 7TM_GPCR_Rhodpsn; IPR017452; GPCR_Rhodpsn_supfam	IPI00003048; IPI00015395; IPI00553192	hsa:3363	K04163		182137; gene		13312	NX_P34969		NSSGRPD		EOG4F1X37						PF00001; 7tm_1; 1	PA29561		P34969	A48881; A48881			P34969	PR00652; 5HT7RECEPTR; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P34969	REACT_111102; Signal Transduction				P34969; 78-401	P34969						uc001kgz.3; human; uc001kha.3; human	Hs.73739
5NT1A_HUMAN	Q9BXI3; Q3SYB9; Q5TG98; Q9BWT8;	RecName: Full=Cytosolic 5'-nucleotidase 1A; Short=cN1A; EC=3.1.3.5; AltName: Full=Cytosolic 5'-nucleotidase IA; Short=cN-I; Short=cN-IA;	NP_115915.1	NM_032526.1		ENST00000235628	ENSP00000235628	ENSG00000116981						368	41021	Q9BXI3	Q3SYB9	Q5TG98	Q9BWT8		Q9BXI3	Q9BXI3	MetaCyc:MONOMER-15168	3.1.3.5; 2681		HS_NT5C1A		84618			47116736				NOG46880	AF331801; AAK01294.1; -; mRNA; AY028778; AAK30000.1; -; mRNA; AL035404; CAI19573.1; -; Genomic_DNA; BC103879; AAI03880.1; -; mRNA; BC103880; AAI03881.1; -; mRNA			GC01M040154	84618	ENSGT00390000017767	Q9BXI3	ENSG00000116981; Homo sapiens		GO:0005829; C:cytosol; NAS:UniProtKB; GO:0008253; F:5'-nucleotidase activity; NAS:UniProtKB; GO:0000287; F:magnesium ion binding; IEA:InterPro; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW; GO:0006144; P:purine base metabolic process; TAS:Reactome; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome; GO:0006206; P:pyrimidine base metabolic process; TAS:Reactome; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome	HGNC:17819; NT5C1A	HIX0200031	HBG350968	HBG101325			Q9BXI3		IPR010394; 5-nucleotidase	IPI00000146	hsa:84618	K01081		610525; gene		74492	NX_Q9BXI3		LEHENEP		EOG4PNXHC						PF06189; 5-nucleotidase; 1	PA31799	Q9BXI3	Q9BXI3				Q9BXI3				Q9BXI3	REACT_111217; Metabolism					Q9BXI3						uc001cdq.1; human	Hs.307006
5NT1B_HUMAN	Q96M25; Q96SA3;	RecName: Full=Cytosolic 5'-nucleotidase 1B; Short=cN1B; EC=3.1.3.5; AltName: Full=Autoimmune infertility-related protein; AltName: Full=Cytosolic 5'-nucleotidase IB; Short=cN-IB;	NP_001002006.1; NP_001186015.1; NP_001186016.1; NP_001186017.1; NP_001186033.1; NP_150278.2	NM_001002006.2; NM_001199086.1; NM_001199087.1; NM_001199088.1; NM_001199104.1; NM_033253.3		ENST00000359846; ENST00000403770	ENSP00000352904; ENSP00000384831	ENSG00000185013; ENSG00000185013						610	68804	Q96M25	Q96SA3		Q53RX2		Q96P26	Q96P26				HS_NT5C1B		100526794; 93034			47116569				NOG46880	AF356185; AAK39108.1; ALT_INIT; mRNA; AF417165; AAL11910.1; -; mRNA; AK093234; BAC04103.1; ALT_INIT; mRNA; AK093464; BAC04174.1; -; mRNA; AK057444; BAB71489.1; -; mRNA; AC079148; AAX93260.1; -; Genomic_DNA; CH471053; EAX00853.1; -; Genomic_DNA; BC136387; AAI36388.1; -; mRNA; BC171761; AAI71761.1; -; mRNA; AF352326; AAK83285.1; ALT_FRAME; mRNA; AJ295254; CAC44363.1; ALT_INIT; mRNA			GC02M018744	100526794; 93034	ENSGT00390000017767	Q96P26	ENSG00000185013; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0008253; F:5'-nucleotidase activity; IEA:EC; GO:0000287; F:magnesium ion binding; IEA:InterPro; GO:0000166; F:nucleotide binding; IEA:InterPro; GO:0006144; P:purine base metabolic process; TAS:Reactome; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome	HGNC:17818; NT5C1B	HIX0001850		HBG050426			Q96P26		IPR010394; 5-nucleotidase	IPI00169426; IPI00410373; IPI00410375; IPI00892609	hsa:100526794; hsa:93034	K01081		610526; gene		77947	NX_Q96P26				EOG44XJGN						PF06189; 5-nucleotidase; 1	PA31800	Q96P26	Q96P26				Q96P26				Q96P26	REACT_111217; Metabolism					Q96P26						uc002rcy.3; human; uc002rcz.3; human; uc002rda.3; human	Hs.120319
5NT3L_HUMAN	Q969T7; A8MWB9; Q7L3B7;	RecName: Full=Cytosolic 5'-nucleotidase III-like protein; Short=cN-III-like protein; EC=3.1.3.5;				ENST00000269534; ENST00000393911	ENSP00000269534; ENSP00000377488	ENSG00000141698; ENSG00000141698						292	33528	Q969T7	A8MWB9	Q7L3B7			Q969T7	Q969T7				HS_NT5C3L					296439454				NOG266578	AC091172; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471152; EAW60771.1; -; Genomic_DNA; BC013742; AAH13742.2; -; mRNA; BC014132; AAH14132.2; -; mRNA; BC016971; AAH16971.2; -; mRNA; BC067788; AAH67788.1; -; mRNA		G3DSA:3.40.50.1000; HAD-like_dom; 1	GC17M039981		ENSGT00390000012959	Q969T7			GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell; GO:0008253; F:5'-nucleotidase activity; IEA:EC; GO:0000287; F:magnesium ion binding; IEA:InterPro; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW; GO:0005515; F:protein binding; IPI:IntAct; GO:0016740; F:transferase activity; IEA:UniProtKB-KW; GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW	HGNC:28300; NT5C3L		HBG382723	HBG059750	HPA030786	Q9UC45; 2CN1	Q969T7	Q969T7; 1	IPR023214; HAD-like_dom; IPR006434; Pyrimidine_nucleotidase_eu	IPI00056505						79498	NX_Q969T7		QLQGKTN		EOG4JWVDW	PTHR13045; HAD-SF_hydro_IE; 1					PF05822; UMPH-1; 1		Q969T7	Q969T7				Q969T7				Q969T7					Q969T7; 1-281	Q969T7	SSF56784; HAD-like_dom; 1			TIGR01544; HAD-SF-IE; 1		uc002hxy.4; human	Hs.237536
5NT3_HUMAN	Q9UC42; Q9UC43; Q9UC44; Q9UC45;	RecName: Full=Cytosolic 5'-nucleotidase 3; EC=3.1.3.5; AltName: Full=Cytosolic 5'-nucleotidase III; Short=cN-III; AltName: Full=Pyrimidine 5'-nucleotidase 1; Short=P5'N-1; Short=P5N-1; Short=PN-I; AltName: Full=Uridine 5'-monophosphate hydrolase 1; AltName: Full=p36;	NP_001002010.1; NP_001159590.1; NP_057573.2	NM_001002010.1; NM_001166118.1; NM_016489.11		ENST00000242210	ENSP00000242210	ENSG00000122643						336	37948	Q9UC42	Q9UC43	Q9UC44	Q9UC45		Q9H0P0	Q9H0P0						51251			117949804	51251			NOG266578	AF312735; AAG33630.1; ALT_SEQ; mRNA; AL136716; CAB66650.1; -; mRNA; AK290118; BAF82807.1; -; mRNA; AK314109; BAG36802.1; -; mRNA; CR533518; CAG38549.1; -; mRNA; AC074338; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC083863; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471073; EAW94007.1; -; Genomic_DNA; CH471073; EAW94008.1; -; Genomic_DNA; BC013292; AAH13292.2; -; mRNA; BC015856; AAH15856.2; -; mRNA; BC066914; AAH66914.1; -; mRNA; BC071652; AAH71652.2; -; mRNA; AF151067; AAF36153.1; ALT_INIT; mRNA	Q9H0P0	G3DSA:3.40.50.1000; HAD-like_dom; 1	GC07M033053	51251	ENSGT00390000012959	Q9H0P0	ENSG00000122643; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB; GO:0008665; F:2'-phosphotransferase activity; NAS:UniProtKB; GO:0008253; F:5'-nucleotidase activity; IDA:UniProtKB; GO:0000287; F:magnesium ion binding; NAS:UniProtKB; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW; GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW; GO:0006206; P:pyrimidine base metabolic process; TAS:Reactome; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome	HGNC:17820; NT5C3			HBG059750	HPA029058		Q9H0P0	Q9H0P0; 3	IPR023214; HAD-like_dom; IPR006434; Pyrimidine_nucleotidase_eu	IPI00100192; IPI00619911; IPI00647805; IPI00807412	hsa:51251	K01081		266120; phenotype; 606224; gene		54391	NX_Q9H0P0		NTEYFKQ	35120; Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency		PTHR13045; HAD-SF_hydro_IE; 1		2CN1; X-ray; 2.67 A; A=64-336; 2JGA; X-ray; 3.01 A; A=64-336; 2VKQ; X-ray; 2.50 A; A=64-336	2CN1; 2JGA; 2VKQ		PF05822; UMPH-1; 1	PA31802	Q9H0P0	Q9H0P0				Q9H0P0				Q9H0P0	REACT_111217; Metabolism				Q9H0P0; 64-336	Q9H0P0	SSF56784; HAD-like_dom; 1			TIGR01544; HAD-SF-IE; 1		uc003tdi.3; human; uc003tdk.3; human	Hs.487933
5NTC_HUMAN	P49902; D3DR91; Q5JUV5;	RecName: Full=Cytosolic purine 5'-nucleotidase; EC=3.1.3.5; AltName: Full=Cytosolic 5'-nucleotidase II;	NP_001127845.1; NP_036361.1	NM_001134373.2; NM_012229.4		ENST00000343289; ENST00000404739	ENSP00000339479; ENSP00000383960	ENSG00000076685; ENSG00000076685						561	64970	P49902	D3DR91	Q5JUV5			P49902	P49902	MetaCyc:MONOMER-15169	3.1.3.5; 2681		HS_NT5C2		22978			1703012	22978		DB00171; Adenosine triphosphate; DB00811; Ribavirin	NOG75103	D38524; BAA07529.1; -; mRNA; AL139817; CAI40080.1; -; Genomic_DNA; AL360001; CAI40080.1; JOINED; Genomic_DNA; AL360001; CAI13473.1; -; Genomic_DNA; AL139817; CAI13473.1; JOINED; Genomic_DNA; CH471066; EAW49656.1; -; Genomic_DNA; CH471066; EAW49657.1; -; Genomic_DNA; BC001595; AAH01595.1; -; mRNA	P49902		GC10M104837	22978	ENSGT00550000074539	P49902	ENSG00000076685; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0008253; F:5'-nucleotidase activity; EXP:Reactome; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW; GO:0005515; F:protein binding; IPI:IntAct; GO:0006144; P:purine base metabolic process; TAS:Reactome; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome	HGNC:8022; NT5C2	HIX0009172	HBG506335	HBG000025	HPA003751		P49902	P49902; 6	IPR023214; HAD-like_dom; IPR008380; HAD-SF_hydro_IG_5-nucl; IPR016695; Pur_nucleotidase	IPI00029054	hsa:22978	K01081		600417; gene	MINT-1436872	43793	NX_P49902		WERVFRA		EOG4MGS72	PTHR12103; HAD-SF_hydro_IG_5-nucl; 1		2J2C; X-ray; 2.20 A; A=1-536; 2JC9; X-ray; 1.50 A; A=1-536; 2JCM; X-ray; 2.15 A; A=1-536; 2XCV; X-ray; 2.30 A; A=1-536; 2XCW; X-ray; 1.90 A; A=1-536; 2XCX; X-ray; 2.30 A; A=1-536; 2XJB; X-ray; 2.30 A; A=1-536; 2XJC; X-ray; 2.00 A; A=1-536; 2XJD; X-ray; 2.00 A; A=1-536; 2XJE; X-ray; 2.30 A; A=1-536; 2XJF; X-ray; 2.10 A; A=1-536	2J2C; 2JC9; 2JCM; 2XCV; 2XCW; 2XCX; 2XJB; 2XJC; 2XJD; 2XJE; 2XJF	P49902	PF05761; 5_nucleotid; 1	PA31801	P49902	P49902	JC2436; JC2436	PIRSF017434; Purine_5'-nucleotidase; 1		P49902				P49902	REACT_111217; Metabolism				P49902; 3-488	P49902	SSF56784; HAD-like_dom; 1			TIGR02244; HAD-IG-Ncltidse; 1		uc001kwo.3; human	Hs.97439
5NTD_HUMAN	P21589; B3KQI8; O75520; Q5W116;	RecName: Full=5'-nucleotidase; Short=5'-NT; EC=3.1.3.5; AltName: Full=Ecto-5'-nucleotidase; AltName: CD_antigen=CD73; Flags: Precursor;	NP_001191742.1; NP_002517.1	NM_001204813.1; NM_002526.3		ENST00000257770; ENST00000369651	ENSP00000257770; ENSP00000358665	ENSG00000135318; ENSG00000135318						574	63368	P21589	B3KQI8	O75520	Q5W116		P21589	P21589				HS_NT5E		4907			112825	4907		DB00806; Pentoxifylline	COG0737	X55740; CAA39271.1; -; mRNA; AK075008; BAG52050.1; -; mRNA; AL135903; CAH72337.1; -; Genomic_DNA; AL589666; CAH72337.1; JOINED; Genomic_DNA; AL589666; CAI40168.1; -; Genomic_DNA; AL135903; CAI40168.1; JOINED; Genomic_DNA; U21730; AAA96950.1; -; Genomic_DNA; AF069067; AAC98672.1; -; Genomic_DNA		G3DSA:3.90.780.10; 5'-Nucleotdase_C; 1	GC06P086216	4907	ENSGT00530000063775	P21589	ENSG00000135318; Homo sapiens		GO:0031225; C:anchored to membrane; IEA:UniProtKB-KW; GO:0005737; C:cytoplasm; IDA:HPA; GO:0005624; C:membrane fraction; TAS:ProtInc; GO:0005886; C:plasma membrane; IDA:HPA; GO:0008253; F:5'-nucleotidase activity; EXP:Reactome; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW; GO:0006259; P:DNA metabolic process; TAS:ProtInc; GO:0006144; P:purine base metabolic process; TAS:Reactome; GO:0006206; P:pyrimidine base metabolic process; TAS:Reactome; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome	HGNC:8021; NT5E	HIX0032840	HBG534106	HBG000026	HPA017357		P21589		IPR008334; 5'-Nucleotdase_C; IPR006146; 5'-Nucleotdase_CS; IPR006179; 5_nucleotidase/apyrase; IPR004843; Metallo_PEstase_dom	IPI00009456; IPI00552302	hsa:4907	K01081		129190; gene; 211800; phenotype		18883	NX_P21589		TGSHCHG		EOG4TMR1Q	PTHR11575; 5_nucleotidase; 1	hif1_tfpathway; HIF-1-alpha transcription factor network				PF02872; 5_nucleotid_C; 1; PF00149; Metallophos; 1	PA31804		P21589	S11032; S11032			P21589	PR01607; APYRASEFAMLY		PS00785; 5_NUCLEOTIDASE_1; 1; PS00786; 5_NUCLEOTIDASE_2; 1	P21589	REACT_111217; Metabolism				P21589; 27-550	P21589	SSF55816; 5'-Nucleotdase_C; 1					uc003pko.4; human	Hs.153952
68MP_HUMAN	P56378; B2R588; Q86TT7;	RecName: Full=6.8 kDa mitochondrial proteolipid;	NP_001120865.1; NP_004885.1	NM_001127393.1; NM_004894.2		ENST00000286953; ENST00000414262	ENSP00000286953; ENSP00000401770	ENSG00000156411; ENSG00000156411						58	6662	P56378	B2R588	Q86TT7			P56378	P56378				HS_C14orf2		9556			3023202				NOG47225	AF054175; AAC39909.1; -; mRNA; AF116639; AAF71062.1; -; mRNA; BX161388; CAD61878.1; ALT_INIT; mRNA; AK312099; BAG35035.1; -; mRNA; CH471061; EAW81850.1; -; Genomic_DNA; BC000429; AAH00429.1; -; mRNA; BC001944; AAH01944.1; -; mRNA			GC14M104378	9556	ENSGT00390000016760	P56378	ENSG00000156411; Homo sapiens		GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell	HGNC:1188; C14orf2	HIX0012010	HBG127351	HBG000027			P56378		IPR012574; Mit_proteolip	IPI00749237	hsa:9556			604573; gene		35845	NX_P56378				EOG4KD6NR	PTHR15233; Mit_preoteolip; 1					PF08039; Mit_proteolip; 1	PA25514	P56378	P56378				P56378				P56378						P56378						uc001yoi.4; human	Hs.109052
6PGD_HUMAN	P52209; Q9BWD8;	RecName: Full=6-phosphogluconate dehydrogenase, decarboxylating; EC=1.1.1.44;	NP_002622.2	NM_002631.2		ENST00000270776	ENSP00000270776	ENSG00000142657						483	53140	P52209	Q9BWD8				P52209	P52209				HS_PGD		5226			20981679	5226			COG0362	U30255; AAA75302.1; -; mRNA; BC000368; AAH00368.1; -; mRNA	P52209	G3DSA:1.20.5.320; Fibritin/6PGD_C-extension; 1; G3DSA:3.40.50.720; NAD(P)-bd; 1; G3DSA:1.10.1040.10; Opine_DH; 1	GC01P010393	5226	ENSGT00390000009023	P52209	ENSG00000142657; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0050661; F:NADP binding; IEA:InterPro; GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; ISS:UniProtKB; GO:0009051; P:pentose-phosphate shunt, oxidative branch; IDA:UniProtKB	HGNC:8891; PGD	HIX0000112	HBG286913	HBG000029	HPA031314		P52209	P52209; 6	IPR008927; 6-PGluconate_DH_C-like; IPR006114; 6PGDH_C; IPR006113; 6PGDH_decarbox; IPR006115; 6PGDH_NADP-bd; IPR006184; 6PGdom_BS; IPR013328; DH_multihelical; IPR012284; Fibritin/6PGD_C-extension; IPR016040; NAD(P)-bd_dom	IPI00219525	hsa:5226	K00033		172200; gene	MINT-1415782	20204	NX_P52209		MEHNEMA		EOG4C2H9D			2JKV; X-ray; 2.53 A; A/B/C/D/E/F=1-483	2JKV	P52209	PF00393; 6PGD; 1; PF03446; NAD_binding_2; 1	PA33229	P52209	P52209	G01922; G01922	PIRSF000109; 6PGD; 1		P52209			PS00461; 6PGD; 1	P52209	REACT_111217; Metabolism				P52209; 2-483	P52209	SSF48179; 6DGDH_C_like; 1			TIGR00873; Gnd; 1		uc001arc.3; human	Hs.464071
6PGL_HUMAN	O95336;	RecName: Full=6-phosphogluconolactonase; Short=6PGL; EC=3.1.1.31;	NP_036220.1	NM_012088.2		ENST00000252603	ENSP00000252603	ENSG00000130313						258	27547	O95336					O95336	O95336		3.1.1.31; 2681		HS_PGLS		25796				25796			COG0363	AJ243972; CAB57866.1; -; mRNA; BC014006; AAH14006.1; -; mRNA; AF091091; AAC72960.1; ALT_INIT; mRNA			GC19P017622	25796	ENSGT00550000075110	O95336	ENSG00000130313; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0017057; F:6-phosphogluconolactonase activity; IDA:UniProtKB	HGNC:8903; PGLS	HIX0202829	HBG725991	HBG000030			O95336		IPR005900; 6-phosphogluconolactonase_DevB; IPR006148; Glc/Gal-6P_isomerase	IPI00029997	hsa:25796	K01057		604951; gene	MINT-5000838	46981	NX_O95336	O95336	TYGLYRT		EOG4ZS945					O95336	PF01182; Glucosamine_iso; 1	PA33240	O95336	O95336				O95336				O95336	REACT_111217; Metabolism	IPI00029997			O95336; 7-250	O95336				TIGR01198; Pgl; 1		uc002ngw.3; human	Hs.466165
7B2_HUMAN	P05408; P01164; Q9BS38;	RecName: Full=Neuroendocrine protein 7B2; AltName: Full=Pituitary polypeptide; AltName: Full=Secretogranin V; AltName: Full=Secretogranin-5; AltName: Full=Secretory granule endocrine protein I; Contains: RecName: Full=N-terminal peptide; Contains: RecName: Full=C-terminal peptide; Flags: Precursor;	NP_001138229.1; NP_003011.1	NM_001144757.1; NM_003020.3		ENST00000300175	ENSP00000300175	ENSG00000166922						212	23730	P05408	P01164	Q9BS38			P05408	P05408				HS_SCG5		6447			23830842	6447			NOG271457	Y00757; CAA68726.1; -; mRNA; AJ290438; CAB90397.1; -; Genomic_DNA; AJ290439; CAB90397.1; JOINED; Genomic_DNA; AJ290440; CAB90397.1; JOINED; Genomic_DNA; AJ290441; CAB90397.1; JOINED; Genomic_DNA; AJ290442; CAB90397.1; JOINED; Genomic_DNA; BC005349; AAH05349.1; -; mRNA			GC15P032933	6447	ENSGT00390000009816	P05408	ENSG00000166922; Homo sapiens		GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell; GO:0030141; C:secretory granule; ISS:UniProtKB; GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB; GO:0005525; F:GTP binding; TAS:ProtInc; GO:0051082; F:unfolded protein binding; IDA:UniProtKB; GO:0006886; P:intracellular protein transport; ISS:UniProtKB; GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW; GO:0016486; P:peptide hormone processing; ISS:UniProtKB; GO:0046883; P:regulation of hormone secretion; ISS:UniProtKB	HGNC:10816; SCG5		HBG713767	HBG000031	HPA013136		P05408	P05408; 2	IPR007945; Secretogranin_V	IPI00008944; IPI00470716	hsa:6447		I21.001	173120; gene	MINT-1402757	25057	NX_P05408		GPYGNIP		EOG44MXSZ	PTHR12738; Secretogranin_V; 1					PF05281; Secretogranin_V; 1	PA35724	P05408	P05408	S01008; PUHU			P05408				P05408						P05408						uc001zha.2; human	Hs.156540
8ODP_HUMAN	P36639; A4D205; Q6P0Y6; Q8IV95; Q9UBM0; Q9UBM9;	RecName: Full=7,8-dihydro-8-oxoguanine triphosphatase; EC=3.6.1.55; AltName: Full=2-hydroxy-dATP diphosphatase; EC=3.6.1.56; AltName: Full=8-oxo-dGTPase; AltName: Full=Nucleoside diphosphate-linked moiety X motif 1; Short=Nudix motif 1;	NP_002443.3; NP_945186.1; NP_945187.1; NP_945188.1; NP_945190.1; NP_945191.1; NP_945192.1	NM_002452.3; NM_198948.1; NM_198949.1; NM_198950.1; NM_198952.1; NM_198953.1; NM_198954.1		ENST00000343985; ENST00000397048; ENST00000397049	ENSP00000339503; ENSP00000380241; ENSP00000380242	ENSG00000106268; ENSG00000106268; ENSG00000106268						197	22520	P36639	A4D205	Q6P0Y6	Q8IV95		P36639	P36639				HS_NUDT1		4521			254763430	4521			COG0494	D16581; BAA04013.1; -; mRNA; D38594; BAA07601.1; -; Genomic_DNA; AB025233; BAA83791.1; -; mRNA; AB025234; BAA83792.1; -; mRNA; AB025235; BAA83793.1; -; mRNA; AB025236; BAA83794.1; -; mRNA; AB025237; BAA83795.1; -; mRNA; AB025238; BAA83796.1; -; mRNA; AB025239; BAA83797.1; -; mRNA; AB025240; BAA83798.1; -; mRNA; AB025241; BAA83799.1; -; mRNA; AB025242; BAA83800.1; -; mRNA; DQ230907; ABB02181.1; -; Genomic_DNA; AC004971; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH236953; EAL23948.1; -; Genomic_DNA; CH471144; EAW87227.1; -; Genomic_DNA; BC014618; AAH14618.1; -; mRNA; BC040144; AAH40144.2; -; mRNA; BC065367; AAH65367.1; -; mRNA	P36639	G3DSA:3.90.79.10; NUDIX_hydrolase; 1	GC07P002248	4521	ENSGT00390000000341	P36639	ENSG00000106268; Homo sapiens		GO:0005737; C:cytoplasm; IDA:HPA; GO:0035539; F:8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity; IDA:UniProtKB; GO:0003924; F:GTPase activity; TAS:ProtInc; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW; GO:0042262; P:DNA protection; IDA:UniProtKB; GO:0006281; P:DNA repair; IEA:InterPro; GO:0006979; P:response to oxidative stress; TAS:ProtInc	HGNC:8048; NUDT1		HBG322338	HBG000032	HPA012636		P36639	P36639; 4	IPR020476; Nudix_hydrolase; IPR020084; NUDIX_hydrolase_CS; IPR000086; NUDIX_hydrolase_dom; IPR015797; NUDIX_hydrolase_dom-like; IPR003563; OxG-triPHTase	IPI00004392; IPI00396056; IPI00759462; IPI00759578	hsa:4521	K03574		600312; gene		17452	NX_P36639		QWFQLDQ					1IRY; NMR; -; A=42-197; 3Q93; X-ray; 1.80 A; A/B=42-197; 3ZR0; X-ray; 1.80 A; A/B=42-197; 3ZR1; X-ray; 1.90 A; A/B=42-197	1IRY; 3Q93; 3ZR0; 3ZR1		PF00293; NUDIX; 1	PA31830						P36639	PR01403; 8OXTPHPHTASE; PR00502; NUDIXFAMILY		PS51462; NUDIX; 1; PS00893; NUDIX_BOX; 1	P36639					P36639; 44-197	P36639	SSF55811; NUDIX_hydrolase; 1					uc003slp.1; human	Hs.534331
A16A1_HUMAN	Q8IZ83; C9JBH6; Q86YF0; Q8IYL4; Q8TEI8;	RecName: Full=Aldehyde dehydrogenase family 16 member A1;	NP_699160.2	NM_153329.3		ENST00000293350	ENSP00000293350	ENSG00000161618						802	85127	Q8IZ83	C9JBH6	Q86YF0	Q8IYL4		Q8IZ83	Q8IZ83				HS_ALDH16A1		126133			269849532				COG1012	AK074136; BAB84962.1; ALT_SEQ; mRNA; AC010619; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC014895; AAH14895.2; -; mRNA; BC035641; AAH35641.1; ALT_INIT; mRNA; BC042142; AAH42142.1; -; mRNA		G3DSA:3.40.309.10; Aldehyde_dehydrogenase_C; 1; G3DSA:3.40.605.10; Aldehyde_dehydrogenase_N; 2	GC19P049958	126133	ENSGT00560000077032	Q8IZ83			GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro	HGNC:28114; ALDH16A1		HBG752218	HBG069396			Q8IZ83	Q8IZ83; 7	IPR016161; Ald_DH/histidinol_DH; IPR016163; Ald_DH_C; IPR016162; Ald_DH_N; IPR011408; Aldehyde_DH; IPR015590; Aldehyde_DH_dom	IPI00217920; IPI00646424	hsa:126133			613358; gene		81700	NX_Q8IZ83		CPIPALE		EOG4CNQQG						PF00171; Aldedh; 2	PA134903503	Q8IZ83	Q8IZ83		PIRSF036490; Aldedh_dupl; 1		Q8IZ83			PS00070; ALDEHYDE_DEHYDR_CYS; FALSE_NEG; PS00687; ALDEHYDE_DEHYDR_GLU; FALSE_NEG	Q8IZ83					Q8IZ83; 36-495, 519-794	Q8IZ83	SSF53720; Aldehyde_DH/Histidinol_DH; 2					uc002pnt.3; human	Hs.719998
A16L1_HUMAN	Q676U5; A3EXK9; Q6IPN1; Q6UXW4; Q6ZVZ5; Q8NCY2; Q96JV5; Q9H619;	RecName: Full=Autophagy-related protein 16-1; AltName: Full=APG16-like 1;	NP_001177195.1; NP_001177196.1; NP_060444.3; NP_110430.5; NP_942593.2	NM_001190266.1; NM_001190267.1; NM_017974.3; NM_030803.6; NM_198890.2		ENST00000392017	ENSP00000375872	ENSG00000085978						607	68265	Q676U5	A3EXK9	Q6IPN1	Q6UXW4		Q676U5	Q676U5				HS_ATG16L1		55054	DIP-27552N		62510482	55054			COG2319	AY398617; AAR32130.1; -; mRNA; EF079889; ABN48554.1; -; mRNA; AY358182; AAQ88549.1; -; mRNA; AK026330; BAB15448.1; ALT_SEQ; mRNA; AK027854; BAB55412.1; ALT_INIT; mRNA; AK123876; BAC85713.1; -; mRNA; CH471063; EAW71034.1; -; Genomic_DNA; BC071846; AAH71846.1; -; mRNA; AL834526; CAD39182.1; -; mRNA		G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 2	GC02P234118	55054	ENSGT00650000093357	Q676U5	ENSG00000085978; Homo sapiens		GO:0005776; C:autophagic vacuole; ISS:UniProtKB; GO:0034045; C:pre-autophagosomal structure membrane; IEA:UniProtKB-SubCell; GO:0005515; F:protein binding; IPI:IntAct; GO:0000045; P:autophagic vacuole assembly; NAS:UniProtKB; GO:0051260; P:protein homooligomerization; NAS:UniProtKB; GO:0015031; P:protein transport; IEA:UniProtKB-KW	HGNC:21498; ATG16L1			HBG050534	HPA012577			Q676U5; 20	IPR013923; Autophagy-rel_prot_16; IPR020472; G-protein_beta_WD-40_rep; IPR015943; WD40/YVTN_repeat-like_dom; IPR001680; WD40_repeat; IPR019775; WD40_repeat_CS; IPR017986; WD40_repeat_dom	IPI00432751; IPI00446614; IPI00470446; IPI00555905	hsa:55054			610767; gene; 611081; phenotype	MINT-1141152	58531	NX_Q676U5			206; Crohn disease	EOG4SXNC8						PF08614; ATG16; 1; PF00400; WD40; 5	PA134902949	Q676U5					Q676U5	PR00320; GPROTEINBRPT		PS00678; WD_REPEATS_1; 3; PS50082; WD_REPEATS_2; 6; PS50294; WD_REPEATS_REGION; 1	Q676U5				SM00320; WD40; 7	Q676U5; 310-606	Q676U5	SSF50978; WD40_like; 1					uc002vty.3; human; uc002vtz.3; human; uc002vua.3; human	Hs.529322
A16L2_HUMAN	Q8NAA4; A5PL30; B2RPK5; Q658V4; Q6PID3; Q8NBG0;	RecName: Full=Autophagy-related protein 16-2; AltName: Full=APG16-like 2; AltName: Full=WD repeat-containing protein 80;	NP_203746.1	NM_033388.1		ENST00000321297	ENSP00000326340	ENSG00000168010						619	68998	Q8NAA4	A5PL30	B2RPK5	Q658V4		Q8NAA4	Q8NAA4				HS_ATG16L2		89849			189027648				COG2319	AK093017; BAC04021.1; -; mRNA; AK090597; BAC03485.1; -; mRNA; CH471076; EAW74876.1; -; Genomic_DNA; CH471076; EAW74874.1; -; Genomic_DNA; BC036713; AAH36713.1; -; mRNA; BC137489; AAI37490.1; -; mRNA; BC137490; AAI37491.1; -; mRNA; BC142718; AAI42719.1; -; mRNA; BC146660; AAI46661.1; -; mRNA; AL832974; CAH56355.1; -; mRNA		G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 1	GC11P072525	89849	ENSGT00650000093357	Q8NAA4			GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell; GO:0006914; P:autophagy; IEA:UniProtKB-KW; GO:0015031; P:protein transport; IEA:UniProtKB-KW	HGNC:25464; ATG16L2	HIX0009913	HBG564640	HBG050534			Q8NAA4	Q8NAA4; 3	IPR013923; Autophagy-rel_prot_16; IPR020472; G-protein_beta_WD-40_rep; IPR015943; WD40/YVTN_repeat-like_dom; IPR001680; WD40_repeat; IPR019775; WD40_repeat_CS; IPR017986; WD40_repeat_dom	IPI00300536; IPI00892538; IPI00892678	hsa:89849					76342	NX_Q8NAA4		LRVKWQE		EOG44F68R						PF08614; ATG16; 1; PF00400; WD40; 4	PA142672575	Q8NAA4	Q8NAA4				Q8NAA4	PR00320; GPROTEINBRPT		PS00678; WD_REPEATS_1; 3; PS50082; WD_REPEATS_2; 4; PS50294; WD_REPEATS_REGION; 1	Q8NAA4				SM00320; WD40; 7	Q8NAA4; 327-619		SSF50978; WD40_like; 1					uc001otd.3; human	Hs.653186
A1AG1_HUMAN	P02763; B7ZKQ5; Q5T539; Q5U067; Q8TC16;	RecName: Full=Alpha-1-acid glycoprotein 1; Short=AGP 1; AltName: Full=Orosomucoid-1; Short=OMD 1; Flags: Precursor;	NP_000598.2	NM_000607.2		ENST00000259396	ENSP00000259396	ENSG00000229314						201	23512	P02763	B7ZKQ5	Q5T539	Q5U067		P02763	P02763				HS_ORM1		5004			112877	5004		DB01418; Acenocoumarol; DB00802; Alfentanil; DB01429; Aprindine; DB00280; Disopyramide; DB01359; Penbutolol; DB00946; Phenprocoumon; DB00908; Quinidine; DB00706; Tamsulosin	NOG41523	X02544; CAA26397.1; -; mRNA; M13692; AAA35515.1; -; mRNA; X05779; CAA29229.1; ALT_SEQ; Genomic_DNA; X05780; CAA29229.1; JOINED; Genomic_DNA; X05781; CAA29229.1; JOINED; Genomic_DNA; X05782; CAA29229.1; JOINED; Genomic_DNA; X05783; CAA29229.1; JOINED; Genomic_DNA; X05784; CAA29229.1; JOINED; Genomic_DNA; X06676; -; NOT_ANNOTATED_CDS; Genomic_DNA; X06680; -; NOT_ANNOTATED_CDS; Genomic_DNA; BT019790; AAV38593.1; -; mRNA; AK312035; BAG34972.1; -; mRNA; AL356796; CAI16859.1; -; Genomic_DNA; CH471090; EAW87416.1; -; Genomic_DNA; BC104818; AAI04819.1; -; mRNA; BC104820; AAI04821.1; -; mRNA; BC143313; AAI43314.1; -; mRNA; BC143314; AAI43315.1; -; mRNA; BC026238; AAH26238.1; -; mRNA	P02763	G3DSA:2.40.128.20; Calycin; 1	GC09P117085	5004	ENSGT00390000012130	P02763	ENSG00000187681; Homo sapiens	P02763	GO:0005615; C:extracellular space; TAS:ProtInc; GO:0005515; F:protein binding; IPI:IntAct; GO:0006953; P:acute-phase response; TAS:ProtInc; GO:0002682; P:regulation of immune system process; IEA:InterPro; GO:0006810; P:transport; IEA:UniProtKB-KW	HGNC:8498; ORM1		HBG126438	HBG000035	CAB006265		P02763	P02763; 7	IPR001500; A1A_glycop; IPR012674; Calycin; IPR011038; Calycin-like; IPR000566; Lipocln_cytosolic_FA-bd_dom	IPI00022429	hsa:5004			138600; gene		19272	NX_P02763				EOG4V9TS3	PTHR11967; A1A_glycop; 1		3KQ0; X-ray; 1.80 A; A=20-201	3KQ0	P02763	PF00061; Lipocalin; 1	PA260			A28346; OMHU1	PIRSF036899; AGP; 1		P02763	PR00708; A1AGLPROTEIN		PS00213; LIPOCALIN; FALSE_NEG	P02763			P02763			P02763	SSF50814; Calycin; 1	P02763				uc004bik.4; human	Hs.522356
A1AG2_HUMAN	P19652; B2R5L2; Q16571; Q5T538; Q6IB74;	RecName: Full=Alpha-1-acid glycoprotein 2; Short=AGP 2; AltName: Full=Orosomucoid-2; Short=OMD 2; Flags: Precursor;	NP_000599.1	NM_000608.2		ENST00000431067	ENSP00000394936	ENSG00000228278						201	23603	P19652	B2R5L2	Q16571	Q5T538		P19652	P19652						5005			231458	5005	P19652			X06675; CAA29874.1; ALT_SEQ; Genomic_DNA; X05780; -; NOT_ANNOTATED_CDS; Genomic_DNA; X06674; CAA29873.2; ALT_SEQ; Genomic_DNA; X06676; CAA29873.2; JOINED; Genomic_DNA; X06677; CAA29873.2; JOINED; Genomic_DNA; X06678; CAA29873.2; JOINED; Genomic_DNA; X06679; CAA29873.2; JOINED; Genomic_DNA; X06680; CAA29873.2; JOINED; Genomic_DNA; X05784; -; NOT_ANNOTATED_CDS; Genomic_DNA; M21540; AAA51549.1; -; Genomic_DNA; AK312226; BAG35159.1; -; mRNA; CR456930; CAG33211.1; -; mRNA; AL356796; CAI16860.1; -; Genomic_DNA; CH471090; EAW87417.1; -; Genomic_DNA; BC015964; AAH15964.1; -; mRNA; BC056239; AAH56239.1; -; mRNA	P19652	G3DSA:2.40.128.20; Calycin; 1	GC09P117092	5005	ENSGT00390000012130	P19652	ENSG00000204154; Homo sapiens	P19652	GO:0005615; C:extracellular space; TAS:ProtInc; GO:0005488; F:binding; IEA:InterPro; GO:0006953; P:acute-phase response; TAS:ProtInc; GO:0002682; P:regulation of immune system process; IEA:InterPro; GO:0006810; P:transport; IEA:UniProtKB-KW	HGNC:8499; ORM2		HBG126438	HBG000035			P19652	P19652; 3	IPR001500; A1A_glycop; IPR012674; Calycin; IPR011038; Calycin-like; IPR000566; Lipocln_cytosolic_FA-bd_dom	IPI00020091	hsa:5005			138610; gene		19276	NX_P19652		FYIASAS		EOG4V9TS3	PTHR11967; A1A_glycop; 1		3APU; X-ray; 2.10 A; A/B=19-201; 3APV; X-ray; 2.15 A; A/B=19-201; 3APW; X-ray; 2.20 A; A/B=19-201; 3APX; X-ray; 2.20 A; A=19-201	3APU; 3APV; 3APW; 3APX	P19652	PF00061; Lipocalin; 1	PA32818			JT0326; OMHU2	PIRSF036899; AGP; 1		P19652	PR00708; A1AGLPROTEIN		PS00213; LIPOCALIN; FALSE_NEG	P19652					P19652; 19-193	P19652	SSF50814; Calycin; 1	P19652				uc004bil.3; human	Hs.719954
A1ATR_HUMAN	P20848;	RecName: Full=Putative alpha-1-antitrypsin-related protein; AltName: Full=Serpin A2; Flags: Precursor;				ENST00000238576	ENSP00000238576	ENSG00000165951						420	47891	P20848					P20848					HS_ATR					112891				COG4826	M19684; AAA51544.1; -; Genomic_DNA; M19685; AAA51544.1; JOINED; Genomic_DNA			GC14M094830			P20848	ENSG00000165951; Homo sapiens		GO:0005576; C:extracellular region; IBA:RefGenome; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome; GO:0030162; P:regulation of proteolysis; IBA:RefGenome	HGNC:8985; SERPINA2		HBG714743	HBG005957			P20848		IPR000215; Protease_inhib_I4_serpin; IPR023795; Protease_inhib_I4_serpin_CS; IPR023796; Sepin_dom	IPI00736763			I04.952	107410; gene			NX_P20848				EOG47WNP9	PTHR11461; Prot_inh_serpin; 1					PF00079; Serpin; 1				A28882; A28882			P20848			PS00284; SERPIN; 1	P20848				SM00093; SERPIN; 1	P20848; 47-420	P20848	SSF56574; Prot_inh_serpin; 1						Hs.666160
A1AT_HUMAN	Q86U18; Q86U19; Q96BF9; Q96ES1; Q9P1P0; Q9UCE6; Q9UCM3;	RecName: Full=Alpha-1-antitrypsin; AltName: Full=Alpha-1 protease inhibitor; AltName: Full=Alpha-1-antiproteinase; AltName: Full=Serpin A1; Contains: RecName: Full=Short peptide from AAT; Short=SPAAT; Flags: Precursor;	NP_000286.3; NP_001002235.1; NP_001002236.1; NP_001121172.1; NP_001121173.1; NP_001121174.1; NP_001121175.1; NP_001121176.1; NP_001121177.1; NP_001121178.1; NP_001121179.1	NM_000295.4; NM_001002235.2; NM_001002236.2; NM_001127700.1; NM_001127701.1; NM_001127702.1; NM_001127703.1; NM_001127704.1; NM_001127705.1; NM_001127706.1; NM_001127707.1		ENST00000355814; ENST00000393087; ENST00000393088; ENST00000404814; ENST00000426226; ENST00000437074; ENST00000437397; ENST00000440909; ENST00000448140; ENST00000448921; ENST00000449399	ENSP00000348068; ENSP00000376802; ENSP00000376803; ENSP00000385960; ENSP00000415603; ENSP00000408878; ENSP00000408474; ENSP00000390299; ENSP00000416462; ENSP00000416066; ENSP00000416354	ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249; ENSG00000197249						418	46737	Q86U18	Q86U19	Q96BF9	Q96ES1		P01009	P01009					P01009	5265			1703025	5265	P01009	DB00058; Alpha-1-proteinase inhibitor	COG4826	K01396; AAB59375.1; -; mRNA; K02212; AAB59495.1; -; Genomic_DNA; X01683; CAA25838.1; -; mRNA; M11465; AAA51546.1; -; mRNA; J02619; AAA51547.1; -; Genomic_DNA; DQ682455; ABG73380.1; -; mRNA; AM048838; CAJ15161.1; -; Genomic_DNA; AF113676; AAF29581.1; -; mRNA; AF130068; AAG35496.1; -; mRNA; BX161449; CAD61914.1; -; mRNA; BX247968; CAD62306.1; -; mRNA; BX248002; CAD62334.1; ALT_INIT; mRNA; BX248257; CAD62585.1; ALT_INIT; mRNA; AK315637; BAG38005.1; -; mRNA; BT019455; AAV38262.1; -; mRNA; BC011991; AAH11991.1; -; mRNA; BC015642; AAH15642.1; -; mRNA; J00064; AAB59369.1; -; Genomic_DNA; J00066; AAB59370.1; -; Genomic_DNA; J00065; AAB59370.1; JOINED; Genomic_DNA; J00067; AAB59371.1; -; Genomic_DNA; X02920; CAA26677.1; -; mRNA; V00496; CAA23755.1; -; mRNA; M26123; AAA51545.1; -; mRNA	P01009		GC14M094843	5265	ENSGT00560000076583	P01009	ENSG00000197249; Homo sapiens	P01009	GO:0005615; C:extracellular space; IMP:UniProtKB; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell; GO:0002020; F:protease binding; IPI:UniProtKB; GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW; GO:0030168; P:platelet activation; TAS:Reactome; GO:0002576; P:platelet degranulation; TAS:Reactome; GO:0030162; P:regulation of proteolysis; IBA:RefGenome	HGNC:8941; SERPINA1	HIX0011929		HBG005957	CAB013211; CAB016648; HPA000927; HPA001292		P01009	P01009; 15	IPR000215; Protease_inhib_I4_serpin; IPR023795; Protease_inhib_I4_serpin_CS; IPR023796; Sepin_dom	IPI00553177; IPI00790784; IPI00869004	hsa:5265	K03984	I04.001	107400; gene; 613490; phenotype	MINT-365327	20336	NX_P01009	P01009	PMMNRLG	60; Alpha-1 antitrypsin deficiency; 178396; Hemorrhagic disease due to alpha-1 antitrypsin Pittsburgh mutation	EOG4FR0S4	PTHR11461; Prot_inh_serpin; 1	hnf3apathway; FOXA1 transcription factor network	1ATU; X-ray; 2.70 A; A=45-418; 1D5S; X-ray; 3.00 A; A=44-377, B=378-418; 1EZX; X-ray; 2.60 A; A=48-382, B=383-418; 1HP7; X-ray; 2.10 A; A=25-418; 1IZ2; X-ray; 2.20 A; A=25-418; 1KCT; X-ray; 3.46 A; A=25-418; 1OO8; X-ray; 2.65 A; A=26-418; 1OPH; X-ray; 2.30 A; A=26-418; 1PSI; X-ray; 2.92 A; A=26-418; 1QLP; X-ray; 2.00 A; A=26-418; 1QMB; X-ray; 2.60 A; A=49-376, B=377-418; 2D26; X-ray; 3.30 A; A=26-382, B=383-418; 2QUG; X-ray; 2.00 A; A=25-418; 3CWL; X-ray; 2.44 A; A=25-418; 3CWM; X-ray; 2.51 A; A=25-418; 3DRM; X-ray; 2.20 A; A=26-418; 3DRU; X-ray; 3.20 A; A/B/C=26-418; 3NDD; X-ray; 1.50 A; A=46-372, B=383-418; 3NDF; X-ray; 2.70 A; A=46-381, B=383-418; 3NE4; X-ray; 1.81 A; A=1-418; 3T1P; X-ray; 3.90 A; A=48-418; 7API; X-ray; 3.00 A; A=36-382, B=383-418; 8API; X-ray; 3.10 A; A=36-382, B=383-418; 9API; X-ray; 3.00 A; A=36-382, B=383-418	1ATU; 1D5S; 1EZX; 1HP7; 1IZ2; 1KCT; 1OO8; 1OPH; 1PSI; 1QLP; 1QMB; 2D26; 2QUG; 3CWL; 3CWM; 3DRM; 3DRU; 3NDD; 3NDF; 3NE4; 3T1P; 7API; 8API; 9API		PF00079; Serpin; 1	PA35509	P01009	P01009	A21853; ITHU; A61391; A61391		P01009	P01009			PS00284; SERPIN; 1	P01009	REACT_604; Hemostasis	IPI00553177; P01009	P01009	SM00093; SERPIN; 1	P01009; 48-417	P01009	SSF56574; Prot_inh_serpin; 1	P01009			P01009	uc001ycx.4; human; uc001yda.1; human	Hs.525557
A1BG_HUMAN	P04217; A8K052; Q68CK0; Q8IYJ6; Q96P39;	RecName: Full=Alpha-1B-glycoprotein; AltName: Full=Alpha-1-B glycoprotein; Flags: Precursor;	NP_570602.2	NM_130786.3		ENST00000263100	ENSP00000263100	ENSG00000121410						495	54254	P04217	A8K052	Q68CK0	Q8IYJ6		P04217	P04217				HS_A1BG	P04217	1			46577680		P04217		NOG26440	AB073611; BAD38648.1; -; mRNA; AF414429; AAL07469.1; -; mRNA; AK289417; BAF82106.1; -; mRNA; AC010642; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC012313; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC035719; AAH35719.1; -; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 5	GC19M058858	1	ENSGT00570000078800	P04217	ENSG00000121410; Homo sapiens		GO:0005576; C:extracellular region; IDA:UniProtKB	HGNC:5; A1BG		HBG125406	HBG000037	CAB016673		P04217	P04217; 3	IPR016332; A1B_glyco/leuk_Ig-like_rcpt; IPR007110; Ig-like; IPR013783; Ig-like_fold; IPR003598; Ig_sub2	IPI00022895; IPI00644018	hsa:1		I43.950	138670; gene		1	NX_P04217		EATFPVH		EOG45MN53					P04217		PA24356		P04217		PIRSF001979; Alpha_1B_glycoprot_prd; 1		P04217			PS50835; IG_LIKE; 1	P04217		IPI00022895	P04217	SM00408; IGc2; 1	P04217; 25-495	P04217		P04217				uc002qsd.4; human	Hs.529161
A1CF_HUMAN	Q9NXC9; Q9NZD3;	RecName: Full=APOBEC1 complementation factor; AltName: Full=APOBEC1-stimulating protein;	NP_001185747.1; NP_001185748.1; NP_001185749.1; NP_055391.2; NP_620310.1; NP_620311.1	NM_001198818.1; NM_001198819.1; NM_001198820.1; NM_014576.3; NM_138932.2; NM_138933.2		ENST00000282641; ENST00000373993	ENSP00000282641; ENSP00000363105	ENSG00000148584; ENSG00000148584						594	65202	Q9NXC9	Q9NZD3		B7ZM14		Q9NQ94	Q9NQ94				HS_A1CF		29974			74761651				NOG258596	AJ272078; CAB94754.1; -; mRNA; AJ272079; CAB94755.1; -; mRNA; AF209192; AAF34824.1; -; mRNA; AF271789; AAF76221.1; -; mRNA; AF271790; AAF76222.1; -; mRNA; AK000324; BAA91086.1; ALT_FRAME; mRNA; AK291982; BAF84671.1; -; mRNA; AL512366; CAI14233.1; -; Genomic_DNA; AL589794; CAI14233.1; JOINED; Genomic_DNA; AL512366; CAI14235.1; -; Genomic_DNA; AL589794; CAI14235.1; JOINED; Genomic_DNA; AL512366; CAI14236.1; -; Genomic_DNA; AL589794; CAI14236.1; JOINED; Genomic_DNA; AL589794; CAI15762.1; -; Genomic_DNA; AL512366; CAI15762.1; JOINED; Genomic_DNA; AL589794; CAI15763.1; -; Genomic_DNA; AL512366; CAI15763.1; JOINED; Genomic_DNA; AL589794; CAI15764.1; -; Genomic_DNA; AL512366; CAI15764.1; JOINED; Genomic_DNA; CH471083; EAW54133.1; -; Genomic_DNA; CH471083; EAW54134.1; -; Genomic_DNA; CH471083; EAW54135.1; -; Genomic_DNA; BC130519; AAI30520.1; -; mRNA; BC144196; AAI44197.1; -; mRNA	Q9NQ94	G3DSA:3.30.70.330; a_b_plait_nuc_bd; 3; G3DSA:3.30.160.20; dsRNA-bd-like; 1	GC10M052566	29974	ENSGT00550000074366	Q9NQ94	ENSG00000148584; Homo sapiens		GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IDA:UniProtKB; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell; GO:0005654; C:nucleoplasm; TAS:Reactome; GO:0000166; F:nucleotide binding; IEA:InterPro; GO:0005515; F:protein binding; IPI:UniProtKB; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB; GO:0016554; P:cytidine to uridine editing; TAS:Reactome; GO:0016556; P:mRNA modification; TAS:Reactome; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW; GO:0050821; P:protein stabilization; IDA:UniProtKB	HGNC:24086; A1CF	HIX0008828		HBG051917	HPA037779		Q9NQ94	Q9NQ94; 1	IPR014720; dsRNA-bd-like; IPR006535; HnRNP_R/Q_splicing_fac; IPR012677; Nucleotide-bd_a/b_plait; IPR000504; RRM_dom	IPI00071360; IPI00148257; IPI00299499; IPI00657723; IPI00657770; IPI00981528	hsa:29974					52719	NX_Q9NQ94		TMLQGEY					2CPD; NMR; -; A=223-308	2CPD		PF00076; RRM_1; 2	PA162375098	Q9NQ94	Q9NQ94				Q9NQ94			PS50102; RRM; 3	Q9NQ94	REACT_1675; mRNA Processing; REACT_71; Gene Expression			SM00360; RRM; 3	Q9NQ94; 13-308	Q9NQ94				TIGR01648; HnRNP-R-Q; 1		uc001jjh.3; human; uc001jji.3; human; uc001jjj.3; human	Hs.282795
A20A1_HUMAN	Q5TYW2; Q9H0H6;	RecName: Full=Ankyrin repeat domain-containing protein 20A1;	NP_115626.2	NM_032250.3		ENST00000377477	ENSP00000366697	ENSG00000196774						823	94048	Q5TYW2	Q9H0H6					Q5TYW2				HS_ANKRD20A1		84210			74746676	84210			COG0666	AL136793; CAB66727.1; -; mRNA; BX649567; CAH71137.1; -; Genomic_DNA		G3DSA:1.25.40.20; ANK; 1	GC09P067926	84210	ENSGT00560000076605	Q5TYW2	ENSG00000196774; Homo sapiens		GO:0005886; C:plasma membrane; IDA:LIFEdb	HGNC:23665; ANKRD20A1		HBG100718	HBG079958			Q5TYW2		IPR002110; Ankyrin_rpt; IPR020683; Ankyrin_rpt-contain_dom	IPI00020265	hsa:84210					73621	NX_Q5TYW2				EOG4CNQQH						PF00023; Ank; 1; PF12796; Ank_2; 2	PA134953648	Q5TYW2	Q5TYW2				Q5TYW2	PR01415; ANKYRIN		PS50297; ANK_REP_REGION; 1; PS50088; ANK_REPEAT; 4	Q5TYW2				SM00248; ANK; 6	Q5TYW2; 6-255		SSF48403; ANK; 1					uc010mnn.3; human	Hs.632671
A20A2_HUMAN	Q5SQ80;	RecName: Full=Ankyrin repeat domain-containing protein 20A2;	NP_001012421.1	NM_001012421.1		ENST00000377601	ENSP00000366826	ENSG00000183148						823	94087	Q5SQ80										HS_ANKRD20A2		441430							COG0666	AL773545; CAI12706.1; -; Genomic_DNA; BX664727; CAI12706.1; JOINED; Genomic_DNA; BX664727; CAI39536.1; -; Genomic_DNA; AL773545; CAI39536.1; JOINED; Genomic_DNA		G3DSA:1.25.40.20; ANK; 1	GC09P042358	441430	ENSGT00560000076605	Q5SQ80	ENSG00000183148; Homo sapiens			HGNC:31979; ANKRD20A2		HBG100718	HBG079958			Q5SQ80		IPR002110; Ankyrin_rpt; IPR020683; Ankyrin_rpt-contain_dom	IPI00644106	hsa:441430					110164	NX_Q5SQ80		HEEIVIN		EOG4CNQQH						PF00023; Ank; 1; PF12796; Ank_2; 2	PA142672619	Q5SQ80	Q5SQ80				Q5SQ80	PR01415; ANKYRIN		PS50297; ANK_REP_REGION; 1; PS50088; ANK_REPEAT; 4	Q5SQ80				SM00248; ANK; 6	Q5SQ80; 7-254		SSF48403; ANK; 1					uc004acw.1; human	Hs.632663
A20A3_HUMAN	Q5VUR7;	RecName: Full=Ankyrin repeat domain-containing protein 20A3;	NP_001012419.1	NM_001012419.1		ENST00000254835	ENSP00000254835	ENSG00000132498						823	94108	Q5VUR7						Q5VUR7						441425			74747147	441425			COG0666	AL513478; CAH72532.1; -; Genomic_DNA		G3DSA:1.25.40.20; ANK; 1	GC09M043079	441425	ENSGT00560000076605	Q5VUR7	ENSG00000132498; Homo sapiens			HGNC:31981; ANKRD20A3		HBG100718	HBG079958			Q5VUR7		IPR002110; Ankyrin_rpt; IPR020683; Ankyrin_rpt-contain_dom	IPI00478457	hsa:441425					110155	NX_Q5VUR7				EOG4CNQQH						PF00023; Ank; 1; PF12796; Ank_2; 2	PA143485301	Q5VUR7	Q5VUR7				Q5VUR7	PR01415; ANKYRIN		PS50297; ANK_REP_REGION; 1; PS50088; ANK_REPEAT; 4	Q5VUR7				SM00248; ANK; 6	Q5VUR7; 11-255		SSF48403; ANK; 1					uc004acd.3; human	Hs.632663
A20A4_HUMAN	Q4UJ75;	RecName: Full=Ankyrin repeat domain-containing protein 20A4;	NP_001092275.1	NM_001098805.1		ENST00000357336	ENSP00000349891	ENSG00000172014						823	94149	Q4UJ75						Q4UJ75				HS_ANKRD20A4		728747			74753541					CR769776; CAI95383.1; -; Genomic_DNA		G3DSA:1.25.40.20; ANK; 1	GC09P069381	728747	ENSGT00560000076605	Q4UJ75	ENSG00000172014; Homo sapiens			HGNC:31982; ANKRD20A4		HBG100718	HBG079958			Q4UJ75		IPR002110; Ankyrin_rpt; IPR020683; Ankyrin_rpt-contain_dom	IPI00552956	hsa:728747					128184	NX_Q4UJ75				EOG4CNQQH						PF00023; Ank; 1; PF12796; Ank_2; 2	PA145149866						Q4UJ75	PR01415; ANKYRIN		PS50297; ANK_REP_REGION; 1; PS50088; ANK_REPEAT; 4	Q4UJ75				SM00248; ANK; 6	Q4UJ75; 7-257		SSF48403; ANK; 1					uc004afn.3; human	Hs.645502
A20A5_HUMAN	A0PJZ0; Q4G1B6;	RecName: Full=Putative ankyrin repeat domain-containing protein 20A5; AltName: Full=Ankyrin repeat domain-containing protein 20A5 pseudogene;												165	18446	A0PJZ0	Q4G1B6																		COG0666	AP001004; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC022023; AAH22023.1; ALT_FRAME; mRNA; BC127726; AAI27727.1; -; mRNA		G3DSA:1.25.40.20; ANK; 1	GC18U900665			A0PJZ0				HGNC:33833; ANKRD20A5P						A0PJZ0		IPR002110; Ankyrin_rpt; IPR020683; Ankyrin_rpt-contain_dom	IPI00455358							NX_A0PJZ0										PF12796; Ank_2; 1							A0PJZ0	PR01415; ANKYRIN		PS50297; ANK_REP_REGION; 1; PS50088; ANK_REPEAT; 3	A0PJZ0				SM00248; ANK; 3	A0PJZ0; 7-164		SSF48403; ANK; 1					uc010xag.2; human	Hs.632352
A26L1_HUMAN	Q96IX9;	RecName: Full=Putative ankyrin repeat domain-containing protein 26-like 1; AltName: Full=Ankyrin repeat domain-containing protein 36B pseudogene 1;				ENST00000358576	ENSP00000351384	ENSG00000214262						119	14172	Q96IX9					Q96IX9	Q96IX9									74751951				NOG326299	AL009051; CAI22641.1; -; Genomic_DNA; BC007072; -; NOT_ANNOTATED_CDS; mRNA			GC01M168214		ENSGT00560000077879	Q96IX9				HGNC:28169; ANKRD36BP1							Q96IX9; 3		IPI00063907							NX_Q96IX9		TIAHYSG		EOG45X7Z6									Q96IX9				Q96IX9				Q96IX9						Q96IX9							Hs.537067
A2AP_HUMAN	P08697; Q8N5U7; Q9UCG2; Q9UCG3;	RecName: Full=Alpha-2-antiplasmin; Short=Alpha-2-AP; AltName: Full=Alpha-2-plasmin inhibitor; Short=Alpha-2-PI; AltName: Full=Serpin F2; Flags: Precursor;	NP_000925.2; NP_001159392.1; NP_001159393.1	NM_000934.3; NM_001165920.1; NM_001165921.1		ENST00000324015; ENST00000382061	ENSP00000321853; ENSP00000371493	ENSG00000167711; ENSG00000167711						491	54566	P08697	Q8N5U7	Q9UCG2	Q9UCG3		P08697	P08697				HS_SERPINF2		5345			112907	5345		DB00086; Streptokinase	COG4826	D00174; BAA00124.1; -; mRNA; M20786; AAA51554.1; -; Genomic_DNA; M20782; AAA51554.1; JOINED; Genomic_DNA; M20783; AAA51554.1; JOINED; Genomic_DNA; M20784; AAA51554.1; JOINED; Genomic_DNA; M20785; AAA51554.1; JOINED; Genomic_DNA; BC031592; AAH31592.1; -; mRNA; J02654; AAA35543.1; -; mRNA; D00116; BAA00070.1; -; mRNA			GC17P001593	5345	ENSGT00560000076649	P08697			GO:0005577; C:fibrinogen complex; IDA:BHF-UCL; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome; GO:0043499; F:eukaryotic cell surface binding; IDA:BHF-UCL; GO:0002020; F:protease binding; IPI:UniProtKB; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL; GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW; GO:0048514; P:blood vessel morphogenesis; ISS:BHF-UCL; GO:0030199; P:collagen fibril organization; ISS:BHF-UCL; GO:0042730; P:fibrinolysis; TAS:Reactome; GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL; GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL; GO:0030168; P:platelet activation; TAS:Reactome; GO:0002576; P:platelet degranulation; TAS:Reactome; GO:0045597; P:positive regulation of cell differentiation; IDA:BHF-UCL; GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; TAS:BHF-UCL; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL; GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:BHF-UCL; GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL; GO:0071636; P:positive regulation of transforming growth factor beta production; IDA:BHF-UCL; GO:0002034; P:regulation of blood vessel size by renin-angiotensin; ISS:BHF-UCL; GO:0030162; P:regulation of proteolysis; IBA:RefGenome	HGNC:9075; SERPINF2	HIX0202497	HBG445330	HBG000043	CAB024863; HPA001885		P08697	P08697; 2	IPR000215; Protease_inhib_I4_serpin; IPR023795; Protease_inhib_I4_serpin_CS; IPR023796; Sepin_dom	IPI00879231	hsa:5345	K03983	I04.023	262850; phenotype; 613168; gene		20714	NX_P08697		LFGAKPM	79; Congenital alpha2 antiplasmin deficiency		PTHR11461; Prot_inh_serpin; 1					PF00079; Serpin; 1	PA35522		P08697	A31402; ITHUA2		P08697	P08697			PS00284; SERPIN; 1	P08697	REACT_604; Hemostasis			SM00093; SERPIN; 1	P08697; 74-446	P08697	SSF56574; Prot_inh_serpin; 1	P08697				uc002ftk.1; human	Hs.159509
A2GL_HUMAN	P02750; Q8N4F5; Q96QZ4;	RecName: Full=Leucine-rich alpha-2-glycoprotein; Short=LRG; Flags: Precursor;	NP_443204.1	NM_052972.2		ENST00000306390	ENSP00000302621	ENSG00000171236						347	38178	P02750	Q8N4F5	Q96QZ4			P02750	P02750				HS_LRG1		116844			23503037	116844	P02750		COG4886	AF403428; AAK95527.1; -; mRNA; BC034389; AAH34389.1; -; mRNA; BC070198; AAH70198.1; -; mRNA			GC19M004489	116844	ENSGT00630000089822	P02750	ENSG00000171236; Homo sapiens		GO:0005576; C:extracellular region; NAS:UniProtKB; GO:0016020; C:membrane; NAS:UniProtKB	HGNC:29480; LRG1	HIX0014668	HBG125661	HBG000045	HPA001888; HPA001889		P02750		IPR000483; Cys-rich_flank_reg_C; IPR001611; Leu-rich_rpt; IPR003591; Leu-rich_rpt_typical-subtyp	IPI00022417	hsa:116844			611289; gene		80020	NX_P02750		RCAGPEA		EOG4TMR2P					P02750	PF00560; LRR_1; 2	PA134919634	P02750	P02750	A03211; NBHUA2			P02750			PS51450; LRR; 8	P02750			P02750	SM00369; LRR_TYP; 4; SM00082; LRRCT; 1	P02750; 41-343	P02750		P02750				uc002mau.3; human	Hs.655559
A2LD1_HUMAN	Q9BVM4; B3KTN1; Q9BT41;	RecName: Full=Gamma-glutamylaminecyclotransferase; Short=GGACT; EC=2.3.2.4; AltName: Full=AIG2-like domain-containing protein 1;	NP_001182016.1; NP_149101.1	NM_001195087.1; NM_033110.2		ENST00000376250; ENST00000455100	ENSP00000365426; ENSP00000410449	ENSG00000134864; ENSG00000134864						153	17329	Q9BVM4	B3KTN1	Q9BT41			Q9BVM4	Q9BVM4				HS_A2LD1		87769			74752384	87769			NOG242813	AK095850; BAG53143.1; -; mRNA; AL136526; CAI39558.1; -; Genomic_DNA; CH471085; EAX09037.1; -; Genomic_DNA; BC001077; AAH01077.2; -; mRNA; BC004360; AAH04360.1; ALT_INIT; mRNA	Q9BVM4	G3DSA:3.10.490.10; Butirosin_synth_BtrG-like; 1	GC13M101183	87769	ENSGT00390000010543	Q9BVM4			GO:0003839; F:gamma-glutamylcyclotransferase activity; IDA:UniProtKB; GO:0042219; P:cellular modified amino acid catabolic process; IDA:UniProtKB	HGNC:25100; A2LD1		HBG445045	HBG105481			Q9BVM4		IPR009288; AIG2-like; IPR013024; Butirosin_synth_BtrG-like	IPI00900332	hsa:87769			613378; gene		76214	NX_Q9BVM4		RYNPREN		EOG47WNQ1			3JUB; X-ray; 1.20 A; A=1-153; 3JUC; X-ray; 1.20 A; A=1-153; 3JUD; X-ray; 0.98 A; A=1-153	3JUB; 3JUC; 3JUD		PF06094; AIG2; 1	PA164714645		Q9BVM4				Q9BVM4				Q9BVM4					Q9BVM4; 1-151	Q9BVM4						uc001voq.2; human	Hs.350868
A2MG_HUMAN	P01023; Q13677; Q59F47; Q5QTS0; Q68DN2; Q6PIY3; Q6PN97;	RecName: Full=Alpha-2-macroglobulin; Short=Alpha-2-M; AltName: Full=C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5; Flags: Precursor;	NP_000005.2	NM_000014.4		ENST00000318602	ENSP00000323929	ENSG00000175899						1474	163291	P01023	Q13677	Q59F47	Q5QTS0		P01023	P01023				HS_A2M		2	DIP-1118N		308153640		P01023	DB00626; Bacitracin; DB00102; Becaplermin	COG2373	M11313; AAA51551.1; -; mRNA; AY591530; AAT02228.1; ALT_INIT; mRNA; AB209614; BAD92851.1; ALT_INIT; mRNA; CR749334; CAH18188.1; -; mRNA; AC007436; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC026246; AAH26246.1; -; mRNA; BC040071; AAH40071.1; -; mRNA; Z11711; CAA77774.1; -; Genomic_DNA; X68728; CAA48670.1; -; Genomic_DNA; X68729; CAA48670.1; JOINED; Genomic_DNA; M36501; AAA51552.1; -; mRNA; AF109189; AAQ13498.1; -; mRNA	P01023	G3DSA:2.60.40.690; A-macroglobulin_rcpt-bd; 1	GC12M009220	2	ENSGT00560000076685	P01023	ENSG00000175899; Homo sapiens		GO:0005829; C:cytosol; TAS:Reactome; GO:0005615; C:extracellular space; IEA:InterPro; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome; GO:0019899; F:enzyme binding; IPI:UniProtKB; GO:0019966; F:interleukin-1 binding; IDA:UniProtKB; GO:0019959; F:interleukin-8 binding; IPI:UniProtKB; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB; GO:0043120; F:tumor necrosis factor binding; IDA:UniProtKB; GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome; GO:0001869; P:negative regulation of complement activation, lectin pathway; IDA:UniProtKB; GO:0030168; P:platelet activation; TAS:Reactome; GO:0002576; P:platelet degranulation; TAS:Reactome; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome	HGNC:7; A2M	HIX0026392		HBG000039	CAB017621; HPA002265			P01023; 40	IPR009048; A-macroglobulin_rcpt-bd; IPR011626; A2M_comp; IPR002890; A2M_N; IPR011625; A2M_N_2; IPR001599; Macroglobln_a2; IPR019742; MacrogloblnA2_CS; IPR019565; MacrogloblnA2_thiol-ester-bond; IPR008930; Terpenoid_cyclase/PrenylTrfase; IPR010916; TonB_box_CS	IPI00478003	hsa:2	K03910	I39.001	103950; gene+phenotype	MINT-122288	5	NX_P01023		ICGNGRQ		EOG4H9XJN		il6_7pathway; IL6-mediated signaling events	1BV8; NMR; -; A=1337-1474; 2P9R; X-ray; 2.30 A; A/B=126-227; 4ACQ; X-ray; 4.30 A; A/B/C/D=24-1474	1BV8; 2P9R; 4ACQ	P01023	PF00207; A2M; 1; PF07678; A2M_comp; 1; PF01835; A2M_N; 1; PF07703; A2M_N_2; 1; PF07677; A2M_recep; 1; PF10569; Thiol-ester_cl; 1	PA24357	P01023		A94033; MAHU			P01023			PS00477; ALPHA_2_MACROGLOBULIN; 1	P01023	REACT_111102; Signal Transduction; REACT_604; Hemostasis				P01023; 126-227, 1338-1474	P01023	SSF49410; AM_receptor_bind; 1; SSF48239; Terp_cyc_toroid; 1	P01023				uc001qvk.1; human	Hs.212838
A2ML1_HUMAN	A8K2U0; B5MDD1; Q2M224; Q6ZW52; Q6ZW53; Q8N1M4; Q96LQ8;	RecName: Full=Alpha-2-macroglobulin-like protein 1; AltName: Full=C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9; Flags: Precursor;				ENST00000299698	ENSP00000299698	ENSG00000166535						1454	161107	A8K2U0	B5MDD1	Q2M224	Q6ZW52			A8K2U0				HS_A2ML1									COG2373	AK057908; BAB71612.1; ALT_INIT; mRNA; AK096448; BAC04793.1; ALT_INIT; mRNA; AK123591; BAC85653.1; ALT_INIT; mRNA; AK123592; BAC85654.1; ALT_INIT; mRNA; AK290355; BAF83044.1; -; mRNA; AL832139; -; NOT_ANNOTATED_CDS; mRNA; AC006513; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC006581; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC093840; AAH93840.2; -; mRNA; BC112131; AAI12132.1; -; mRNA		G3DSA:2.60.40.690; A-macroglobulin_rcpt-bd; 1	GC12P008975		ENSGT00560000076685	A8K2U0			GO:0005615; C:extracellular space; IDA:UniProtKB; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW	HGNC:23336; A2ML1		HBG444284	HBG000039	HPA038848				IPR009048; A-macroglobulin_rcpt-bd; IPR011626; A2M_comp; IPR002890; A2M_N; IPR011625; A2M_N_2; IPR001599; Macroglobln_a2; IPR019742; MacrogloblnA2_CS; IPR019565; MacrogloblnA2_thiol-ester-bond; IPR008930; Terpenoid_cyclase/PrenylTrfase	IPI00419215			I39.007	610627; gene			NX_A8K2U0		QVSVCQK		EOG4FTVZQ						PF00207; A2M; 1; PF07678; A2M_comp; 1; PF01835; A2M_N; 1; PF07703; A2M_N_2; 1; PF07677; A2M_recep; 1; PF10569; Thiol-ester_cl; 1							A8K2U0			PS00477; ALPHA_2_MACROGLOBULIN; 1	A8K2U0					A8K2U0; 119-217, 721-952, 957-1257, 1260-1454	A8K2U0	SSF49410; AM_receptor_bind; 1; SSF48239; Terp_cyc_toroid; 1					uc001quz.4; human	Hs.620532
A30BL_HUMAN	A7E2S9; B8ZZL7;	RecName: Full=Putative ankyrin repeat domain-containing protein 30B-like;				ENST00000295181; ENST00000409867	ENSP00000295181; ENSP00000386398	ENSG00000163046; ENSG00000163046						258	28549	A7E2S9	B8ZZL7					A7E2S9													COG0666	AC097532; -; NOT_ANNOTATED_CDS; Genomic_DNA; AC098826; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471058; EAX11682.1; -; Genomic_DNA; BC150521; -; NOT_ANNOTATED_CDS; mRNA		G3DSA:1.25.40.20; ANK; 1	GC02M132906		ENSGT00560000076605	A7E2S9				HGNC:35167; ANKRD30BL		HBG506323	HBG108744			A7E2S9		IPR002110; Ankyrin_rpt; IPR020683; Ankyrin_rpt-contain_dom	IPI00887420; IPI00915765							NX_A7E2S9		KEAVECQ		EOG4PNXHX						PF12796; Ank_2; 2							A7E2S9	PR01415; ANKYRIN		PS50297; ANK_REP_REGION; 1; PS50088; ANK_REPEAT; 3	A7E2S9				SM00248; ANK; 4	A7E2S9; 12-257		SSF48403; ANK; 1						Hs.380689
A4GAT_HUMAN	Q9NPC4; B2R7C4; Q9P1X5;	RecName: Full=Lactosylceramide 4-alpha-galactosyltransferase; EC=2.4.1.228; AltName: Full=Alpha-1,4-N-acetylglucosaminyltransferase; AltName: Full=Alpha-1,4-galactosyltransferase; AltName: Full=Alpha4Gal-T1; AltName: Full=CD77 synthase; AltName: Full=Globotriaosylceramide synthase; Short=Gb3 synthase; AltName: Full=P1/Pk synthase; AltName: Full=UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase;	NP_059132.1	NM_017436.4		ENST00000249005; ENST00000381278; ENST00000401850	ENSP00000249005; ENSP00000370678; ENSP00000384794	ENSG00000128274; ENSG00000128274; ENSG00000128274						353	40499	Q9NPC4	B2R7C4	Q9P1X5			Q9NPC4	Q9NPC4		2.4.1.228; 2681	GT32; Glycosyltransferase Family 32	HS_A4GALT		53947			25452796	53947			NOG251623	AB037883; BAA95915.1; -; mRNA; AJ245581; CAB93532.1; -; mRNA; AB041418; BAA94503.1; -; Genomic_DNA; AY941797; AAX20109.1; -; Genomic_DNA; AK312927; BAG35771.1; -; mRNA; Z82176; CAI18757.1; -; Genomic_DNA; CH471138; EAW73274.1; -; Genomic_DNA; BC017068; AAH17068.1; -; mRNA			GC22M043088	53947	ENSGT00510000047981	Q9NPC4	ENSG00000128274; Homo sapiens		GO:0005795; C:Golgi stack; IEA:InterPro; GO:0030173; C:integral to Golgi membrane; NAS:UniProtKB; GO:0005624; C:membrane fraction; IDA:MGI; GO:0050512; F:lactosylceramide 4-alpha-galactosyltransferase activity; IEA:EC; GO:0006688; P:glycosphingolipid biosynthetic process; NAS:UniProtKB; GO:0007009; P:plasma membrane organization; IDA:MGI	HGNC:18149; A4GALT	HIX0016546		HBG050427	HPA001141		Q9NPC4		IPR007652; A1-4-GlycosylTfrase_dom; IPR007577; GlycoTrfase_DXD_sugar-bd_CS	IPI00033541	hsa:53947	K01988		111400; phenotype; 607922; gene	MINT-5210812	56264	NX_Q9NPC4		RVCTLFI		EOG4NVZKK						PF04572; Gb3_synth; 1; PF04488; Gly_transf_sug; 1	PA24359		Q9NPC4				Q9NPC4				Q9NPC4					Q9NPC4; 171-197	Q9NPC4						uc003bdb.3; human	Hs.105956
A4GCT_HUMAN	Q9UNA3; Q0VDK1; Q0VDK2;	RecName: Full=Alpha-1,4-N-acetylglucosaminyltransferase; Short=Alpha4GnT; EC=2.4.1.-;	NP_057245.1	NM_016161.2		ENST00000236709	ENSP00000236709	ENSG00000118017						340	39497	Q9UNA3	Q0VDK1	Q0VDK2			Q9UNA3	Q9UNA3			GT32; Glycosyltransferase Family 32	HS_A4GNT		51146			25452797	51146			NOG251623	AF141315; AAD48406.1; -; mRNA; BC119639; AAI19640.1; -; mRNA; BC119640; AAI19641.1; -; mRNA			GC03M137842	51146	ENSGT00510000047981	Q9UNA3	ENSG00000118017; Homo sapiens		GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell; GO:0005795; C:Golgi stack; IEA:InterPro; GO:0016021; C:integral to membrane; TAS:ProtInc; GO:0005624; C:membrane fraction; TAS:ProtInc; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:MGI; GO:0008378; F:galactosyltransferase activity; IEA:InterPro; GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc	HGNC:17968; A4GNT	HIX0030726	HBG755248	HBG106704	HPA008017		Q9UNA3		IPR007652; A1-4-GlycosylTfrase_dom; IPR007577; GlycoTrfase_DXD_sugar-bd_CS	IPI00007712	hsa:51146	K08251				54017	NX_Q9UNA3		PSFNDSY		EOG4TTGJ8						PF04572; Gb3_synth; 1; PF04488; Gly_transf_sug; 1	PA134960042						Q9UNA3				Q9UNA3					Q9UNA3; 127-173	Q9UNA3						uc003ers.2; human	Hs.278960
A4_HUMAN	Q9BT38; Q9UC33; Q9UCA9; Q9UCB6; Q9UCC8; Q9UCD1; Q9UQ58;	RecName: Full=Amyloid beta A4 protein; AltName: Full=ABPP; AltName: Full=APPI; Short=APP; AltName: Full=Alzheimer disease amyloid protein; AltName: Full=Cerebral vascular amyloid peptide; Short=CVAP; AltName: Full=PreA4; AltName: Full=Protease nexin-II; Short=PN-II; Contains: RecName: Full=N-APP; Contains: RecName: Full=Soluble APP-alpha; Short=S-APP-alpha; Contains: RecName: Full=Soluble APP-beta; Short=S-APP-beta; Contains: RecName: Full=C99; Contains: RecName: Full=Beta-amyloid protein 42; AltName: Full=Beta-APP42; Contains: RecName: Full=Beta-amyloid protein 40; AltName: Full=Beta-APP40; Contains: RecName: Full=C83; Contains: RecName: Full=P3(42); Contains: RecName: Full=P3(40); Contains: RecName: Full=C80; Contains: RecName: Full=Gamma-secretase C-terminal fragment 59; AltName: Full=Amyloid intracellular domain 59; Short=AICD-59; Short=AID(59); AltName: Full=Gamma-CTF(59); Contains: RecName: Full=Gamma-secretase C-terminal fragment 57; AltName: Full=Amyloid intracellular domain 57; Short=AICD-57; Short=AID(57); AltName: Full=Gamma-CTF(57); Contains: RecName: Full=Gamma-secretase C-terminal fragment 50; AltName: Full=Amyloid intracellular domain 50; Short=AICD-50; Short=AID(50); AltName: Full=Gamma-CTF(50); Contains: RecName: Full=C31; Flags: Precursor;	NP_000475.1; NP_001129601.1; NP_001129602.1; NP_001191230.1; NP_001191231.1; NP_001191232.1; NP_958816.1; NP_958817.1	NM_000484.3; NM_001136129.2; NM_001136130.2; NM_001204301.1; NM_001204302.1; NM_001204303.1; NM_201413.2; NM_201414.2		ENST00000346798	ENSP00000284981	ENSG00000142192						770	86943	Q9BT38	Q9UC33	Q9UCA9	Q9UCB6		P05067	P05067	MetaCyc:ENSG00000142192-MONOMER					351	DIP-574N		112927	351			NOG289770	Y00264; CAA68374.1; -; mRNA; X13466; CAA31830.1; -; Genomic_DNA; X13467; CAA31830.1; JOINED; Genomic_DNA; X13468; CAA31830.1; JOINED; Genomic_DNA; X13469; CAA31830.1; JOINED; Genomic_DNA; X13470; CAA31830.1; JOINED; Genomic_DNA; X13471; CAA31830.1; JOINED; Genomic_DNA; X13472; CAA31830.1; JOINED; Genomic_DNA; X13473; CAA31830.1; JOINED; Genomic_DNA; X13474; CAA31830.1; JOINED; Genomic_DNA; X13475; CAA31830.1; JOINED; Genomic_DNA; X13476; CAA31830.1; JOINED; Genomic_DNA; X13477; CAA31830.1; JOINED; Genomic_DNA; X13478; CAA31830.1; JOINED; Genomic_DNA; X13479; CAA31830.1; JOINED; Genomic_DNA; X13487; CAA31830.1; JOINED; Genomic_DNA; X13488; CAA31830.1; JOINED; Genomic_DNA; X06989; CAA30050.1; -; mRNA; M33112; AAB59502.1; -; Genomic_DNA; M34862; AAB59502.1; JOINED; Genomic_DNA; M34863; AAB59502.1; JOINED; Genomic_DNA; M34864; AAB59502.1; JOINED; Genomic_DNA; M34865; AAB59502.1; JOINED; Genomic_DNA; M34866; AAB59502.1; JOINED; Genomic_DNA; M34867; AAB59502.1; JOINED; Genomic_DNA; M34868; AAB59502.1; JOINED; Genomic_DNA; M34869; AAB59502.1; JOINED; Genomic_DNA; M34870; AAB59502.1; JOINED; Genomic_DNA; M34871; AAB59502.1; JOINED; Genomic_DNA; M34872; AAB59502.1; JOINED; Genomic_DNA; M34873; AAB59502.1; JOINED; Genomic_DNA; M34874; AAB59502.1; JOINED; Genomic_DNA; M34876; AAB59502.1; JOINED; Genomic_DNA; M34877; AAB59502.1; JOINED; Genomic_DNA; M34878; AAB59502.1; JOINED; Genomic_DNA; M34879; AAB59502.1; JOINED; Genomic_DNA; M34875; AAB59501.1; ALT_TERM; Genomic_DNA; M34862; AAB59501.1; JOINED; Genomic_DNA; M34863; AAB59501.1; JOINED; Genomic_DNA; M34864; AAB59501.1; JOINED; Genomic_DNA; M34865; AAB59501.1; JOINED; Genomic_DNA; M34866; AAB59501.1; JOINED; Genomic_DNA; M34867; AAB59501.1; JOINED; Genomic_DNA; M34868; AAB59501.1; JOINED; Genomic_DNA; M34869; AAB59501.1; JOINED; Genomic_DNA; M34870; AAB59501.1; JOINED; Genomic_DNA; M34871; AAB59501.1; JOINED; Genomic_DNA; M34872; AAB59501.1; JOINED; Genomic_DNA; M34873; AAB59501.1; JOINED; Genomic_DNA; D87675; BAA22264.1; -; Genomic_DNA; AY919674; AAW82435.1; -; Genomic_DNA; CH471079; EAX09958.1; -; Genomic_DNA; AK312326; BAG35248.1; -; mRNA; CH471079; EAX09959.1; -; Genomic_DNA; CH471079; EAX09960.1; -; Genomic_DNA; CH471079; EAX09961.1; -; Genomic_DNA; CH471079; EAX09963.1; -; Genomic_DNA; CH471079; EAX09965.1; -; Genomic_DNA; BC004369; AAH04369.1; -; mRNA; BC065529; AAH65529.1; -; mRNA; M35675; AAA60163.1; ALT_SEQ; mRNA; M24547; AAC13654.1; -; Genomic_DNA; M24546; AAC13654.1; JOINED; Genomic_DNA; M28373; AAA58727.1; ALT_SEQ; mRNA; X06982; CAA30042.1; -; mRNA; X06981; CAA30041.1; -; mRNA; M18734; AAA51726.1; -; mRNA; M29270; AAA51768.1; -; Genomic_DNA; M29269; AAA51768.1; JOINED; Genomic_DNA; AB066441; BAB71958.2; -; mRNA; M15533; AAA35540.1; -; mRNA; M15532; AAA51564.1; -; mRNA; M37896; AAA51727.1; -; Genomic_DNA; M37895; AAA51727.1; JOINED; Genomic_DNA; S45136; AAB23646.1; -; Genomic_DNA; S60317; AAC60601.2; -; Genomic_DNA; AF282245; AAQ14327.1; -; mRNA; S60721; AAB26263.2; -; mRNA; S61380; AAB26264.2; -; mRNA; S61383; AAB26265.2; -; mRNA; M16765; AAA51722.1; -; mRNA	P05067	G3DSA:4.10.230.10; Amyloid_glyco_Abeta; 1; G3DSA:3.30.1490.140; Amyloid_glyco_Cu-bd; 1; G3DSA:3.90.570.10; Amyloid_glyco_heparin-bd; 1; G3DSA:4.10.410.10; Prot_inh_Kunz-m; 1	GC21M027252	351	ENSGT00530000063252	P05067	ENSG00000142192; Homo sapiens	P05067	GO:0030424; C:axon; ISS:UniProtKB; GO:0009986; C:cell surface; IDA:UniProtKB; GO:0005905; C:coated pit; IEA:UniProtKB-SubCell; GO:0005829; C:cytosol; TAS:Reactome; GO:0043198; C:dendritic shaft; IDA:MGI; GO:0043197; C:dendritic spine; IDA:MGI; GO:0005576; C:extracellular region; TAS:Reactome; GO:0005794; C:Golgi apparatus; ISS:UniProtKB; GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome; GO:0033130; F:acetylcholine receptor binding; IPI:UniProtKB; GO:0003677; F:DNA binding; ISS:UniProtKB; GO:0008201; F:heparin binding; IEA:UniProtKB-KW; GO:0042802; F:identical protein binding; IPI:IntAct; GO:0005515; F:protein binding; IPI:IntAct; GO:0051425; F:PTB domain binding; IPI:BHF-UCL; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB; GO:0046914; F:transition metal ion binding; IEA:InterPro; GO:0008344; P:adult locomotory behavior; ISS:UniProtKB; GO:0008088; P:axon cargo transport; ISS:UniProtKB; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW; GO:0006878; P:cellular copper ion homeostasis; ISS:UniProtKB; GO:0048669; P:collateral sprouting in absence of injury; ISS:UniProtKB; GO:0016358; P:dendrite development; ISS:UniProtKB; GO:0006897; P:endocytosis; ISS:UniProtKB; GO:0030198; P:extracellular matrix organization; ISS:UniProtKB; GO:0000085; P:G2 phase of mitotic cell cycle; ISS:UniProtKB; GO:0045087; P:innate immune response; TAS:Reactome; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB; GO:0007617; P:mating behavior; ISS:UniProtKB; GO:0006378; P:mRNA polyadenylation; ISS:UniProtKB; GO:0051402; P:neuron apoptosis; IMP:UniProtKB; GO:0016322; P:neuron remodeling; ISS:UniProtKB; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW; GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome; GO:0030168; P:platelet activation; TAS:Reactome; GO:0002576; P:platelet degranulation; TAS:Reactome; GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB; GO:0006468; P:protein phosphorylation; ISS:UniProtKB; GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; ISS:UniProtKB; GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB; GO:0050803; P:regulation of synapse structure and activity; ISS:UniProtKB; GO:0006417; P:regulation of translation; ISS:UniProtKB; GO:0008542; P:visual learning; ISS:UniProtKB	HGNC:620; APP			HBG000051	CAB000157; HPA001462		P05067	P05067; 95	IPR008155; Amyloid_glyco; IPR013803; Amyloid_glyco_Abeta; IPR011178; Amyloid_glyco_Cu-bd; IPR024329; Amyloid_glyco_E2_domain; IPR008154; Amyloid_glyco_extra; IPR019744; Amyloid_glyco_extracell_CS; IPR015849; Amyloid_glyco_heparin-bd; IPR019745; Amyloid_glyco_intracell_CS; IPR019543; APP_amyloid_C; IPR002223; Prot_inh_Kunz-m; IPR020901; Prtase_inh_Kunz-CS	IPI00006608; IPI00219182; IPI00219183; IPI00219185; IPI00219186; IPI00219187; IPI00394658; IPI00412568; IPI00412681; IPI00412924	hsa:351	K04520	I02.015	104300; phenotype; 104760; gene+phenotype; 605714; phenotype	MINT-150767	1445	NX_P05067		RKQCKTH	1020; Early-onset autosomal dominant Alzheimer disease; 85458; Hereditary cerebral hemorrhage with amyloidosis			caspase_pathway; Caspase cascade in apoptosis; glypican_1pathway; Glypican 1 network; p75ntrpathway; p75(NTR)-mediated signaling	1AAP; X-ray; 1.50 A; A/B=287-344; 1AMB; NMR; -; A=672-699; 1AMC; NMR; -; A=672-699; 1AML; NMR; -; A=672-711; 1BA4; NMR; -; A=672-711; 1BA6; NMR; -; A=672-711; 1BJB; NMR; -; A=672-699; 1BJC; NMR; -; A=672-699; 1BRC; X-ray; 2.50 A; I=287-342; 1CA0; X-ray; 2.10 A; D/I=289-342; 1HZ3; NMR; -; A=681-706; 1IYT; NMR; -; A=672-713; 1MWP; X-ray; 1.80 A; A=28-123; 1OWT; NMR; -; A=124-189; 1QCM; NMR; -; A=696-706; 1QWP; NMR; -; A=696-706; 1QXC; NMR; -; A=696-706; 1QYT; NMR; -; A=696-706; 1TAW; X-ray; 1.80 A; B=287-344; 1TKN; NMR; -; A=460-569; 1UO7; Model; -; A=672-713; 1UO8; Model; -; A=672-713; 1UOA; Model; -; A=672-713; 1UOI; Model; -; A=672-713; 1X11; X-ray; 2.50 A; C/D=754-766; 1Z0Q; NMR; -; A=672-713; 1ZE7; NMR; -; A=672-687; 1ZE9; NMR; -; A=672-687; 1ZJD; X-ray; 2.60 A; B=289-344; 2BEG; NMR; -; A/B/C/D/E=672-713; 2BOM; Model; -; A/B=681-713; 2BP4; NMR; -; A=672-687; 2FJZ; X-ray; 1.61 A; A=133-189; 2FK1; X-ray; 1.60 A; A=133-189; 2FK2; X-ray; 1.65 A; A=133-189; 2FK3; X-ray; 2.40 A; A/B/C/D/E/F/G/H=133-189; 2FKL; X-ray; 2.50 A; A/B=124-189; 2FMA; X-ray; 0.85 A; A=133-189; 2G47; X-ray; 2.10 A; C/D=672-711; 2IPU; X-ray; 1.65 A; P/Q=672-679; 2LFM; NMR; -; A=672-711; 2LMN; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-711; 2LMO; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-711; 2LMP; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-711; 2LMQ; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-711; 2LNQ; NMR; -; A/B/C/D/E/F/G/H=672-711; 2OTK; NMR; -; C=672-711; 2R0W; X-ray; 2.50 A; Q=672-679; 2WK3; X-ray; 2.59 A; C/D=672-713; 2Y29; X-ray; 2.30 A; A=687-692; 2Y2A; X-ray; 1.91 A; A=687-692; 2Y3J; X-ray; 1.99 A; A/B/C/D/E/F/G/H=701-706; 2Y3K; X-ray; 1.90 A; A/B/C/D/E/F/G/H=706-713; 2Y3L; X-ray; 2.10 A; A/B/C/G=706-713; 3AYU; X-ray; 2.00 A; B=586-595; 3DXC; X-ray; 2.10 A; B/D=739-770; 3DXD; X-ray; 2.20 A; B/D=739-770; 3DXE; X-ray; 2.00 A; B/D=739-770; 3GCI; X-ray; 2.04 A; P=707-713; 3IFL; X-ray; 1.50 A; P=672-678; 3IFN; X-ray; 1.50 A; P=672-711; 3IFO; X-ray; 2.15 A; P/Q=672-678; 3IFP; X-ray; 2.95 A; P/Q/R/S=672-678; 3JTI; X-ray; 1.80 A; B=699-706; 3KTM; X-ray; 2.70 A; A/B/C/D/E/F/G/H=18-190; 3L33; X-ray; 2.48 A; E/F/G/H=290-341; 3L81; X-ray; 1.60 A; B=761-767; 3MOQ; X-ray; 2.05 A; A/B/C/D=689-712; 3MXC; X-ray; 2.00 A; L=754-762; 3MXY; X-ray; 2.30 A; L=754-762; 3NYJ; X-ray; 3.20 A; A=365-567; 3NYL; X-ray; 2.80 A; A=365-570; 3OVJ; X-ray; 1.80 A; A/B/C/D=687-692; 3OW9; X-ray; 1.80 A; A/B=687-692; 3U0T; X-ray; 2.50 A; E/F=701-711; 3UMH; X-ray; 2.00 A; A=370-575; 3UMI; X-ray; 2.40 A; A=370-575; 3UMK; X-ray; 2.60 A; A=370-575	1AAP; 1AMB; 1AMC; 1AML; 1BA4; 1BA6; 1BJB; 1BJC; 1BRC; 1CA0; 1HZ3; 1IYT; 1MWP; 1OWT; 1QCM; 1QWP; 1QXC; 1QYT; 1TAW; 1TKN; 1UO7; 1UO8; 1UOA; 1UOI; 1X11; 1Z0Q; 1ZE7; 1ZE9; 1ZJD; 2BEG; 2BOM; 2BP4; 2FJZ; 2FK1; 2FK2; 2FK3; 2FKL; 2FMA; 2G47; 2IPU; 2LFM; 2LMN; 2LMO; 2LMP; 2LMQ; 2LNQ; 2OTK; 2R0W; 2WK3; 2Y29; 2Y2A; 2Y3J; 2Y3K; 2Y3L; 3AYU; 3DXC; 3DXD; 3DXE; 3GCI; 3IFL; 3IFN; 3IFO; 3IFP; 3JTI; 3KTM; 3L33; 3L81; 3MOQ; 3MXC; 3MXY; 3NYJ; 3NYL; 3OVJ; 3OW9; 3U0T; 3UMH; 3UMI; 3UMK		PF10515; APP_amyloid; 1; PF12924; APP_Cu_bd; 1; PF12925; APP_E2; 1; PF02177; APP_N; 1; PF03494; Beta-APP; 1; PF00014; Kunitz_BPTI; 1	PA24910	P05067	P05067	S01442; S01442; S02260; QRHUA4		P05067	P05067	PR00203; AMYLOIDA4; PR00759; BASICPTASE; PR00204; BETAAMYLOID		PS00319; A4_EXTRA; 1; PS00320; A4_INTRA; 1; PS00280; BPTI_KUNITZ_1; 1; PS50279; BPTI_KUNITZ_2; 1	P05067	REACT_111102; Signal Transduction; REACT_116125; Disease; REACT_604; Hemostasis; REACT_6900; Immune System			SM00006; A4_EXTRA; 1; SM00131; KU; 1	P05067; 26-192, 287-342, 371-566, 672-770	P05067	SSF56491; A4_extra; 1; SSF89811; Amyloid_glyco_Cu-bd; 1; SSF57362; Prot_inh_Kunz-m; 1; SSF109843; SSF109843; 1	P05067	1.C.50.1.2; amyloid beta,-protein peptide (Abeta,PP) family			uc002ylz.3; human; uc002yma.3; human; uc002ymb.3; human; uc010glj.3; human; uc011acj.2; human; uc021whz.1; human; uc021wia.1; human; uc021wib.1; human	Hs.434980
A7L3B_HUMAN	Q96GX2;	RecName: Full=Putative ataxin-7-like protein 3B;	NP_001129734.1	NM_001136262.1										97	10771	Q96GX2						Q96GX2						552889								AC025257; -; NOT_ANNOTATED_CDS; Genomic_DNA; BC009111; AAH09111.1; ALT_SEQ; mRNA			GC12P074931	552889	ENSGT00390000012202					HGNC:37931; ATXN7L3B							Q96GX2; 1		IPI00062860	hsa:552889					112362	NX_Q96GX2				EOG4XSKRD							PA165512339	Q96GX2					Q96GX2																uc001sxd.4; human	Hs.727494
AA1R_HUMAN	P30542; A6NFY5; A6NGP4; A8K1L3; B3KXQ4; Q6FHK3; Q8TAM8;	RecName: Full=Adenosine receptor A1;	NP_000665.1; NP_001041695.1	NM_000674.2; NM_001048230.1		ENST00000309502; ENST00000337894; ENST00000367236	ENSP00000308549; ENSP00000338435; ENSP00000356205	ENSG00000163485; ENSG00000163485; ENSG00000163485						326	36512	P30542	A6NFY5	A6NGP4	A8K1L3		P30542	P30542				HS_ADORA1		134			231473	134		DB01223; Aminophylline; DB00201; Caffeine; DB04932; Defibrotide; DB00996; Gabapentin; DB00458; Imipramine; DB00061; Pegademase bovine; DB00277; Theophylline	NOG284456	S45235; AAB23388.1; -; mRNA; S56143; AAB25533.2; -; mRNA; L22214; AAA17544.1; -; mRNA; X68485; CAA48503.1; -; mRNA; AB004662; BAA20433.1; -; mRNA; AK127752; BAG54566.1; -; mRNA; AK289928; BAF82617.1; -; mRNA; AY136746; AAN01272.1; -; mRNA; BT019854; AAV38657.1; -; mRNA; CR541749; CAG46549.1; -; mRNA; AC105940; -; NOT_ANNOTATED_CDS; Genomic_DNA; CH471067; EAW91465.1; -; Genomic_DNA; BC026340; AAH26340.1; -; mRNA			GC01P203059	134	ENSGT00550000074524	P30542	ENSG00000163485; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0008624; P:induction of apoptosis by extracellular signals; TAS:ProtInc; GO:0006954; P:inflammatory response; TAS:ProtInc; GO:0007399; P:nervous system development; TAS:ProtInc; GO:0006909; P:phagocytosis; TAS:ProtInc	HGNC:262; ADORA1	HIX0001486		HBG106962			P30542	P30542; 2	IPR000276; 7TM_GPCR_Rhodpsn; IPR001068; Adeno_A1_rcpt; IPR001634; Adenosn_rcpt; IPR017452; GPCR_Rhodpsn_supfam	IPI00026872; IPI00645335	hsa:134	K04265		102775; gene	MINT-138736	537	NX_P30542		IAGCWIL		EOG4BVRV7						PF00001; 7tm_1; 1	PA24583		P30542	A53005; A53005			P30542	PR00552; ADENOSINEA1R; PR00424; ADENOSINER; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P30542	REACT_111102; Signal Transduction				P30542; 10-319	P30542						uc001gze.1; human	Hs.77867
AA2AR_HUMAN	P29274; B2R7E0;	RecName: Full=Adenosine receptor A2a;	NP_000666.2	NM_000675.4		ENST00000337539	ENSP00000336630	ENSG00000128271						412	44707	P29274	B2R7E0					P29274				HS_ADORA2A		135			543740	135		DB00201; Caffeine; DB04932; Defibrotide; DB00061; Pegademase bovine; DB00277; Theophylline	NOG287824	M97370; AAA58356.1; ALT_INIT; mRNA; X68486; CAA48504.1; -; mRNA; S46950; AAB23956.1; -; mRNA; U40771; AAA83270.1; -; Genomic_DNA; U40770; AAA83270.1; JOINED; Genomic_DNA; AY136747; AAN01273.1; -; mRNA; CR456367; CAG30253.1; -; mRNA; BT006999; AAP35645.1; -; mRNA; AK312946; BAG35787.1; -; mRNA; CH471095; EAW59658.1; -; Genomic_DNA; BC013780; AAH13780.1; -; mRNA	P29274		GC22P024813	135	ENSGT00550000074524	P29274	ENSG00000128271; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0044446; C:intracellular organelle part; IDA:UniProtKB; GO:0005624; C:membrane fraction; TAS:ProtInc; GO:0019899; F:enzyme binding; IPI:UniProtKB; GO:0001609; F:G-protein coupled adenosine receptor activity; IEA:InterPro; GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome; GO:0006915; P:apoptotic process; TAS:ProtInc; GO:0008015; P:blood circulation; TAS:ProtInc; GO:0007596; P:blood coagulation; TAS:ProtInc; GO:0006171; P:cAMP biosynthetic process; TAS:ProtInc; GO:0007267; P:cell-cell signaling; TAS:ProtInc; GO:0006968; P:cellular defense response; TAS:ProtInc; GO:0007417; P:central nervous system development; TAS:ProtInc; GO:0007188; P:G-protein signaling, coupled to cAMP nucleotide second messenger; TAS:ProtInc; GO:0006954; P:inflammatory response; TAS:ProtInc; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome; GO:0006909; P:phagocytosis; TAS:ProtInc; GO:0007600; P:sensory perception; TAS:ProtInc	HGNC:263; ADORA2A		HBG445348	HBG106962			P29274	P29274; 8	IPR000276; 7TM_GPCR_Rhodpsn; IPR001513; Adeno_A2A_rcpt; IPR001634; Adenosn_rcpt; IPR017452; GPCR_Rhodpsn_supfam	IPI00020974	hsa:135	K04266		102776; gene	MINT-4823612	543	NX_P29274		PGVWANG					1MMH; Model; -; 1=6-36, 2=42-69, 3=78-102, 4=117-143, 5=175-203, 6=233-260, 7=264-296; 1UPE; Model; -; A=1-304; 2YDO; X-ray; 3.00 A; A=1-317; 2YDV; X-ray; 2.60 A; A=1-317; 3EML; X-ray; 2.60 A; A=2-316; 3PWH; X-ray; 3.30 A; A=1-317; 3QAK; X-ray; 2.71 A; A=2-316; 3REY; X-ray; 3.31 A; A=1-317; 3RFM; X-ray; 3.60 A; A=1-317; 3VG9; X-ray; 2.70 A; A=1-316; 3VGA; X-ray; 3.10 A; A=1-316	1MMH; 1UPE; 2YDO; 2YDV; 3EML; 3PWH; 3QAK; 3REY; 3RFM; 3VG9; 3VGA		PF00001; 7tm_1; 1	PA24584	P29274	P29274	A48978; A48978			P29274	PR00553; ADENOSINA2AR; PR00424; ADENOSINER; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P29274	REACT_111102; Signal Transduction				P29274; 6-310	P29274						uc002zzx.3; human	Hs.197029
AA2BR_HUMAN	P29275;	RecName: Full=Adenosine receptor A2b;	NP_000667.1	NM_000676.2		ENST00000304222	ENSP00000304501	ENSG00000170425						332	36333	P29275					P29275	P29275				HS_ADORA2B		136			112938	136		DB04932; Defibrotide; DB00824; Enprofylline; DB00061; Pegademase bovine; DB00277; Theophylline	NOG287824	M97759; AAA51598.1; -; mRNA; X68487; CAA48505.1; -; mRNA; AY136748; AAN01274.1; -; mRNA; BC025722; AAH25722.1; -; mRNA			GC17P015788	136	ENSGT00550000074524	P29275	ENSG00000170425; Homo sapiens		GO:0005887; C:integral to plasma membrane; TAS:ProtInc; GO:0000187; P:activation of MAPK activity; TAS:ProtInc; GO:0006968; P:cellular defense response; TAS:ProtInc; GO:0007588; P:excretion; TAS:ProtInc; GO:0007254; P:JNK cascade; TAS:ProtInc	HGNC:264; ADORA2B	HIX0013564	HBG445348	HBG106962			P29275	P29275; 2	IPR000276; 7TM_GPCR_Rhodpsn; IPR001435; Adeno_A2B_rcpt; IPR001634; Adenosn_rcpt; IPR017452; GPCR_Rhodpsn_supfam	IPI00020976	hsa:136	K04267		600446; gene		547	NX_P29275		CTDFHSC		EOG4FBHTB						PF00001; 7tm_1; 1	PA24585		P29275	JC1229; JC1229			P29275	PR00554; ADENOSINA2BR; PR00424; ADENOSINER; PR00237; GPCRRHODOPSN		PS00237; G_PROTEIN_RECEP_F1_1; 1; PS50262; G_PROTEIN_RECEP_F1_2; 1	P29275	REACT_111102; Signal Transduction				P29275; 8-310	P29275						uc002gpd.1; human	Hs.167046
AA3RB_HUMAN	Q6P2N6; Q5QNY7;	RecName: Full=Protein ADORA3, isoform 3;	NP_001075445.1	NM_001081976.1		ENST00000369717	ENSP00000358731	ENSG00000121933						266	30327	Q6P2N6	Q5QNY7				Q6P2N6	Q6P2N6						140				140				AL390195; CAI15626.1; -; Genomic_DNA; AL391063; CAI15626.1; JOINED; Genomic_DNA; AL391063; CAI22964.1; -; Genomic_DNA; AL390195; CAI22964.1; JOINED; Genomic_DNA; CH471122; EAW56500.1; ALT_INIT; Genomic_DNA; BC041707; AAH41707.1; ALT_INIT; mRNA; BC064411; AAH64411.1; ALT_INIT; mRNA		G3DSA:2.60.40.10; Ig-like_fold; 1		140					GO:0004872; F:receptor activity; IEA:UniProtKB-KW	HGNC:268; ADORA3			HBG058258					IPR013783; Ig-like_fold	IPI00645655	hsa:140	K04268		600445; gene		553												PA24589						Q6P2N6				Q6P2N6						Q6P2N6							Hs.281342
